<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Public Health</journal-id><journal-id journal-id-type="iso-abbrev">BMC Public Health</journal-id><journal-title-group><journal-title>BMC Public Health</journal-title></journal-title-group><issn pub-type="epub">1471-2458</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24962204</article-id><article-id pub-id-type="pmc">4099157</article-id><article-id pub-id-type="publisher-id">1471-2458-14-643</article-id><article-id pub-id-type="doi">10.1186/1471-2458-14-643</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Beydoun</surname><given-names>May A</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>baydounm@mail.nih.gov</email></contrib><contrib contrib-type="author" id="A2"><name><surname>Beydoun</surname><given-names>Hind A</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>baydouha@evms.edu</email></contrib><contrib contrib-type="author" id="A3"><name><surname>Gamaldo</surname><given-names>Alyssa A</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>gamaldoaa@mail.nih.gov</email></contrib><contrib contrib-type="author" id="A4"><name><surname>Teel</surname><given-names>Alison</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>TeelAL@evms.edu</email></contrib><contrib contrib-type="author" id="A5"><name><surname>Zonderman</surname><given-names>Alan B</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>zondermana@mail.nih.gov</email></contrib><contrib contrib-type="author" id="A6"><name><surname>Wang</surname><given-names>Youfa</given-names></name><xref ref-type="aff" rid="I3">3</xref><xref ref-type="aff" rid="I4">4</xref><email>youfawan@buffalo.edu</email></contrib></contrib-group><aff id="I1"><label>1</label>Laboratory of Epidemiology and Population Sciences, National Institute on Aging, NIA/NIH/IRP, 251 Bayview Blvd., Suite 100, Room #: 04B118, Baltimore, MD 21224, USA</aff><aff id="I2"><label>2</label>Graduate program in Public Health, Eastern Virginia Medical School, Norfolk, VA, UK</aff><aff id="I3"><label>3</label>Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, State University of New York, New York, USA</aff><aff id="I4"><label>4</label>John Hopkins Global Center on Childhood Obesity, Where Systems Science Meets Public Health, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA</aff><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>24</day><month>6</month><year>2014</year></pub-date><volume>14</volume><fpage>643</fpage><lpage>643</lpage><history><date date-type="received"><day>11</day><month>9</month><year>2013</year></date><date date-type="accepted"><day>13</day><month>5</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2014 Beydoun et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Beydoun et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xlink:href="http://www.biomedcentral.com/1471-2458/14/643"/><abstract><sec><title>Background</title><p>Cognitive impairment, including dementia, is a major health concern with the increasing aging population. Preventive measures to delay cognitive decline are of utmost importance. Alzheimer&#x02019;s disease (AD) is the most frequent cause of dementia, increasing in prevalence from &#x0003c;1% below the age of 60&#x000a0;years to &#x0003e;40% above 85&#x000a0;years of age.</p></sec><sec><title>Methods</title><p>We systematically reviewed selected modifiable factors such as education, smoking, alcohol, physical activity, caffeine, antioxidants, homocysteine (Hcy), <italic>n</italic>-3 fatty acids that were studied in relation to various cognitive health outcomes, including incident AD. We searched MEDLINE for published literature (January 1990 through October 2012), including cross-sectional and cohort studies (sample sizes&#x02009;&#x0003e;&#x02009;300). Analyses compared study finding consistency across factors, study designs and study-level characteristics. Selecting studies of incident AD, our meta-analysis estimated pooled risk ratios (RR), population attributable risk percent (PAR%) and assessed publication bias.</p></sec><sec><title>Results</title><p>In total, 247 studies were retrieved for systematic review. Consistency analysis for each risk factor suggested positive findings ranging from ~38.9% for caffeine to ~89% for physical activity. Education also had a significantly higher propensity for &#x0201c;a positive finding&#x0201d; compared to caffeine, smoking and antioxidant-related studies. Meta-analysis of 31 studies with incident AD yielded pooled RR for low education (RR&#x02009;=&#x02009;1.99; 95% CI: 1.30-3.04), high Hcy (RR&#x02009;=&#x02009;1.93; 95% CI: 1.50-2.49), and current/ever smoking status (RR&#x02009;=&#x02009;1.37; 95% CI: 1.23-1.52) while indicating protective effects of higher physical activity and <italic>n</italic>-3 fatty acids. Estimated PAR% were particularly high for physical activity (PAR%&#x02009;=&#x02009;31.9; 95% CI: 22.7-41.2) and smoking (PAR%=31.09%; 95% CI: 17.9-44.3). Overall, no significant publication bias was found.</p></sec><sec><title>Conclusions</title><p>Higher Hcy levels, lower educational attainment, and decreased physical activity were particularly strong predictors of incident AD. Further studies are needed to support other potential modifiable protective factors, such as caffeine.</p></sec></abstract><kwd-group><kwd>Cognition</kwd><kwd>Dementia</kwd><kwd>Alzheimer&#x02019;s disease</kwd><kwd>Risk factor</kwd><kwd>Nutrition</kwd><kwd>Meta-analysis</kwd></kwd-group></article-meta></front><body><sec><title>Background</title><p>Cognitive function refers to those mental processes that are crucial for the conduct of the activities of daily living. Such mental processes include attention, short-term and long-term memory, reasoning, coordination of movement and planning of tasks [<xref ref-type="bibr" rid="B1">1</xref>]. The prevalence of brain disorders affecting cognition (such as stroke and dementia) increases steadily in a linear fashion with age [<xref ref-type="bibr" rid="B2">2</xref>]. Cognitive impairment is a major health concern affecting loss of independence in daily activities in old age. Thus, special attention should be devoted to its prevention [<xref ref-type="bibr" rid="B3">3</xref>].</p><p>Dementia is relatively frequent in the elderly population and was shown to affect about 6.4% of European subjects over the age of 65&#x000a0;years [<xref ref-type="bibr" rid="B4">4</xref>]. A review of 50 original articles published between 1989 and 2002 using international data showed that prevalence of dementia for the very old group (85&#x000a0;years and over) varied from 16.7% in China [<xref ref-type="bibr" rid="B5">5</xref>] to 43% in Germany [<xref ref-type="bibr" rid="B6">6</xref>]. This variability was also reflected within separate age groups among the very old, ranging from 9.6% to 32% for the 85&#x02013;89 age category and from 41% to 58% for the 95+ age group. Incidence varied between 47 and 116.6 per 1000 and a separate meta-analytic study estimated the incidence in that age group (i.e. 85+) to be around 104 per 1000 [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>].</p><p>Alzheimer&#x02019;s disease (AD) is the most frequent cause of dementia, increasing in prevalence from less than 1% below the age of 60&#x000a0;years to more than 40% above 85&#x000a0;years of age. The initial phase is generally marked by a progressive deterioration of episodic memory. Other impairments may be entirely absent in the beginning or consist of mild disturbances in naming and executive function. When the process advances, impairment spreads to other aspects of memory and other domains of cognition. Despite lack of curative treatment, epidemiological evidence reveals important risk factors for sporadic AD, many of which are non-modifiable (e.g. ApoE <italic>&#x003f5;4</italic>, age and sex). This highlights the importance for further evaluation of modifiable risk and preventive factors in that these potential factors may not only delay the onset of cognitive decline, but also can be easily treated. Aside from AD, less frequently occurring forms of dementia include vascular dementia (VaD), mixed dementia, dementia with Lewy bodies (DLB) and Parkinson&#x02019;s disease with dementia (PD-D), diagnostic criteria for which are described in Table&#x000a0;<xref ref-type="table" rid="T1">1</xref>. The relative prevalence of AD and VaD and the mixed version of both remain debatable. Ott and colleagues [<xref ref-type="bibr" rid="B9">9</xref>] estimated that for the very old, the prevalence of AD was 26.8% while that of VaD was 4.4%. However, VaD appears to be more frequent than AD in certain Japanese and Chinese populations [<xref ref-type="bibr" rid="B10">10</xref>].</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Diagnostic criteria of Alzheimer&#x02019;s Disease (AD), Vascular Dementia (VaD), Mixed dementia (MD) and other dementias</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/></colgroup><thead valign="top"><tr><th align="left"><bold>Diagnosis</bold></th><th align="left"><bold>Criteria</bold></th></tr></thead><tbody valign="top"><tr><td rowspan="6" align="left" valign="bottom"><italic>Alzheimer&#x02019;s disease (AD)</italic> (NINCDS-ADRDA) <italic>Source</italic>[<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>]:<hr/></td><td align="left" valign="bottom">Development of multiple cognitive deficits, with both memory impairment and one (or more) of the following cognitive disturbances:<hr/></td></tr><tr><td align="left" valign="bottom">Aphasia (language disturbance)<hr/></td></tr><tr><td align="left" valign="bottom">Apraxia (learned motor skills disturbance)<hr/></td></tr><tr><td align="left" valign="bottom">Agnosia (visuospatial/sensory disturbance)<hr/></td></tr><tr><td align="left" valign="bottom">Executive functioning (foresight, planning, insight anticipation)<hr/></td></tr><tr><td align="left" valign="bottom">Significant impairment in social or occupational functioning, representing a significant decline from a previous level of functioning<hr/></td></tr><tr><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">Other diagnostic criteria: Hachinski Ischemic Score, ICD-10; DSM-IV; ADDTC; updated NINCDS-ADRDA<hr/></td></tr><tr><td rowspan="4" align="left" valign="bottom"><italic>Vascular Dementia (VaD)</italic> (NINDS-AIREN) <italic>Source</italic>[<xref ref-type="bibr" rid="B13">13</xref>]:<hr/></td><td align="left" valign="bottom">Cognitive decline from previous higher level of function in three areas of function including memory.<hr/></td></tr><tr><td align="left" valign="bottom">Evidence of cerebrovascular disease by examination<hr/></td></tr><tr><td align="left" valign="bottom">Evidence of cerebrovascular disease by neuroimaging<hr/></td></tr><tr><td align="left" valign="bottom">Onset either abrupt or within three months of a recognized stroke.<hr/></td></tr><tr><td rowspan="9" align="left" valign="bottom"><italic>Vascular Dementia (VaD)</italic> (Modified Hachinski Ischemia Score: &#x02265;4) <italic>Source</italic>[<xref ref-type="bibr" rid="B14">14</xref>]:<hr/></td><td align="left" valign="bottom">Two-point items<hr/></td></tr><tr><td align="left" valign="bottom">Abrupt onset<hr/></td></tr><tr><td align="left" valign="bottom">History of stroke<hr/></td></tr><tr><td align="left" valign="bottom">Focal neurologic symptoms<hr/></td></tr><tr><td align="left" valign="bottom">One-point items<hr/></td></tr><tr><td align="left" valign="bottom">Stepwise deterioration<hr/></td></tr><tr><td align="left" valign="bottom">Somatic complaints<hr/></td></tr><tr><td align="left" valign="bottom">History of hypertension<hr/></td></tr><tr><td align="left" valign="bottom">Emotional incontinence<hr/></td></tr><tr><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">Other diagnostic criteria: ICD-10; DSM-IV<hr/></td></tr><tr><td align="left" valign="bottom"><italic>Mixed Dementias (MDs)</italic><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">Hachinski Ischemic score<hr/></td><td align="left" valign="bottom">Score based on clinical features: &#x02264;4&#x02009;=&#x02009;AD; &#x02265;7&#x02009;=&#x02009;VaD; intermediate score of 5 or 6&#x02009;=&#x02009;MD.<hr/></td></tr><tr><td align="left" valign="bottom">ICD-10<hr/></td><td align="left" valign="bottom">Cases that met criteria for VaD and AD<hr/></td></tr><tr><td align="left" valign="bottom">DSM-IV<hr/></td><td align="left" valign="bottom">Cases with criteria for primary degenerative dementia of the Alzheimer type and clinical or neuroimagery feature of VaD.<hr/></td></tr><tr><td align="left" valign="bottom">ADDTC<hr/></td><td align="left" valign="bottom">Presence of ischemic vascular disease and a second systemic or brain disorder.<hr/></td></tr><tr><td align="left" valign="bottom">NINDS-AIREN<hr/></td><td align="left" valign="bottom">Typical AD associated with clinical and radiological evidence of stroke.<hr/></td></tr><tr><td align="left" valign="bottom"><italic>Other Dementias</italic><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td rowspan="7" align="left" valign="bottom"><italic>Fronto-Parietal Dementia (FTD) Source</italic>[<xref ref-type="bibr" rid="B15">15</xref>]:<hr/></td><td align="left" valign="bottom">Behavioral or cognitive deficits manifested by either <bold>(1)</bold> or <bold>(2)</bold>:<hr/></td></tr><tr><td align="left" valign="bottom"><bold>(1)</bold> Early and progressive personality change, with problems in modulating behavior; inappropriate responses/activities.<hr/></td></tr><tr><td align="left" valign="bottom"><bold>(2)</bold> Early and progressive language changes, with problems in language expression, word meaning, severe dysnomia.<hr/></td></tr><tr><td align="left" valign="bottom">Deficits represent a decline from baseline and cause significant impairment in social and occupational functioning.<hr/></td></tr><tr><td align="left" valign="bottom">Course characterized by gradual onset and continuing decline in function.<hr/></td></tr><tr><td align="left" valign="bottom">Other causes (eg, stroke, delirium) are excluded<hr/></td></tr><tr><td align="left" valign="bottom">Gradual onset and progressive cognitive decline.<hr/></td></tr><tr><td align="left" valign="bottom"><italic>Dementia with Lewy Bodies (DLB)</italic> (Consensus Guidelines for the Clinical Diagnosis for Dementia with Lewy Bodies) <italic>Source</italic>[<xref ref-type="bibr" rid="B16">16</xref>]:<hr/></td><td align="left" valign="bottom">Fluctuating in cognitive performance: Marked variation in cognition or function, or episodic confusion/decreased responsiveness.<hr/></td></tr><tr><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">Visual hallucinations: Usually well formed, unprovoked, benign.<hr/></td></tr><tr><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">Parkinsonism: Can be identical to Parkinson&#x02019;s Disease (PD), milder or symmetric.<hr/></td></tr><tr><td align="left" valign="bottom"><italic>Parkinson&#x02019;s Disease with Dementia (PD-D) Source</italic>[<xref ref-type="bibr" rid="B17">17</xref>]:<hr/></td><td align="left" valign="bottom">Bradyphrenia (slowness of thought)<hr/></td></tr><tr><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">Executive impairment<hr/></td></tr><tr><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">Neuropsychiatric symptoms<hr/></td></tr><tr><td align="left">&#x000a0;</td><td align="left">Dysphonia</td></tr></tbody></table><table-wrap-foot><p><italic>Sources</italic>[<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B18">18</xref>]:.</p><p><bold>
<italic>Abbreviations: </italic>
</bold><bold>ADDTC:</bold> Alzheimer's Disease Diagnostic and Treatment Centers; <bold>DSM-IV</bold>: Diagnostic and Statistical Manual, 4<sup>th</sup> edition; <bold>ICD-10</bold>: International Classification of Disease, 10<sup>th</sup> edition; <bold>NINCDS-ADRDA</bold>: National Institute of Neurological and Communicative Disorders and Stroke -- the Alzheimer's Disease and Related Disorders Association; <bold>NINDS-AIREN</bold>: National Institute of Neurological and Communicative Disorders and Stroke--Association Internationale pour la Recherche et l&#x02019;Enseignement en Neurosciences; <bold>PD-D</bold>: Parkinson&#x02019;s disease with dementia.</p></table-wrap-foot></table-wrap><p>The present review focuses on selected modifiable risk and protective factors of cognitive impairment, cognitive decline and dementia (including AD), given that they are commonly studied and provide reliable and comparable data. In particular, we focused on the risk and protective factors that could be grouped under three broad categories, namely socioeconomic, behavioral, and nutritional. Consequently, other known risk factors that are modifiable but did not fall under these categories were excluded (e.g. obesity, type 2 diabetes, hypertension, depression, traumatic head injury etc.). In addition, the latter risk factors are potential mediating factors in the causal pathway between our selected factors and cognitive outcomes (e.g. obesity, depression, type 2 diabetes and hypertension may be on the causal pathway between physical activity and cognition; the same for diet&#x02192;depression, obesity, type 2 diabetes, hypertension&#x02192;cognition) and thus are more appropriately studied together rather than with their antecedent putative causes. This is the first study to systematically review those selected modifiable risk and protective factors for cognitive health outcomes in cross-sectional and cohort studies while comparing the consistency of association between those factors and across study-level characteristics. It is also among few recent studies to compare the strength of association across those factors in relation to incident AD using a similar approach [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref>]. Our findings could help guide future research and interventions.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Literature search</title><p>Using MEDLINE, we conducted a systematic review of the literature on cognitive function, decline and dementia focusing on specific risk factors. We considered both original research published between January 1990 and October 2012. We did not include titles prior to 1990 to ensure that diagnostic criteria for dementia and AD were comparable across studies. After an initial search using MESH keywords for risk factors (i.e. education, smoking, physical activity, caffeine/coffee/tea, alcohol, antioxidant/vitamin E, homocysteine and fatty acid) and a title containing the words (cognitive, dementia and Alzheimer), we assessed the retrieved papers for relevance by reading the titles and abstracts. Among those that were selected for review, information was retrieved including study design, contextual setting, sample size, main outcome and key findings.</p><p>Final inclusion criteria were: <bold>(1)</bold> Study sample size&#x02009;&#x0003e;&#x02009;300. Although this number is arbitrary, it was based on the fact that some study outcomes were relatively rare (e.g. incident AD: &#x0003c;10%) and thus a smaller sample size for a cohort study for example might yield an underpowered study, depending on the distribution of the risk factor. <bold>(2)</bold> Study design is either cross-sectional or cohort study (thus case-control studies, review articles, commentaries, and basic science papers were excluded); <bold>(3)</bold> Outcomes include dementia, AD, cognitive function, cognitive decline or cognitive impairment (including MCI)). Although all types of dementia were presented in our description of selected studies, focus was on the more prevalent sub-types including AD and VaD <bold>(4)</bold> Baseline sample includes general healthy population rather than special groups at risk (e.g. coronary heart disease patients). For the &#x0201c;cognitive decline&#x0201d; and &#x0201c;cognitive function&#x0201d; outcomes, we searched risk factors in the title to expand the range of studies selected beyond those based just on MESH keywords (i.e. &#x0201c;caffeine,&#x0201d; &#x0201c;alcohol&#x0201d; and all other risk factors were also searched in titles when the outcome was &#x0201c;cognitive&#x0201d;). Both cohort and cross-sectional studies that were selected are presented in Table&#x000a0;<xref ref-type="table" rid="T2">2</xref>. The MEDLINE search and the studies excluded are laid out in Figure&#x000a0;<xref ref-type="fig" rid="F1">1</xref>, showing main reasons for exclusion and final number of studies included for each risk factor. After inclusion of a study, we did not examine cross-references in order to ensure the comparability of the search strategy between risk factors.</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Summary of epidemiologic studies of risk and protective factors for cognitive outcomes included in the review</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead valign="top"><tr><th align="left"><bold>Study</bold></th><th align="left"><bold>Age/gender</bold></th><th align="left"><bold>Year</bold></th><th align="left"><bold>Country</bold></th><th align="left"><bold>Study design</bold></th><th align="left"><bold>Sample size</bold></th><th align="left"><bold>Outcomes</bold></th><th align="left"><bold>Findings</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="bottom"><italic>(1) Education</italic><hr/></td><td colspan="7" align="left" valign="bottom"><italic>Hypothesis: Lower education is associated with lower cognitive function or higher rate of cognitive decline or increased risk of dementia(including AD)</italic><hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B21">21</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">1990<hr/></td><td align="left" valign="bottom">China<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;5,055<hr/></td><td align="left" valign="bottom">Prevalent AD and dementia<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B22">22</xref>]<hr/></td><td align="left" valign="bottom">Mean:58.5/B<hr/></td><td align="left" valign="bottom">1991<hr/></td><td align="left" valign="bottom">Nigeria<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,350<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B23">23</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">1992<hr/></td><td align="left" valign="bottom">France<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;2,792<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B24">24</xref>]<hr/></td><td align="left" valign="bottom">68-77/B<hr/></td><td align="left" valign="bottom">1992<hr/></td><td align="left" valign="bottom">Finland<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;403<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B25">25</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">1993<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;4,485<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B26">26</xref>]<hr/></td><td align="left" valign="bottom">75+/B<hr/></td><td align="left" valign="bottom">1994<hr/></td><td align="left" valign="bottom">England<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,195<hr/></td><td align="left" valign="bottom">Indicent dementia<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B27">27</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">1994<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;10,294<hr/></td><td align="left" valign="bottom">Incident cognitive impairment<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B28">28</xref>]<hr/></td><td align="left" valign="bottom">55+/B<hr/></td><td align="left" valign="bottom">1995<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;3,330<hr/></td><td align="left" valign="bottom">Incident AD and VaD<hr/></td><td align="left" valign="bottom">+(VaD)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B29">29</xref>]<hr/></td><td align="left" valign="bottom">18+/B<hr/></td><td align="left" valign="bottom">1995<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;14,883<hr/></td><td align="left" valign="bottom">Indicent dementia<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B9">9</xref>]<hr/></td><td align="left" valign="bottom">55-106/B<hr/></td><td align="left" valign="bottom">1995<hr/></td><td align="left" valign="bottom">The Netherlands<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;7,528<hr/></td><td align="left" valign="bottom">Prevalent dementia, AD and VaD<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B30">30</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">1996<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;2,212<hr/></td><td align="left" valign="bottom">Prevalent dementia and cognitive impairment<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B31">31</xref>]<hr/></td><td align="left" valign="bottom">68-78/B<hr/></td><td align="left" valign="bottom">1996<hr/></td><td align="left" valign="bottom">Finland<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;403<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B32">32</xref>]<hr/></td><td align="left" valign="bottom">70+/B<hr/></td><td align="left" valign="bottom">1997<hr/></td><td align="left" valign="bottom">Australia<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;652<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B33">33</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">1997<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;642<hr/></td><td align="left" valign="bottom">Incident AD<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B34">34</xref>]<hr/></td><td align="left" valign="bottom">50-80/B<hr/></td><td align="left" valign="bottom">1997<hr/></td><td align="left" valign="bottom">Austria<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,927<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B35">35</xref>]<hr/></td><td align="left" valign="bottom">Mean:75/M<hr/></td><td align="left" valign="bottom">1997<hr/></td><td align="left" valign="bottom">The Netherlands<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;528<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B36">36</xref>]<hr/></td><td align="left" valign="bottom">69-74/M<hr/></td><td align="left" valign="bottom">1997<hr/></td><td align="left" valign="bottom">Sweden<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;504<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B37">37</xref>]<hr/></td><td align="left" valign="bottom">55-84/B<hr/></td><td align="left" valign="bottom">1997<hr/></td><td align="left" valign="bottom">The Netherlands<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;5,825<hr/></td><td align="left" valign="bottom">Cognitive function, decline and incident/prevalent dementia<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B38">38</xref>]<hr/></td><td align="left" valign="bottom">65-84/B<hr/></td><td align="left" valign="bottom">1997<hr/></td><td align="left" valign="bottom">The Netherlands<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;2,063<hr/></td><td align="left" valign="bottom">Incident dementia<hr/></td><td align="left" valign="bottom">+(IQ better predcitor)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B39">39</xref>]<hr/></td><td align="left" valign="bottom">47-68/B<hr/></td><td align="left" valign="bottom">1998<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;14,000<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B40">40</xref>]<hr/></td><td align="left" valign="bottom">60+/B<hr/></td><td align="left" valign="bottom">1998<hr/></td><td align="left" valign="bottom">Italy<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;495<hr/></td><td align="left" valign="bottom">Prevalent dementia<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B41">41</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">1998<hr/></td><td align="left" valign="bottom">Taiwan<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;2,915<hr/></td><td align="left" valign="bottom">Prevalent dementia, AD and VaD<hr/></td><td align="left" valign="bottom">+(AD)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B42">42</xref>]<hr/></td><td align="left" valign="bottom">18+/B<hr/></td><td align="left" valign="bottom">1999<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,488<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B43">43</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">1999<hr/></td><td align="left" valign="bottom">France<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;3,675<hr/></td><td align="left" valign="bottom">Incident AD<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B44">44</xref>]<hr/></td><td align="left" valign="bottom">55-106/B<hr/></td><td align="left" valign="bottom">1999<hr/></td><td align="left" valign="bottom">The Netherlands<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;6,827<hr/></td><td align="left" valign="bottom">Incident dementia<hr/></td><td align="left" valign="bottom">+(women)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B45">45</xref>]<hr/></td><td align="left" valign="bottom">85+/B<hr/></td><td align="left" valign="bottom">2000<hr/></td><td align="left" valign="bottom">Sweden<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;494<hr/></td><td align="left" valign="bottom">Cognitive decline and function<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B46">46</xref>]<hr/></td><td align="left" valign="bottom">75+/B<hr/></td><td align="left" valign="bottom">2001<hr/></td><td align="left" valign="bottom">Sweden<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,296<hr/></td><td align="left" valign="bottom">Incident dementia and AD<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B47">47</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2002<hr/></td><td align="left" valign="bottom">Spain<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;557<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B48">48</xref>]<hr/></td><td align="left" valign="bottom">70+/B<hr/></td><td align="left" valign="bottom">2002<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;6,577<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B49">49</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2002<hr/></td><td align="left" valign="bottom">Brazil<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,656<hr/></td><td align="left" valign="bottom">Prevalent dementia and AD<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B50">50</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2002<hr/></td><td align="left" valign="bottom">Italy<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,016<hr/></td><td align="left" valign="bottom">Prevalent AD and VaD<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B51">51</xref>]<hr/></td><td align="left" valign="bottom">45-59/M<hr/></td><td align="left" valign="bottom">2002<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,839<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B52">52</xref>]<hr/></td><td align="left" valign="bottom">70-79/W<hr/></td><td align="left" valign="bottom">2003<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;19,319<hr/></td><td align="left" valign="bottom">Cognitive function and decline<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B53">53</xref>]<hr/></td><td align="left" valign="bottom">70-79/B<hr/></td><td align="left" valign="bottom">2005<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;4,030<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">+(ApoE-)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B54">54</xref>]<hr/></td><td align="left" valign="bottom">66+/W<hr/></td><td align="left" valign="bottom">2006<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;6,314<hr/></td><td align="left" valign="bottom">Cognitive function and decline<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B55">55</xref>]<hr/></td><td align="left" valign="bottom">Mean age: ~75/B<hr/></td><td align="left" valign="bottom">2006<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;2,786<hr/></td><td align="left" valign="bottom">Incident dementia<hr/></td><td align="left" valign="bottom">+(both whites and blacks)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B56">56</xref>]<hr/></td><td align="left" valign="bottom">55+/B<hr/></td><td align="left" valign="bottom">2006<hr/></td><td align="left" valign="bottom">China<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;34,807<hr/></td><td align="left" valign="bottom">Prevalent AD and VaD<hr/></td><td align="left" valign="bottom">+(AD)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B57">57</xref>]<hr/></td><td align="left" valign="bottom">50+/B<hr/></td><td align="left" valign="bottom">2006<hr/></td><td align="left" valign="bottom">China<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;16,095<hr/></td><td align="left" valign="bottom">Prevalent dementia and AD<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B58">58</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2007<hr/></td><td align="left" valign="bottom">Guam<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;2,789<hr/></td><td align="left" valign="bottom">Prevalent dementia and AD<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B59">59</xref>]<hr/></td><td align="left" valign="bottom">64-81/B<hr/></td><td align="left" valign="bottom">2007<hr/></td><td align="left" valign="bottom">The Netherlands<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;578<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B60">60</xref>]<hr/></td><td align="left" valign="bottom">60-64/B<hr/></td><td align="left" valign="bottom">2009<hr/></td><td align="left" valign="bottom">Australia<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;416<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B61">61</xref>]<hr/></td><td align="left" valign="bottom">30-64/B<hr/></td><td align="left" valign="bottom">2009<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,345<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+(literacy better predictor)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B62">62</xref>]<hr/></td><td align="left" valign="bottom">65-96/B<hr/></td><td align="left" valign="bottom">2009<hr/></td><td align="left" valign="bottom">Spain<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,074<hr/></td><td align="left" valign="bottom">Prevalent dementia<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B63">63</xref>]<hr/></td><td align="left" valign="bottom">80+/B<hr/></td><td align="left" valign="bottom">2009<hr/></td><td align="left" valign="bottom">UK<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;3,336<hr/></td><td align="left" valign="bottom">Incident dementia<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B64">64</xref>]<hr/></td><td align="left" valign="bottom">Mean:72/B<hr/></td><td align="left" valign="bottom">2009<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;6,000<hr/></td><td align="left" valign="bottom">Cognitive function and decline<hr/></td><td align="left" valign="bottom">+(cognitive function) 0(cognitive decline)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B65">65</xref>]<hr/></td><td align="left" valign="bottom">60+/B<hr/></td><td align="left" valign="bottom">2010<hr/></td><td align="left" valign="bottom">Malaysa<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;2,980<hr/></td><td align="left" valign="bottom">Prevalent dementia<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B66">66</xref>]<hr/></td><td align="left" valign="bottom">55+/B<hr/></td><td align="left" valign="bottom">2010<hr/></td><td align="left" valign="bottom">India<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;2,466<hr/></td><td align="left" valign="bottom">Prevalent dementia and AD<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B67">67</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2010<hr/></td><td align="left" valign="bottom">Brazil<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;2,003<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B68">68</xref>]<hr/></td><td align="left" valign="bottom">60+/B<hr/></td><td align="left" valign="bottom">2011<hr/></td><td align="left" valign="bottom">Brazil<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,461<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">-<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B69">69</xref>]<hr/></td><td align="left" valign="bottom">60-98/B<hr/></td><td align="left" valign="bottom">2011<hr/></td><td align="left" valign="bottom">Italy<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,270<hr/></td><td align="left" valign="bottom">Incident cognitive impairment<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B70">70</xref>]<hr/></td><td align="left" valign="bottom">60+/B<hr/></td><td align="left" valign="bottom">2011<hr/></td><td align="left" valign="bottom">Mexico<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;7,000<hr/></td><td align="left" valign="bottom">Prevalent and incident dementia<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B71">71</xref>]<hr/></td><td align="left" valign="bottom">54-95/B<hr/></td><td align="left" valign="bottom">2011<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,014<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">Study<hr/></td><td align="left" valign="bottom">Age/gender<hr/></td><td align="left" valign="bottom">Year<hr/></td><td align="left" valign="bottom">Country<hr/></td><td align="left" valign="bottom">Design<hr/></td><td align="left" valign="bottom">Sample size<hr/></td><td align="left" valign="bottom">Outcome<hr/></td><td align="left" valign="bottom">Finding<hr/></td></tr><tr><td align="left" valign="bottom"><italic>(2) Behavioral</italic><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom"><italic>(2.1.) Smoking</italic><hr/></td><td colspan="7" align="left" valign="bottom"><italic>Hypothesis: Current or ever smoking status is associated with lower cognitive function or higher rate of cognitive decline or increased risk of dementia(including AD)</italic><hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B72">72</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">1993<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,201<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B73">73</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">1994<hr/></td><td align="left" valign="bottom">France<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;3,770<hr/></td><td align="left" valign="bottom">Prevalent AD, cognitive impairment<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B74">74</xref>]<hr/></td><td align="left" valign="bottom">74+/B<hr/></td><td align="left" valign="bottom">1996<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;647<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B75">75</xref>]<hr/></td><td align="left" valign="bottom">Mean:58.6/M<hr/></td><td align="left" valign="bottom">1997<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;3,429<hr/></td><td align="left" valign="bottom">Cognitive impairment<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B36">36</xref>]<hr/></td><td align="left" valign="bottom">69-74/M<hr/></td><td align="left" valign="bottom">1997<hr/></td><td align="left" valign="bottom">Sweden<hr/></td><td align="left" valign="bottom">cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;504<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B76">76</xref>]<hr/></td><td align="left" valign="bottom">75+/B<hr/></td><td align="left" valign="bottom">1998<hr/></td><td align="left" valign="bottom">Australia<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;327<hr/></td><td align="left" valign="bottom">Incident dementia and AD<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B77">77</xref>]<hr/></td><td align="left" valign="bottom">adults/B<hr/></td><td align="left" valign="bottom">1998<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,469<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B78">78</xref>]<hr/></td><td align="left" valign="bottom">55+/B<hr/></td><td align="left" valign="bottom">1998<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;6,870<hr/></td><td align="left" valign="bottom">Incident dementia and AD<hr/></td><td align="left" valign="bottom">+(ApoE4<sup>&#x02212;</sup>)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B79">79</xref>]<hr/></td><td align="left" valign="bottom">56-69/M<hr/></td><td align="left" valign="bottom">1999<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;569<hr/></td><td align="left" valign="bottom">Cognitive impairment<hr/></td><td align="left" valign="bottom">+(ApoE4<sup>&#x02212;</sup>)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B80">80</xref>]<hr/></td><td align="left" valign="bottom">45-59/M<hr/></td><td align="left" valign="bottom">1999<hr/></td><td align="left" valign="bottom">UK<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,870<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B81">81</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2000<hr/></td><td align="left" valign="bottom">UK<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;889<hr/></td><td align="left" valign="bottom">Cognitive Impairment<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B82">82</xref>]<hr/></td><td align="left" valign="bottom">Mean: 81/M<hr/></td><td align="left" valign="bottom">2000<hr/></td><td align="left" valign="bottom">UK<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;34,439<hr/></td><td align="left" valign="bottom">Definite or probable AD<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B83">83</xref>]<hr/></td><td align="left" valign="bottom">45-70/B<hr/></td><td align="left" valign="bottom">2002<hr/></td><td align="left" valign="bottom">Netherlands<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,927<hr/></td><td align="left" valign="bottom">Cognitive change<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B84">84</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2003<hr/></td><td align="left" valign="bottom">Taiwan<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;798<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B85">85</xref>]<hr/></td><td align="left" valign="bottom">43-53/B<hr/></td><td align="left" valign="bottom">2003<hr/></td><td align="left" valign="bottom">UK<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;3,035<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B86">86</xref>]<hr/></td><td align="left" valign="bottom">Mean:78/M<hr/></td><td align="left" valign="bottom">2003<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;3,734<hr/></td><td align="left" valign="bottom">Incident AD<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B87">87</xref>]<hr/></td><td align="left" valign="bottom">60+/B<hr/></td><td align="left" valign="bottom">2003<hr/></td><td align="left" valign="bottom">China<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;3,012<hr/></td><td align="left" valign="bottom">Cognitive impairment<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B88">88</xref>]<hr/></td><td align="left" valign="bottom">60+/B<hr/></td><td align="left" valign="bottom">2004<hr/></td><td align="left" valign="bottom">China<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;2,820<hr/></td><td align="left" valign="bottom">Incident dementia and AD<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B89">89</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2004<hr/></td><td align="left" valign="bottom">European cohorts<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;17,610<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B90">90</xref>]<hr/></td><td align="left" valign="bottom">65-84/B<hr/></td><td align="left" valign="bottom">2004<hr/></td><td align="left" valign="bottom">Italy<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;5,632<hr/></td><td align="left" valign="bottom">Mild cognitive impairment<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B91">91</xref>]<hr/></td><td align="left" valign="bottom">40-80/M<hr/></td><td align="left" valign="bottom">2004<hr/></td><td align="left" valign="bottom">The Netherlands<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;900<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B92">92</xref>]<hr/></td><td align="left" valign="bottom">Mean:75/B<hr/></td><td align="left" valign="bottom">2005<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;791<hr/></td><td align="left" valign="bottom">Cognitive function and decline<hr/></td><td align="left" valign="bottom">+(75&#x02009;+&#x02009;and ApoE4<sup>&#x02212;</sup>)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B93">93</xref>]<hr/></td><td align="left" valign="bottom">40-44/B<hr/></td><td align="left" valign="bottom">2005<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;8,845<hr/></td><td align="left" valign="bottom">Incident dementia<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B94">94</xref>]<hr/></td><td align="left" valign="bottom">50+/B<hr/></td><td align="left" valign="bottom">2006<hr/></td><td align="left" valign="bottom">UK<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;2,000<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B95">95</xref>]<hr/></td><td align="left" valign="bottom">55+/B<hr/></td><td align="left" valign="bottom">2007<hr/></td><td align="left" valign="bottom">The Netherlands<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;6,868<hr/></td><td align="left" valign="bottom">Incident dementia and AD<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B96">96</xref>]<hr/></td><td align="left" valign="bottom">43-70/B<hr/></td><td align="left" valign="bottom">2008<hr/></td><td align="left" valign="bottom">The Netherlands<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,964<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B97">97</xref>]<hr/></td><td align="left" valign="bottom">35-55/B<hr/></td><td align="left" valign="bottom">2008<hr/></td><td align="left" valign="bottom">France<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;4,659<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+(memory)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B98">98</xref>]<hr/></td><td align="left" valign="bottom">46-70/B<hr/></td><td align="left" valign="bottom">2009<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;11,151<hr/></td><td align="left" valign="bottom">Incident dementia<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B99">99</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2009<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,557<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B100">100</xref>]<hr/></td><td align="left" valign="bottom">90-108/B<hr/></td><td align="left" valign="bottom">2009<hr/></td><td align="left" valign="bottom">China<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;681<hr/></td><td align="left" valign="bottom">Cognitive impairment<hr/></td><td align="left" valign="bottom">+(men)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B63">63</xref>]<hr/></td><td align="left" valign="bottom">Mean:83.5/B<hr/></td><td align="left" valign="bottom">2009<hr/></td><td align="left" valign="bottom">UK<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;3,336<hr/></td><td align="left" valign="bottom">Incident dementia<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B101">101</xref>]<hr/></td><td align="left" valign="bottom">65-79/B<hr/></td><td align="left" valign="bottom">2010<hr/></td><td align="left" valign="bottom">Finland<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,449<hr/></td><td align="left" valign="bottom">Incident dementia and AD<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B102">102</xref>]<hr/></td><td align="left" valign="bottom">Mean:71.8/B<hr/></td><td align="left" valign="bottom">2010<hr/></td><td align="left" valign="bottom">Taiwan<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,436<hr/></td><td align="left" valign="bottom">Incident cognitive impairment<hr/></td><td align="left" valign="bottom">-<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B103">103</xref>]<hr/></td><td align="left" valign="bottom">50y/M<hr/></td><td align="left" valign="bottom">2011<hr/></td><td align="left" valign="bottom">Sweden<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;2,268<hr/></td><td align="left" valign="bottom">Incident dementia and AD<hr/></td><td align="left" valign="bottom">+(non-AD)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B104">104</xref>]<hr/></td><td align="left" valign="bottom">Mean:60.1/B<hr/></td><td align="left" valign="bottom">2011<hr/></td><td align="left" valign="bottom">Finland<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;21,123<hr/></td><td align="left" valign="bottom">Incident dementia and AD<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B105">105</xref>]<hr/></td><td align="left" valign="bottom">44-69/B<hr/></td><td align="left" valign="bottom">2012<hr/></td><td align="left" valign="bottom">UK<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;7,236<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">+(men)<hr/></td></tr><tr><td align="left" valign="bottom">Study<hr/></td><td align="left" valign="bottom">Age/gender<hr/></td><td align="left" valign="bottom">Year<hr/></td><td align="left" valign="bottom">Country<hr/></td><td align="left" valign="bottom">Design<hr/></td><td align="left" valign="bottom">Sample size<hr/></td><td align="left" valign="bottom">Outcome<hr/></td><td align="left" valign="bottom">Finding<hr/></td></tr><tr><td align="left" valign="bottom"><italic>(2.2.) Alcohol</italic><hr/></td><td colspan="7" align="left" valign="bottom"><italic>Hypothesis: Moderate alcohol consumption is protective against poorer cognitive function, higher rate of cognitive decline and dementia</italic><hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B106">106</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">1996<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;2,040<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+(J-shaped)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B107">107</xref>]<hr/></td><td align="left" valign="bottom">59-71/B<hr/></td><td align="left" valign="bottom">1997<hr/></td><td align="left" valign="bottom">France<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,389<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+ (women)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B76">76</xref>]<hr/></td><td align="left" valign="bottom">75+/B<hr/></td><td align="left" valign="bottom">1998<hr/></td><td align="left" valign="bottom">Australia<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;327<hr/></td><td align="left" valign="bottom">Incident dementia and AD<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B77">77</xref>]<hr/></td><td align="left" valign="bottom">40-80/B<hr/></td><td align="left" valign="bottom">1998<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1469<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B108">108</xref>]<hr/></td><td align="left" valign="bottom">55-88/B<hr/></td><td align="left" valign="bottom">1999<hr/></td><td align="left" valign="bottom">USA<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1786<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+(U-shaped)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B109">109</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2001<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,836<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+(U-shaped for men, linear for women)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B110">110</xref>]<hr/></td><td align="left" valign="bottom">Mean:70/B<hr/></td><td align="left" valign="bottom">2001<hr/></td><td align="left" valign="bottom">Italy<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;15,807<hr/></td><td align="left" valign="bottom">Cognitive impairment<hr/></td><td align="left" valign="bottom">+(U-shaped)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B83">83</xref>]<hr/></td><td align="left" valign="bottom">45-70/B<hr/></td><td align="left" valign="bottom">2002<hr/></td><td align="left" valign="bottom">Netherlands<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,927<hr/></td><td align="left" valign="bottom">Cognitive change<hr/></td><td align="left" valign="bottom">+(women&#x02009;&#x0003e;&#x02009;men) (J-shaped)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B111">111</xref>]<hr/></td><td align="left" valign="bottom">18+/B<hr/></td><td align="left" valign="bottom">2000<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,448<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">+(women&#x02009;&#x0003e;&#x02009;men) (U-shaped)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B112">112</xref>]<hr/></td><td align="left" valign="bottom">53/B<hr/></td><td align="left" valign="bottom">2003<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;10,317<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B87">87</xref>]<hr/></td><td align="left" valign="bottom">60+/B<hr/></td><td align="left" valign="bottom">2003<hr/></td><td align="left" valign="bottom">China<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;3,012<hr/></td><td align="left" valign="bottom">Cognitive impairment<hr/></td><td align="left" valign="bottom">-<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B113">113</xref>]<hr/></td><td align="left" valign="bottom">65-79/B<hr/></td><td align="left" valign="bottom">2004<hr/></td><td align="left" valign="bottom">Finland<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,464<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+(U-shaped) - (ApoE4<sup>+</sup>)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B114">114</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2004<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;4,417<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+(current drinker <italic>vs</italic>. former or abstainer)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B115">115</xref>]<hr/></td><td align="left" valign="bottom">35-55/B<hr/></td><td align="left" valign="bottom">2004<hr/></td><td align="left" valign="bottom">UK<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;10,308<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+(linear, some cognitive domains)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B116">116</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2005<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,624<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+(current drinker <italic>vs</italic>. former or abstainer)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B117">117</xref>]<hr/></td><td align="left" valign="bottom">Mean:74/B<hr/></td><td align="left" valign="bottom">2005<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,098<hr/></td><td align="left" valign="bottom">Cognitive function and decline<hr/></td><td align="left" valign="bottom">+(J-shaped)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B118">118</xref>]<hr/></td><td align="left" valign="bottom">43-53/B<hr/></td><td align="left" valign="bottom">2005<hr/></td><td align="left" valign="bottom">UK<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,764<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">Linear&#x02009;+&#x02009;(slower memory decline: men) -(faster psychomotor speed decline: women)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B119">119</xref>]<hr/></td><td align="left" valign="bottom">20-24,40-44,60-64/B<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">Australia<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;7,485<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">J-shaped&#x02009;+&#x02009;(light drinkers vs. abstainers)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B120">120</xref>]<hr/></td><td align="left" valign="bottom">70-81/W<hr/></td><td align="left" valign="bottom">2005<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;11,102<hr/></td><td align="left" valign="bottom">Cognitive function and decline<hr/></td><td align="left" valign="bottom">+(J-shaped) (cognitive decline)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B121">121</xref>]<hr/></td><td align="left" valign="bottom">65-89/M<hr/></td><td align="left" valign="bottom">2006<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;760<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+(linear, J-shaped)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B122">122</xref>]<hr/></td><td align="left" valign="bottom">40+/B<hr/></td><td align="left" valign="bottom">2006<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,428<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">+(linear)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B123">123</xref>]<hr/></td><td align="left" valign="bottom">65-79/B<hr/></td><td align="left" valign="bottom">2006<hr/></td><td align="left" valign="bottom">Finland<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,341<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+(linear)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B124">124</xref>]<hr/></td><td align="left" valign="bottom">65-84/B<hr/></td><td align="left" valign="bottom">2007<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,445<hr/></td><td align="left" valign="bottom">Incident MCI and MCI&#x02192; dementia<hr/></td><td align="left" valign="bottom">+(U-shaped)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B125">125</xref>]<hr/></td><td align="left" valign="bottom">50+/B<hr/></td><td align="left" valign="bottom">2010<hr/></td><td align="left" valign="bottom">China<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;30,499<hr/></td><td align="left" valign="bottom">MCI&#x02192; dementia<hr/></td><td align="left" valign="bottom">+(J-shaped)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B126">126</xref>]<hr/></td><td align="left" valign="bottom">50+/B<hr/></td><td align="left" valign="bottom">2010<hr/></td><td align="left" valign="bottom">China<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;9,571-28,537<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+(occasional alcohol use vs. none)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B127">127</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2009<hr/></td><td align="left" valign="bottom">China<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;314<hr/></td><td align="left" valign="bottom">Cognitive impairment<hr/></td><td align="left" valign="bottom">+(U-shaped)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B128">128</xref>]<hr/></td><td align="left" valign="bottom">70/B<hr/></td><td align="left" valign="bottom">2011<hr/></td><td align="left" valign="bottom">UK<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;922<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+(linear, verbal memory)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B129">129</xref>]<hr/></td><td align="left" valign="bottom">55+/B<hr/></td><td align="left" valign="bottom">2011<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,337<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">0 -(executive function)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B130">130</xref>]<hr/></td><td align="left" valign="bottom">55+/B<hr/></td><td align="left" valign="bottom">2011<hr/></td><td align="left" valign="bottom">France<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;4,073<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">-(high alcohol use, Low SES)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B131">131</xref>]<hr/></td><td align="left" valign="bottom">45+/B<hr/></td><td align="left" valign="bottom">2012<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;571<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">+(heavy drinking)<hr/></td></tr><tr><td align="left" valign="bottom">Study<hr/></td><td align="left" valign="bottom">Age/gender<hr/></td><td align="left" valign="bottom">Year<hr/></td><td align="left" valign="bottom">Country<hr/></td><td align="left" valign="bottom">Design<hr/></td><td align="left" valign="bottom">Sample size<hr/></td><td align="left" valign="bottom">Outcome<hr/></td><td align="left" valign="bottom">Finding<hr/></td></tr><tr><td align="left" valign="bottom"><italic>(2.3.) Physical activity</italic><hr/></td><td colspan="7" align="left" valign="bottom"><italic>Hypothesis: Physical activity is protective against poorer cognitive function, higher rate of cognitive decline and dementia(including AD)</italic><hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B132">132</xref>]<hr/></td><td align="left" valign="bottom">70+/B<hr/></td><td align="left" valign="bottom">2001<hr/></td><td align="left" valign="bottom">Hong Kong<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;2030<hr/></td><td align="left" valign="bottom">Cognitive impairment<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B133">133</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2001<hr/></td><td align="left" valign="bottom">Canada<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;4615<hr/></td><td align="left" valign="bottom">Incident cognitive impairment and AD<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B134">134</xref>]<hr/></td><td align="left" valign="bottom">65-84/M<hr/></td><td align="left" valign="bottom">2001<hr/></td><td align="left" valign="bottom">Netherlands<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;347<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">+(ApoE4+)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B135">135</xref>]<hr/></td><td align="left" valign="bottom">65+/F<hr/></td><td align="left" valign="bottom">2001<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;5,925<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B136">136</xref>]<hr/></td><td align="left" valign="bottom">75+/B<hr/></td><td align="left" valign="bottom">2003<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;469<hr/></td><td align="left" valign="bottom">Incident dementias (AD, VaD and others)<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B137">137</xref>]<hr/></td><td align="left" valign="bottom">71-93/M<hr/></td><td align="left" valign="bottom">2004<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;2257<hr/></td><td align="left" valign="bottom">Incident dementia and AD<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B138">138</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2004<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1146<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B139">139</xref>]<hr/></td><td align="left" valign="bottom">80+/M<hr/></td><td align="left" valign="bottom">2004<hr/></td><td align="left" valign="bottom">European countries<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;295<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B140">140</xref>]<hr/></td><td align="left" valign="bottom">70-81/W<hr/></td><td align="left" valign="bottom">2004<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;18766<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B141">141</xref>]<hr/></td><td align="left" valign="bottom">65+/M<hr/></td><td align="left" valign="bottom">2005<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;3375<hr/></td><td align="left" valign="bottom">Incident dementia and AD<hr/></td><td align="left" valign="bottom">+(ApoE4-)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B142">142</xref>]<hr/></td><td align="left" valign="bottom">65-79/B<hr/></td><td align="left" valign="bottom">2005<hr/></td><td align="left" valign="bottom">Sweden<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1449<hr/></td><td align="left" valign="bottom">Incident dementia and AD<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B143">143</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2005<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;4055<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">-<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B144">144</xref>]<hr/></td><td align="left" valign="bottom">75+/B<hr/></td><td align="left" valign="bottom">2006<hr/></td><td align="left" valign="bottom">Sweden<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;776<hr/></td><td align="left" valign="bottom">Incident dementia<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B145">145</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2006<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1740<hr/></td><td align="left" valign="bottom">Incident dementia and AD<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B146">146</xref>]<hr/></td><td align="left" valign="bottom">65+/W<hr/></td><td align="left" valign="bottom">2010<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;9344<hr/></td><td align="left" valign="bottom">Cognitive impairment<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B147">147</xref>]<hr/></td><td align="left" valign="bottom">60+/B<hr/></td><td align="left" valign="bottom">2008<hr/></td><td align="left" valign="bottom">Greece<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;732<hr/></td><td align="left" valign="bottom">Cognitive impairment<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B148">148</xref>]<hr/></td><td align="left" valign="bottom">71-92/M<hr/></td><td align="left" valign="bottom">2008<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;2263<hr/></td><td align="left" valign="bottom">Dementia<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B149">149</xref>]<hr/></td><td align="left" valign="bottom">70+/B<hr/></td><td align="left" valign="bottom">2009<hr/></td><td align="left" valign="bottom">Italy<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;668<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B100">100</xref>]<hr/></td><td align="left" valign="bottom">90-108/B<hr/></td><td align="left" valign="bottom">2009<hr/></td><td align="left" valign="bottom">China<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;681<hr/></td><td align="left" valign="bottom">Cognitive impairment<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B150">150</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2009<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1880<hr/></td><td align="left" valign="bottom">Incident AD<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B151">151</xref>]<hr/></td><td align="left" valign="bottom">70-79/B<hr/></td><td align="left" valign="bottom">2009<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;2509<hr/></td><td align="left" valign="bottom">Cognitive function and decline<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B152">152</xref>]<hr/></td><td align="left" valign="bottom">Mean:51y/B<hr/></td><td align="left" valign="bottom">2010<hr/></td><td align="left" valign="bottom">Iceland<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;4945<hr/></td><td align="left" valign="bottom">Cognitive function and dementia<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B153">153</xref>]<hr/></td><td align="left" valign="bottom">55+/B<hr/></td><td align="left" valign="bottom">2010<hr/></td><td align="left" valign="bottom">Germany<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;3903<hr/></td><td align="left" valign="bottom">Incident cognitive impairment<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B154">154</xref>]<hr/></td><td align="left" valign="bottom">60+/B<hr/></td><td align="left" valign="bottom">2010<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;5903<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B155">155</xref>]<hr/></td><td align="left" valign="bottom">65+/W<hr/></td><td align="left" valign="bottom">2010<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;9344<hr/></td><td align="left" valign="bottom">Cognitive function and impairment<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B156">156</xref>]<hr/></td><td align="left" valign="bottom">Mean:82/B<hr/></td><td align="left" valign="bottom">2012<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;716<hr/></td><td align="left" valign="bottom">AD Cognitive decline<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B157">157</xref>]<hr/></td><td align="left" valign="bottom">40-84/B<hr/></td><td align="left" valign="bottom">2012<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;405 (40&#x02013;59 years) N&#x02009;=&#x02009;342 (60&#x02013;84 years)<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B158">158</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2012<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;2491<hr/></td><td align="left" valign="bottom">Incident dementia &#x00026; AD<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">Study<hr/></td><td align="left" valign="bottom">Age/gender<hr/></td><td align="left" valign="bottom">Year<hr/></td><td align="left" valign="bottom">Country<hr/></td><td align="left" valign="bottom">Design<hr/></td><td align="left" valign="bottom">Sample size<hr/></td><td align="left" valign="bottom">Outcome<hr/></td><td align="left" valign="bottom">Finding<hr/></td></tr><tr><td align="left" valign="bottom"><italic>(3) Nutritional</italic><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom"><italic>(3.1) Caffeine(coffee or tea)</italic><hr/></td><td colspan="7" align="left" valign="bottom"><italic>Hypothesis: Caffeine consumption is protective against poorer cognitive function, higher rate of cognitive decline and dementia</italic><hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B159">159</xref>]<hr/></td><td align="left" valign="bottom">18+/B<hr/></td><td align="left" valign="bottom">1993<hr/></td><td align="left" valign="bottom">UK<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;9,003<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+(caffeine)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B160">160</xref>]<hr/></td><td align="left" valign="bottom">Mean: 73/B<hr/></td><td align="left" valign="bottom">2002<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,528<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">0(coffee)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B161">161</xref>]<hr/></td><td align="left" valign="bottom">24-81/B<hr/></td><td align="left" valign="bottom">2003<hr/></td><td align="left" valign="bottom">The Netherlands<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,376<hr/></td><td align="left" valign="bottom">Cognitive change<hr/></td><td align="left" valign="bottom">0(caffeine)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B162">162</xref>]<hr/></td><td align="left" valign="bottom">70+/B<hr/></td><td align="left" valign="bottom">2006<hr/></td><td align="left" valign="bottom">Japan<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,003<hr/></td><td align="left" valign="bottom">Cognitive impairment<hr/></td><td align="left" valign="bottom">+(green tea)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B163">163</xref>]<hr/></td><td align="left" valign="bottom">Mean&#x02009;~&#x02009;75/M<hr/></td><td align="left" valign="bottom">2007<hr/></td><td align="left" valign="bottom">Finland, the Netherlands and Italy<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;667<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">+(coffee, J-shaped)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B164">164</xref>]<hr/></td><td align="left" valign="bottom">55+/B<hr/></td><td align="left" valign="bottom">2008<hr/></td><td align="left" valign="bottom">Singapore<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,438<hr/></td><td align="left" valign="bottom">Cognitive impairment and decline<hr/></td><td align="left" valign="bottom">+(tea)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B165">165</xref>]<hr/></td><td align="left" valign="bottom">65-79/B<hr/></td><td align="left" valign="bottom">2009<hr/></td><td align="left" valign="bottom">Finland<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,409<hr/></td><td align="left" valign="bottom">Incident dementia and AD<hr/></td><td align="left" valign="bottom">+(coffee), 0(tea)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B100">100</xref>]<hr/></td><td align="left" valign="bottom">90+/B<hr/></td><td align="left" valign="bottom">2009<hr/></td><td align="left" valign="bottom">China<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;681<hr/></td><td align="left" valign="bottom">Cognitive impairment<hr/></td><td align="left" valign="bottom">+(tea, men)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B166">166</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2009<hr/></td><td align="left" valign="bottom">Finland<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;2,606<hr/></td><td align="left" valign="bottom">Cognitive function, incident dementia and MCI<hr/></td><td align="left" valign="bottom">0(coffee)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B167">167</xref>]<hr/></td><td align="left" valign="bottom">70-74/B<hr/></td><td align="left" valign="bottom">2009<hr/></td><td align="left" valign="bottom">Norway<hr/></td><td align="left" valign="bottom">Cross-sectiona<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;2,031<hr/></td><td align="left" valign="bottom">Cognitive impairment<hr/></td><td align="left" valign="bottom">+(tea)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B168">168</xref>]<hr/></td><td align="left" valign="bottom">17-92/B<hr/></td><td align="left" valign="bottom">2009<hr/></td><td align="left" valign="bottom">UK<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;3,223<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">0(caffeine)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B169">169</xref>]<hr/></td><td align="left" valign="bottom">70/B<hr/></td><td align="left" valign="bottom">2010<hr/></td><td align="left" valign="bottom">UK<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;923<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+(coffee); &#x02212;(tea)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B170">170</xref>]<hr/></td><td align="left" valign="bottom">55+/B<hr/></td><td align="left" valign="bottom">2010<hr/></td><td align="left" valign="bottom">Singapore<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;716<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+(tea)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B171">171</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2010<hr/></td><td align="left" valign="bottom">France<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;641<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">+(caffeine, women)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B172">172</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2010<hr/></td><td align="left" valign="bottom">Portugal<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;648<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">+(caffeine, women)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B173">173</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2011<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;4,809<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">+(caffeine, women)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B174">174</xref>]<hr/></td><td align="left" valign="bottom">Mean:54/M<hr/></td><td align="left" valign="bottom">2011<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;3,494<hr/></td><td align="left" valign="bottom">Incident dementia and cognitive impairment<hr/></td><td align="left" valign="bottom">0(caffeine)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B175">175</xref>]<hr/></td><td align="left" valign="bottom">Mean:91.4/B<hr/></td><td align="left" valign="bottom">2012<hr/></td><td align="left" valign="bottom">Singapore<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;7,139<hr/></td><td align="left" valign="bottom">Cognitive change<hr/></td><td align="left" valign="bottom">+(tea)<hr/></td></tr><tr><td align="left" valign="bottom">Study<hr/></td><td align="left" valign="bottom">Age/gender<hr/></td><td align="left" valign="bottom">Year<hr/></td><td align="left" valign="bottom">Country<hr/></td><td align="left" valign="bottom">Design<hr/></td><td align="left" valign="bottom">Sample size<hr/></td><td align="left" valign="bottom">Outcome<hr/></td><td align="left" valign="bottom">Finding<hr/></td></tr><tr><td align="left" valign="bottom"><italic>(3.2) Antioxidants/Vitamin E</italic><hr/></td><td colspan="7" align="left" valign="bottom"><italic>Hypothesis: Antioxidants, including vitamin E, are protective against poorer cognitive function, higher rate of cognitive decline and dementia(including AD)</italic><hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B176">176</xref>]<hr/></td><td align="left" valign="bottom">55-95/B<hr/></td><td align="left" valign="bottom">1996<hr/></td><td align="left" valign="bottom">Netherlands<hr/></td><td align="left" valign="bottom">cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;5,182<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B177">177</xref>]<hr/></td><td align="left" valign="bottom">66-97/B<hr/></td><td align="left" valign="bottom">1998<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,059<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B178">178</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">1998<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;633<hr/></td><td align="left" valign="bottom">Incident AD<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B179">179</xref>]<hr/></td><td align="left" valign="bottom">5075/B<hr/></td><td align="left" valign="bottom">1998<hr/></td><td align="left" valign="bottom">Austria<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,769<hr/></td><td align="left" valign="bottom">Cognitive performance<hr/></td><td align="left" valign="bottom">+(Vit. E)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B180">180</xref>]<hr/></td><td align="left" valign="bottom">71-93/M<hr/></td><td align="left" valign="bottom">2000<hr/></td><td align="left" valign="bottom">Hawaii<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;3,385<hr/></td><td align="left" valign="bottom">Incident AD, VaD, MD and OD<hr/></td><td align="left" valign="bottom">+(VaD)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B181">181</xref>]<hr/></td><td align="left" valign="bottom">48-67/B<hr/></td><td align="left" valign="bottom">2000<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;12,187<hr/></td><td align="left" valign="bottom">Cognitive performance<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B182">182</xref>]<hr/></td><td align="left" valign="bottom">55+/B<hr/></td><td align="left" valign="bottom">2002<hr/></td><td align="left" valign="bottom">Netherlands<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;5,395<hr/></td><td align="left" valign="bottom">Incident AD<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B183">183</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2002<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;815<hr/></td><td align="left" valign="bottom">Incident AD<hr/></td><td align="left" valign="bottom">+(Vit. E, ApoE4<sup>&#x02212;</sup>)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B184">184</xref>]<hr/></td><td align="left" valign="bottom">65-102/B<hr/></td><td align="left" valign="bottom">2002<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;2,889<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B185">185</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2003<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;2,969<hr/></td><td align="left" valign="bottom">Incident dementia Incident AD<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B186">186</xref>]<hr/></td><td align="left" valign="bottom">70-79/W<hr/></td><td align="left" valign="bottom">2003<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;14,968<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+(Vit. E)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B187">187</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2003<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;980<hr/></td><td align="left" valign="bottom">Incident AD<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B188">188</xref>]<hr/></td><td align="left" valign="bottom">45-68/M<hr/></td><td align="left" valign="bottom">2004<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;2,459<hr/></td><td align="left" valign="bottom">Incident dementia and AD<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B189">189</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2004<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;4,740<hr/></td><td align="left" valign="bottom">Incident and prevalent AD<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B190">190</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2005<hr/></td><td align="left" valign="bottom">Italy<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,033<hr/></td><td align="left" valign="bottom">Prevalent dementia and cognitive impairment<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B191">191</xref>]<hr/></td><td align="left" valign="bottom">55+/B<hr/></td><td align="left" valign="bottom">2005<hr/></td><td align="left" valign="bottom">Netherlands<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;3,717<hr/></td><td align="left" valign="bottom">Prevalent AD<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B192">192</xref>]<hr/></td><td align="left" valign="bottom">65-105/B<hr/></td><td align="left" valign="bottom">2005<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;616<hr/></td><td align="left" valign="bottom">Incident Dementia Incident AD<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B193">193</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2005<hr/></td><td align="left" valign="bottom">Canada<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;894<hr/></td><td align="left" valign="bottom">Cognitive decline Dementia<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B194">194</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2005<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;3,718<hr/></td><td align="left" valign="bottom">Incident AD Cognitive function<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B195">195</xref>]<hr/></td><td align="left" valign="bottom">Mean:73.5/B<hr/></td><td align="left" valign="bottom">2007<hr/></td><td align="left" valign="bottom">France<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;589<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B196">196</xref>]<hr/></td><td align="left" valign="bottom">60+/W<hr/></td><td align="left" valign="bottom">2007<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;526<hr/></td><td align="left" valign="bottom">Cognitive impairment<hr/></td><td align="left" valign="bottom">+(Vit. E)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B197">197</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2007<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;3,831<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B198">198</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2008<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;3,376<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B199">199</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2008<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;2,969<hr/></td><td align="left" valign="bottom">Incident Dementia Incident AD<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B200">200</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2008<hr/></td><td align="left" valign="bottom">Italy<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;761<hr/></td><td align="left" valign="bottom">Cognitive impairment<hr/></td><td align="left" valign="bottom">+(Vit. E Sub-type)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B201">201</xref>]<hr/></td><td align="left" valign="bottom">70+/W<hr/></td><td align="left" valign="bottom">2010<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;16,010<hr/></td><td align="left" valign="bottom">Cognitive function &#x00026; decline<hr/></td><td align="left" valign="bottom">+(cognitive function)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B202">202</xref>]<hr/></td><td align="left" valign="bottom">70/B<hr/></td><td align="left" valign="bottom">2011<hr/></td><td align="left" valign="bottom">UK<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;882<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">Study<hr/></td><td align="left" valign="bottom">Age/gender<hr/></td><td align="left" valign="bottom">Year<hr/></td><td align="left" valign="bottom">Country<hr/></td><td align="left" valign="bottom">Design<hr/></td><td align="left" valign="bottom">Sample size<hr/></td><td align="left" valign="bottom">Outcome<hr/></td><td align="left" valign="bottom">Finding<hr/></td></tr><tr><td align="left" valign="bottom"><italic>(3.3) Homocysteine</italic><hr/></td><td colspan="7" align="left" valign="bottom"><italic>Hypothesis: Homocysteine is a risk factor for poorer cognitive function, higher rate of cognitive decline and dementia (including AD)</italic><hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B203">203</xref>]<hr/></td><td align="left" valign="bottom">55+/B<hr/></td><td align="left" valign="bottom">1999<hr/></td><td align="left" valign="bottom">Netherlands<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;702<hr/></td><td align="left" valign="bottom">Cognitive function and decline<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B204">204</xref>]<hr/></td><td align="left" valign="bottom">60+/B<hr/></td><td align="left" valign="bottom">2002<hr/></td><td align="left" valign="bottom">UK<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;391<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B205">205</xref>]<hr/></td><td align="left" valign="bottom">55+/B<hr/></td><td align="left" valign="bottom">2002<hr/></td><td align="left" valign="bottom">The Netherlands<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,077<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B206">206</xref>]<hr/></td><td align="left" valign="bottom">Mean:76/B<hr/></td><td align="left" valign="bottom">2002<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,092<hr/></td><td align="left" valign="bottom">Incident AD<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B207">207</xref>]<hr/></td><td align="left" valign="bottom">60+/B<hr/></td><td align="left" valign="bottom">2003<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,789<hr/></td><td align="left" valign="bottom">Global cognitive function<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B208">208</xref>]<hr/></td><td align="left" valign="bottom">Mean:73/B<hr/></td><td align="left" valign="bottom">2003<hr/></td><td align="left" valign="bottom">Italy<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;650<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B209">209</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2004<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;679<hr/></td><td align="left" valign="bottom">Incident and prevalent AD<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B210">210</xref>]<hr/></td><td align="left" valign="bottom">Mean:72/B<hr/></td><td align="left" valign="bottom">2005<hr/></td><td align="left" valign="bottom">Turkey<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,249<hr/></td><td align="left" valign="bottom">Incident dementia, AD, MCI<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B211">211</xref>]<hr/></td><td align="left" valign="bottom">60+/B<hr/></td><td align="left" valign="bottom">2005<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,789<hr/></td><td align="left" valign="bottom">Cognitive impairment and dementia<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B212">212</xref>]<hr/></td><td align="left" valign="bottom">40-82/B<hr/></td><td align="left" valign="bottom">2005<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;2,096<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+(60&#x02009;+&#x02009;y)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B213">213</xref>]<hr/></td><td align="left" valign="bottom">70-79/B<hr/></td><td align="left" valign="bottom">2005<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;499<hr/></td><td align="left" valign="bottom">Cognitive function and decline<hr/></td><td align="left" valign="bottom">+(cognitive function)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B214">214</xref>]<hr/></td><td align="left" valign="bottom">85+/B<hr/></td><td align="left" valign="bottom">2005<hr/></td><td align="left" valign="bottom">Netherlands<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;599<hr/></td><td align="left" valign="bottom">Cognitive impairment and decline<hr/></td><td align="left" valign="bottom">+(with impairment)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B215">215</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2005<hr/></td><td align="left" valign="bottom">Switzerland<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;623<hr/></td><td align="left" valign="bottom">Incident MCI, dementia, AD and VaD<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B216">216</xref>]<hr/></td><td align="left" valign="bottom">60+/B<hr/></td><td align="left" valign="bottom">2005<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,789<hr/></td><td align="left" valign="bottom">Cognitive impairment and dementia<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B217">217</xref>]<hr/></td><td align="left" valign="bottom">Mean:74/B<hr/></td><td align="left" valign="bottom">2005<hr/></td><td align="left" valign="bottom">Italy<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;816<hr/></td><td align="left" valign="bottom">Incident AD<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B218">218</xref>]<hr/></td><td align="left" valign="bottom">50-70/B<hr/></td><td align="left" valign="bottom">2005<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,140<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B219">219</xref>]<hr/></td><td align="left" valign="bottom">50-85/M<hr/></td><td align="left" valign="bottom">2005<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;321<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B220">220</xref>]<hr/></td><td align="left" valign="bottom">Mean:62/B<hr/></td><td align="left" valign="bottom">2006<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;812<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B221">221</xref>]<hr/></td><td align="left" valign="bottom">55+/B<hr/></td><td align="left" valign="bottom">2006<hr/></td><td align="left" valign="bottom">China<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;451<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B222">222</xref>]<hr/></td><td align="left" valign="bottom">Mean:59/B<hr/></td><td align="left" valign="bottom">2006<hr/></td><td align="left" valign="bottom">The Netherlands<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;345<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B223">223</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2007<hr/></td><td align="left" valign="bottom">UK<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,648<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B224">224</xref>]<hr/></td><td align="left" valign="bottom">60-101/B<hr/></td><td align="left" valign="bottom">2007<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,779<hr/></td><td align="left" valign="bottom">Incident dementia and MCI<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B225">225</xref>]<hr/></td><td align="left" valign="bottom">60-85/B<hr/></td><td align="left" valign="bottom">2007<hr/></td><td align="left" valign="bottom">South Korea<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,215<hr/></td><td align="left" valign="bottom">Prevalent MCI<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B226">226</xref>]<hr/></td><td align="left" valign="bottom">26-98/B<hr/></td><td align="left" valign="bottom">2008<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;911<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+(ApoE4+)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B227">227</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2008<hr/></td><td align="left" valign="bottom">Korea<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;607<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B228">228</xref>]<hr/></td><td align="left" valign="bottom">Mean:72/B<hr/></td><td align="left" valign="bottom">2008<hr/></td><td align="left" valign="bottom">Korea<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;518<hr/></td><td align="left" valign="bottom">Incident dementia and AD<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B229">229</xref>]<hr/></td><td align="left" valign="bottom">Mean:77/B<hr/></td><td align="left" valign="bottom">2009<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;516<hr/></td><td align="left" valign="bottom">Prevalent and incident MCI<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B230">230</xref>]<hr/></td><td align="left" valign="bottom">38-85/B<hr/></td><td align="left" valign="bottom">2010<hr/></td><td align="left" valign="bottom">Sweden<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;488<hr/></td><td align="left" valign="bottom">Incident dementia<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B231">231</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2010<hr/></td><td align="left" valign="bottom">The Netherlands<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,076<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B232">232</xref>]<hr/></td><td align="left" valign="bottom">Mean:78/W<hr/></td><td align="left" valign="bottom">2011<hr/></td><td align="left" valign="bottom">Germany<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;420<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B233">233</xref>]<hr/></td><td align="left" valign="bottom">38-60/W<hr/></td><td align="left" valign="bottom">2011<hr/></td><td align="left" valign="bottom">Sweden<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,368<hr/></td><td align="left" valign="bottom">Incident dementia and AD<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B234">234</xref>]<hr/></td><td align="left" valign="bottom">70-89/M<hr/></td><td align="left" valign="bottom">2012<hr/></td><td align="left" valign="bottom">Australia<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;4,227<hr/></td><td align="left" valign="bottom">Incident dementia<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B235">235</xref>]<hr/></td><td align="left" valign="bottom">70-89/M<hr/></td><td align="left" valign="bottom">2012<hr/></td><td align="left" valign="bottom">Australia<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,778<hr/></td><td align="left" valign="bottom">Incident cognitive impairment<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">Study<hr/></td><td align="left" valign="bottom">Age/gender<hr/></td><td align="left" valign="bottom">Year<hr/></td><td align="left" valign="bottom">Country<hr/></td><td align="left" valign="bottom">Design<hr/></td><td align="left" valign="bottom">Sample size<hr/></td><td align="left" valign="bottom">Outcome<hr/></td><td align="left" valign="bottom">Finding<hr/></td></tr><tr><td align="left" valign="bottom"><italic>(3.4) n-3 fatty acids</italic><hr/></td><td colspan="7" align="left" valign="bottom"><italic>Hypothesis: n-3 fatty acids are protective against poorer cognitive function, higher rate of cognitive decline and dementia(including AD)</italic><hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B236">236</xref>]<hr/></td><td align="left" valign="bottom">69-89/M<hr/></td><td align="left" valign="bottom">1997<hr/></td><td align="left" valign="bottom">Netherlands<hr/></td><td align="left" valign="bottom">cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;476<hr/></td><td align="left" valign="bottom">Cognitive impairment &#x00026; decline<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B237">237</xref>]<hr/></td><td align="left" valign="bottom">55+/B<hr/></td><td align="left" valign="bottom">1997<hr/></td><td align="left" valign="bottom">Netherlands<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;5,386<hr/></td><td align="left" valign="bottom">Incident dementia and AD<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B238">238</xref>]<hr/></td><td align="left" valign="bottom">55+/B<hr/></td><td align="left" valign="bottom">2002<hr/></td><td align="left" valign="bottom">Netherlands<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;5,395<hr/></td><td align="left" valign="bottom">Incident dementia and AD<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B239">239</xref>]<hr/></td><td align="left" valign="bottom">65-94/B<hr/></td><td align="left" valign="bottom">2003<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;815<hr/></td><td align="left" valign="bottom">Incident AD<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B240">240</xref>]<hr/></td><td align="left" valign="bottom">45-70/B<hr/></td><td align="left" valign="bottom">2004<hr/></td><td align="left" valign="bottom">Netherlands<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,613<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B241">241</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2005<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;3,718<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B242">242</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2007<hr/></td><td align="left" valign="bottom">France<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;8,085<hr/></td><td align="left" valign="bottom">Incident dementia and AD<hr/></td><td align="left" valign="bottom">+(ApoE4-)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B243">243</xref>]<hr/></td><td align="left" valign="bottom">50+/B<hr/></td><td align="left" valign="bottom">2007<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;2,251<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">+(hypertensive, Dyslipidemic)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B244">244</xref>]<hr/></td><td align="left" valign="bottom">Mean:76/B<hr/></td><td align="left" valign="bottom">2007<hr/></td><td align="left" valign="bottom">Italy<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;935<hr/></td><td align="left" valign="bottom">Prevalent dementia<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B245">245</xref>]<hr/></td><td align="left" valign="bottom">50-70/B<hr/></td><td align="left" valign="bottom">2007<hr/></td><td align="left" valign="bottom">Netherlands<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;404-807<hr/></td><td align="left" valign="bottom">Cognitive function and change<hr/></td><td align="left" valign="bottom">+(change)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B246">246</xref>]<hr/></td><td align="left" valign="bottom">50+/B<hr/></td><td align="left" valign="bottom">2008<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;2,251-7,814<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">+(hypertensives)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B247">247</xref>]<hr/></td><td align="left" valign="bottom">65-80/B<hr/></td><td align="left" valign="bottom">2008<hr/></td><td align="left" valign="bottom">Finland<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,449<hr/></td><td align="left" valign="bottom">MCI and cognitive function<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B248">248</xref>]<hr/></td><td align="left" valign="bottom">Mean:78/B<hr/></td><td align="left" valign="bottom">2008<hr/></td><td align="left" valign="bottom">France<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,214<hr/></td><td align="left" valign="bottom">Incident dementia<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B249">249</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2009<hr/></td><td align="left" valign="bottom">Multi-national<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;14,960<hr/></td><td align="left" valign="bottom">Prevalent dementia<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B250">250</xref>]<hr/></td><td align="left" valign="bottom">55+/B<hr/></td><td align="left" valign="bottom">2009<hr/></td><td align="left" valign="bottom">Netherlands<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;5,395<hr/></td><td align="left" valign="bottom">Incident dementia and AD<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B251">251</xref>]<hr/></td><td align="left" valign="bottom">65+/B<hr/></td><td align="left" valign="bottom">2009<hr/></td><td align="left" valign="bottom">Canada<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;663<hr/></td><td align="left" valign="bottom">Incident dementia or AD<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B252">252</xref>]<hr/></td><td align="left" valign="bottom">Mean:68/M<hr/></td><td align="left" valign="bottom">2009<hr/></td><td align="left" valign="bottom">Netherlands<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,025<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">0<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B253">253</xref>]<hr/></td><td align="left" valign="bottom">76-82/W<hr/></td><td align="left" valign="bottom">2009<hr/></td><td align="left" valign="bottom">France<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;4,809<hr/></td><td align="left" valign="bottom">Cognitive decline<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B254">254</xref>]<hr/></td><td align="left" valign="bottom">Mean:75/B<hr/></td><td align="left" valign="bottom">2010<hr/></td><td align="left" valign="bottom">Spain<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;304<hr/></td><td align="left" valign="bottom">Cognitive impairment<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B255">255</xref>]<hr/></td><td align="left" valign="bottom">35-54/B<hr/></td><td align="left" valign="bottom">2010<hr/></td><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;280<hr/></td><td align="left" valign="bottom">Cognitive function<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B256">256</xref>]<hr/></td><td align="left" valign="bottom">55+/B<hr/></td><td align="left" valign="bottom">2011<hr/></td><td align="left" valign="bottom">Singapore<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;1,475<hr/></td><td align="left" valign="bottom">Cognitive function and decline<hr/></td><td align="left" valign="bottom">+(supplements)<hr/></td></tr><tr><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B257">257</xref>]<hr/></td><td align="left" valign="bottom">Mean:~64/B<hr/></td><td align="left" valign="bottom">2011<hr/></td><td align="left" valign="bottom">France<hr/></td><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">N&#x02009;=&#x02009;3,294<hr/></td><td align="left" valign="bottom">Cognitive impairment<hr/></td><td align="left" valign="bottom">+<hr/></td></tr><tr><td align="left">[<xref ref-type="bibr" rid="B258">258</xref>]</td><td align="left">65+/B</td><td align="left">2011</td><td align="left">France</td><td align="left">Cohort</td><td align="left">N&#x02009;=&#x02009;1,228</td><td align="left">Cognitive decline</td><td align="left">+(ApoE4<sup>+</sup>; depressed)</td></tr></tbody></table><table-wrap-foot><p><sup>+</sup>Hypothesized association; &#x02212; Association against hypothesis; 0: No association.</p><p><italic>Abbreviations</italic>: <bold>AD</bold>: Alzheimer&#x02019;s Disease; <bold>ApoE</bold>: Apolipoprotein E; <bold>B</bold>: Both; <bold>M</bold>: Men; <bold>MCI</bold>: Mild Cognitive Impairment; MD&#x02009;=&#x02009;Mixed Dementia; OD&#x02009;=&#x02009;Other dementia; <bold>UK</bold>: United Kingdom; <bold>US</bold>: United States; <bold>VaD</bold>: Vascular Dementia; <bold>W</bold>: Women.</p></table-wrap-foot></table-wrap><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>Flowchart of study selection for systematic review and meta-analysis. </bold><italic>Notes</italic>: MEDLINE searches (1990&#x02013;2012) included the following: (1) &#x0201c;Risk factor&#x0201d; as MESH term AND &#x0201c;Dementia&#x0201d; in title; (2) &#x0201c;Risk factor&#x0201d; as MESH term AND &#x0201c;Alzheimer&#x0201d; in title; (3) &#x0201c;Risk factor&#x0201d; as MESH term AND &#x0201c;Alzheimer&#x0201d; in title; (4) &#x0201c;Risk factor&#x0201d; as MESH term AND &#x0201c;cognitive&#x0201d; in title; (5) &#x0201c;Risk factor&#x0201d; in title and &#x0201c;cognitive&#x0201d; in title. Given that each search is not mutually exclusive of other searches, there were duplicates which were deleted from the final number of included studies. The following notations are defined follows: N1&#x02009;=&#x02009;Studies excluded from all searches combined due to small sample size; N2&#x02009;=&#x02009;Studies excluded from all searches combined due to design being neither cross-sectional nor cohort; N3&#x02009;=&#x02009;Studies excluded from all searches combined due to being a review or a letter to the editor; N4&#x02009;=&#x02009;Studies excluded from all searches combined due to lack of relevance to topic or hypothesis; N5&#x02009;=&#x02009;Studies excluded from all searches combined for other reasons (e.g. special group of people); N6&#x02009;=&#x02009;Final included studies; N6a&#x02009;=&#x02009;Final included cohort studies; N6b&#x02009;=&#x02009;Final included cross-sectional studies.</p></caption><graphic xlink:href="1471-2458-14-643-1"/></fig><p>Out of a total search of 6,837 titles and abstracts between 1990 and 2012 (range:126 for caffeine to 1,692 for education), 247 published original epidemiologic studies (167 cohort-, 80 cross-sectional studies) were included in our review. A database was built accordingly using Endnote ver. X3 [<xref ref-type="bibr" rid="B259">259</xref>]. Each study was summarized in Table&#x000a0;<xref ref-type="table" rid="T2">2</xref> by listing the sample characteristics (age, gender, country), study design, sample size and type of outcome. Given the diversity of types of outcomes, a quantitative meta-analysis for all studies with all outcomes was not possible. Thus, a qualitative method to assess overall consistency was conducted. This analysis was mainly based on the hypothesized direction of association and the final conclusion of the study. Thus, main findings based on the pre-set hypothesis was coded (+: supports the hypothesis; 0: no significant finding; &#x02212;: against the hypothesis). In addition, within +, we coded studies as partially supporting the hypothesis for three main reasons: &#x0201c;some outcomes but not others&#x0201d;, &#x0201c;some exposures but not others&#x0201d;, &#x0201c;some sub-group(s) but not others&#x0201d;. These papers are sorted by risk factor, year of publication and first author&#x02019;s last name.</p></sec><sec><title>Descriptive analysis</title><p>In the descriptive part of the analysis, a data point consisted of a study finding within a design/risk factor dyad (e.g. cohort/education). Using the data points, we conducted an analysis to assess consistency of positive findings across risk factors and study designs (cohort vs. cross-sectional). In particular, we estimated the % of positive findings for all participants and most outcomes; % of positive findings for some outcomes or exposures but not others; % of positive findings for sub-groups; % null findings; % of findings against hypothesized direction. In addition, study-level characteristics (e.g. year and country of publication, study design, type of cognitive outcome, sample size, age group, sex) were described in detail and compared across risk factors, using <italic>&#x003c7;</italic><sup>2</sup> test, independent samples <italic>t</italic>-test and one-way ANOVA.</p></sec><sec><title>Consistency analysis: all data points</title><p>In this part of the analysis, we modeled study finding as a binary outcome coded as 0=&#x0201d;null finding or finding against hypothesized direction&#x0201d; (referent category), 1=&#x0201d;positive or partially positive finding&#x0201d;, as a function of study-level characteristics using a logistic regression model. The study-level characteristics were entered as main effects as follows: <bold>(1)</bold> Year of publication; <bold>(2)</bold> Country of publication (1&#x02009;=&#x02009;US, 2&#x02009;=&#x02009;European country, 3&#x02009;=&#x02009;Others), (3) risk factor (1&#x02009;=&#x02009;education, 2&#x02009;=&#x02009;smoking, 3&#x02009;=&#x02009;alcohol, 4&#x02009;=&#x02009;physical activity, 5&#x02009;=&#x02009;caffeine, 6&#x02009;=&#x02009;antioxidants, 7&#x02009;=&#x02009;homocysteine, 8&#x02009;=&#x02009;<italic>n</italic>-3 fatty acids); <bold>(4)</bold> sample size (when a range was provided, the average was taken), (5) Study participant age group: 1&#x02009;=&#x02009;contains ages &#x0003c;65y, 0&#x02009;=&#x02009;does not contain ages &#x0003c;65y; <bold>(6)</bold> Participant gender composition: 1&#x02009;=&#x02009;Men only; 2&#x02009;=&#x02009;Women only; 3&#x02009;=&#x02009;Both; <bold>(7)</bold> Study design: 1&#x02009;=&#x02009;cross-sectional; 2&#x02009;=&#x02009;cohort; <bold>(8)</bold> Number of cognitive outcomes included in the study (e.g. 1 if only incident AD was the outcome; 2 if it is both incident AD and incident dementia); <bold>(9)</bold> General category of cognitive outcome(s): 1&#x02009;=&#x02009;dementia/AD/impairment; 2&#x02009;=&#x02009;cognitive function/decline; 3&#x02009;=&#x02009;both.</p></sec><sec><title>Meta-analysis: data points with incident AD and selected risk or protective factors</title><p>Focusing on data points with incident AD as an outcome, we conducted further meta-analysis to assess the strength of the association between selected risk or protective factors and this outcome. This analysis was thus restricted to prospective cohort studies with available data points that had comparable measurements for each risk/protective factor, thus allowing to estimate a pooled measure of association across those data points and studies. The original reported odd ratios (ORs), relative risks (RRs) or Hazard Ratios (HRs) were combined into a pooled value with 95% confidence interval (CI). The RRs were then pooled using <italic>random effects</italic> models when included study data points were deemed heterogeneous based on the Q-test for homogeneity (p&#x02009;&#x0003c;&#x02009;0.05) or <italic>fixed effect</italic> when study data points were homogenous (p&#x02009;&#x0003e;&#x02009;0.05), which are also presented among results. As such, a summary or pooled RR was provided using forest plots and computed by computing the weighted average of the natural logarithm of each relative measure of interest weighting by the inverse of each RR&#x02019;s respective variance [<xref ref-type="bibr" rid="B260">260</xref>]. Random effects models that further incorporated between-study variability were conducted using DerSimonian and Laird&#x02019;s methodology.</p><p>Considering estimates of exposure prevalence from the largest study with available data on each exposure, we also computed a population attributable risk percentage (PAR%) by pooling data points from all studies together.</p><p><disp-formula id="bmcM1.1"><label>(1.1)</label><mml:math id="M1" name="1471-2458-14-643-i1" overflow="scroll"><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mi mathvariant="italic">PAR</mml:mi><mml:msub><mml:mo mathvariant="normal">%</mml:mo><mml:mrow><mml:mi mathvariant="italic">p</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="italic">lcl</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="italic">ucl</mml:mi><mml:mo>;</mml:mo><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>100</mml:mn><mml:mo>&#x000d7;</mml:mo><mml:mfenced open="(" close=")"><mml:mrow><mml:msub><mml:mo>Pr</mml:mo><mml:mtext>exp</mml:mtext></mml:msub><mml:mo>&#x000d7;</mml:mo><mml:mfenced open="(" close=")"><mml:mrow><mml:mi mathvariant="italic">R</mml:mi><mml:msub><mml:mi mathvariant="italic">R</mml:mi><mml:mrow><mml:mi mathvariant="italic">p</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="italic">lcl</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="italic">ucl</mml:mi><mml:mo>;</mml:mo><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>&#x02212;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mo>(</mml:mo><mml:msub><mml:mo>Pr</mml:mo><mml:mtext>exp</mml:mtext></mml:msub><mml:mfenced open="(" close=")"><mml:mrow><mml:mi mathvariant="italic">R</mml:mi><mml:msub><mml:mi mathvariant="italic">R</mml:mi><mml:mrow><mml:mi mathvariant="italic">p</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="italic">lcl</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="italic">ucl</mml:mi><mml:mo>;</mml:mo><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>&#x02212;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mspace width="8.8em"/><mml:mo>=</mml:mo><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mi mathvariant="italic">&#x003b8;</mml:mi><mml:mi mathvariant="italic">ij</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula></p><p><disp-formula id="bmcM1.2"><label>(1.2)</label><mml:math id="M2" name="1471-2458-14-643-i2" overflow="scroll"><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mi mathvariant="italic">Var</mml:mi><mml:mfenced open="(" close=")"><mml:msub><mml:mi mathvariant="italic">&#x003b8;</mml:mi><mml:mi mathvariant="italic">ij</mml:mi></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:mi mathvariant="italic">Var</mml:mi><mml:mo stretchy="true">(</mml:mo><mml:mn>1</mml:mn><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mi mathvariant="italic">&#x003b8;</mml:mi><mml:mi mathvariant="italic">ij</mml:mi></mml:msub><mml:mo stretchy="true">)</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="true">(</mml:mo><mml:mn>1</mml:mn><mml:mo>&#x02212;</mml:mo><mml:mi mathvariant="italic">PA</mml:mi><mml:msub><mml:mi mathvariant="italic">R</mml:mi><mml:mrow><mml:mi mathvariant="italic">p</mml:mi><mml:mo>;</mml:mo><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="true">)</mml:mo><mml:msup><mml:mrow/><mml:mn>2</mml:mn></mml:msup><mml:mo>&#x000d7;</mml:mo><mml:mi mathvariant="italic">Var</mml:mi><mml:mo stretchy="true">(</mml:mo><mml:mi mathvariant="italic">Ln</mml:mi><mml:mo stretchy="true">(</mml:mo><mml:mn>1</mml:mn><mml:mo>&#x02212;</mml:mo><mml:mi mathvariant="italic">PA</mml:mi><mml:msub><mml:mi mathvariant="italic">R</mml:mi><mml:mrow><mml:mi mathvariant="italic">p</mml:mi><mml:mo>;</mml:mo><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="true">)</mml:mo><mml:mo stretchy="true">)</mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mspace width="3.9em"/><mml:mo>=</mml:mo><mml:msup><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo>&#x02212;</mml:mo><mml:mi mathvariant="italic">PA</mml:mi><mml:msub><mml:mi mathvariant="italic">R</mml:mi><mml:mrow><mml:mi mathvariant="italic">p</mml:mi><mml:mo>;</mml:mo><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mn>2</mml:mn></mml:msup><mml:mo>&#x000d7;</mml:mo><mml:mo stretchy="true">(</mml:mo><mml:mi mathvariant="italic">Ln</mml:mi><mml:mo stretchy="true">(</mml:mo><mml:mn>1</mml:mn><mml:mo>&#x02212;</mml:mo><mml:mi mathvariant="italic">PA</mml:mi><mml:msub><mml:mi mathvariant="italic">R</mml:mi><mml:mrow><mml:mi mathvariant="italic">lcl</mml:mi><mml:mo>;</mml:mo><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="true">)</mml:mo><mml:mo>&#x02212;</mml:mo><mml:mi mathvariant="italic">Ln</mml:mi><mml:mo stretchy="true">(</mml:mo><mml:mn>1</mml:mn><mml:mo>&#x02212;</mml:mo><mml:mi mathvariant="italic">PA</mml:mi><mml:msub><mml:mi mathvariant="italic">R</mml:mi><mml:mrow><mml:mi mathvariant="italic">ucl</mml:mi><mml:mo>;</mml:mo><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="true">)</mml:mo><mml:mo stretchy="true">/</mml:mo><mml:mn>3.92</mml:mn><mml:mo stretchy="true">)</mml:mo><mml:msup><mml:mrow/><mml:mn>2</mml:mn></mml:msup></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula></p><p><disp-formula id="bmcM1.3"><label>(1.3)</label><mml:math id="M3" name="1471-2458-14-643-i3" overflow="scroll"><mml:mrow><mml:mi mathvariant="italic">PAR</mml:mi><mml:msub><mml:mo mathvariant="normal">%</mml:mo><mml:mrow><mml:mn>95</mml:mn><mml:mo mathvariant="normal">%</mml:mo><mml:mi mathvariant="italic">CI</mml:mi><mml:mo>;</mml:mo><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi mathvariant="italic">PAR</mml:mi><mml:msub><mml:mo>%</mml:mo><mml:mrow><mml:mi mathvariant="italic">p</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>&#x000b1;</mml:mo><mml:mn>1.96</mml:mn><mml:mo>&#x000d7;</mml:mo><mml:msqrt><mml:mrow><mml:mi mathvariant="italic">Var</mml:mi><mml:mfenced open="(" close=")"><mml:msub><mml:mi mathvariant="italic">&#x003b8;</mml:mi><mml:mi mathvariant="italic">ij</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:msqrt><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:math></disp-formula></p><p>As shown in Equations 1.1, 1.2 and 1.3, RR (point estimates per study and data point; 95% CI) was applied to the formula and Pr<sub>exp</sub> was the estimated prevalence of each exposure. The estimation of SE for PAR% was obtained using the delta method [<xref ref-type="bibr" rid="B261">261</xref>].</p><p>Finally, in order to examine publication bias, we used Begg&#x02019;s funnel plots; each RR point estimate was plotted against their corresponding standard errors (SE) for each study on a logarithmic scale [<xref ref-type="bibr" rid="B262">262</xref>,<xref ref-type="bibr" rid="B263">263</xref>], for all exposures combined. This type of bias was also formally tested using the Begg-adjusted rank correlation tests [<xref ref-type="bibr" rid="B264">264</xref>] and the Egger&#x02019;s regression asymmetry test [<xref ref-type="bibr" rid="B265">265</xref>]. All analyses were conducted with STATA 11.0 (StataCorp, College Station, TX) [<xref ref-type="bibr" rid="B266">266</xref>]. Type I error was set at 0.05 for all measures of association.</p></sec></sec><sec><title>Results and discussion</title><sec><title>Socio-economic Status (SES) as indicated by education</title><p>Early life conditions are related to cognitive development and abilities in childhood and cognitive function in adulthood. Low educational attainment and other markers of low socio-economic position (SEP) were associated with poorer cognitive function in adulthood and age-related cognitive decline and impairment, as well as greater risk or prevalence of dementia and AD in the elderly. In this study, we focused our attention on education as a maker of SES, given that it is the most commonly studied protective factor.</p><p>Several possible mechanisms support the finding that less education is related to cognitive decline: First, education may exert direct effects on brain structure early in life by increasing synapse number or vascularization and creating cognitive reserve. This was named the &#x0201c;reserve capacity&#x0201d; hypothesis. Thus, this hypothesis states that early life conditions affect the pace of cognitive decline in later life [<xref ref-type="bibr" rid="B38">38</xref>]. Education in early life may have effects in later life if persons with more education continue searching for mental stimulation (&#x0201c;the use it or lose it&#x0201d; hypothesis), which may lead to beneficial neurochemical or structural alterations in the brain [<xref ref-type="bibr" rid="B267">267</xref>]. Indeed, in one study, recent mental stimulation was associated with improved cognitive functioning [<xref ref-type="bibr" rid="B268">268</xref>]. Alternatively, education may act through several &#x0201c;behavioral mediators&#x0201d; to improve health in general, and cognitive functioning in particular [<xref ref-type="bibr" rid="B267">267</xref>]. This hypothesis was confirmed by a study using the Framingham cohort which suggested that education was uniquely protective against VaD and not associated with AD [<xref ref-type="bibr" rid="B28">28</xref>]. This finding was explained by mediating effects of other risk factors of cognitive decline, including smoking and hypertension, which in turn can initiate cerebrovascular damage. However, Lee and colleagues [<xref ref-type="bibr" rid="B52">52</xref>] found evidence contrary to this hypothesis by showing a sustained strong association between education and cognitive functioning after adjustment for behavioral and health-related factors.</p><p>Based on our findings (Table&#x000a0;<xref ref-type="table" rid="T2">2</xref> and Figure&#x000a0;<xref ref-type="fig" rid="F2">2</xref>A), 18 (66.7%) of the 27 cohort studies that met our selection criteria found that lower education was linked to a worse cognitive outcome in the overall population and for all studied outcomes, 1 found this relationship with incident VaD but not AD [<xref ref-type="bibr" rid="B28">28</xref>], 1 found the relationship with cognitive function but not decline [<xref ref-type="bibr" rid="B64">64</xref>], 1 concluded that IQ was a better predictor than education [<xref ref-type="bibr" rid="B38">38</xref>], and 2 detected a significant association in the hypothesized direction only in women [<xref ref-type="bibr" rid="B44">44</xref>] and in ApoE4- individuals [<xref ref-type="bibr" rid="B53">53</xref>]. The remaining four cohort studies did not find an association in the hypothesized direction [<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B60">60</xref>,<xref ref-type="bibr" rid="B68">68</xref>,<xref ref-type="bibr" rid="B71">71</xref>].</p><fig id="F2" position="float"><label>Figure 2</label><caption><p>Main findings (%) of selected studies, given hypothesis: (A) Cohort Studies (B) Cross-sectional studies.</p></caption><graphic xlink:href="1471-2458-14-643-2"/></fig><p><italic>Note:</italic> +(ALL)&#x02009;=&#x02009;positive finding, given hypothesis, for all subjects and most outcomes of interest; +(some outcomes)&#x02009;=&#x02009;positive finding, given hypothesis, for all subjects and some outcomes of interest but not others; +(some groups)&#x02009;=&#x02009;positive finding, given hypothesis, for some groups and most outcomes of interest; 0&#x02009;=&#x02009;null finding, given hypothesis; &#x02212;&#x02009;=&#x02009;finding against hypothesized direction. *P-value based on <italic>&#x003c7;</italic><sup>2</sup> test for independence between risk factor and finding.</p><p>The association between education and the studied cognitive outcomes was in the hypothesized direction, with higher education being protective, for the majority of the selected cross-sectional studies (21 out of 25, 84%), while 2 found an association with prevalent AD but not VaD [<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B56">56</xref>], 1 found that literacy was a better predictor than education [<xref ref-type="bibr" rid="B61">61</xref>], and 1 failed to detect a significant association [<xref ref-type="bibr" rid="B40">40</xref>] (See Table&#x000a0;<xref ref-type="table" rid="T2">2</xref> and Figure&#x000a0;<xref ref-type="fig" rid="F2">2</xref>B).</p></sec><sec><title>Behavioral factors</title><p>Several behavioral factors were selected, including smoking, alcohol drinking,and physical activity.</p><sec><title>Smoking</title><p>Smoking is a risk factor for several chronic diseases, but its long-term relationship with dementia of various sub-types is still controversial. In fact, smoking is well known to increase the risk of stroke [<xref ref-type="bibr" rid="B269">269</xref>] and thus subsequent vascular types of dementia (VaD). However, many studies have concluded that smoking status influenced risk of VaD independently of stroke status and thus may have an effect beyond cerebrovascular disease. In addition, studies that have shown a direct impact of smoking on AD, suggest that smoking might in fact influence neurodegeneration. A vast amount of literature points to a role of smoking in oxidative stress and inflammation, both mechanisms believed to play a key role in AD [<xref ref-type="bibr" rid="B270">270</xref>].</p><p>However, it is also biologically plausible that smoking might protect against cognitive decline and AD, given that nicotine, a key active component of tobacco, may enhance the release of acetylcholine, increase the density of nicotnic receptors, therefore improving attention and information processing [<xref ref-type="bibr" rid="B271">271</xref>]. It is now known that AD is characterized by cholinergic system deficits which may be delayed through tobacco consumption [<xref ref-type="bibr" rid="B271">271</xref>,<xref ref-type="bibr" rid="B272">272</xref>].</p><p>Population-based evidence of an effect of smoking on cognitive outcomes was inconclusive, with most longitudinal studies reporting weak or null associations [<xref ref-type="bibr" rid="B63">63</xref>,<xref ref-type="bibr" rid="B72">72</xref>,<xref ref-type="bibr" rid="B74">74</xref>,<xref ref-type="bibr" rid="B76">76</xref>,<xref ref-type="bibr" rid="B77">77</xref>,<xref ref-type="bibr" rid="B82">82</xref>,<xref ref-type="bibr" rid="B84">84</xref>,<xref ref-type="bibr" rid="B90">90</xref>]. However, a number of other cohort studies have found a positive association between smoking and risk of incident dementia and AD [<xref ref-type="bibr" rid="B78">78</xref>,<xref ref-type="bibr" rid="B86">86</xref>,<xref ref-type="bibr" rid="B88">88</xref>,<xref ref-type="bibr" rid="B93">93</xref>,<xref ref-type="bibr" rid="B95">95</xref>,<xref ref-type="bibr" rid="B98">98</xref>,<xref ref-type="bibr" rid="B101">101</xref>,<xref ref-type="bibr" rid="B103">103</xref>,<xref ref-type="bibr" rid="B104">104</xref>] as well as incident cognitive impairment [<xref ref-type="bibr" rid="B75">75</xref>,<xref ref-type="bibr" rid="B81">81</xref>,<xref ref-type="bibr" rid="B90">90</xref>] and age-related cognitive decline [<xref ref-type="bibr" rid="B83">83</xref>,<xref ref-type="bibr" rid="B85">85</xref>,<xref ref-type="bibr" rid="B89">89</xref>,<xref ref-type="bibr" rid="B96">96</xref>,<xref ref-type="bibr" rid="B99">99</xref>,<xref ref-type="bibr" rid="B105">105</xref>].</p><p>For instance, the British 1946 birth cohort study pointed to the difficulty of finding an association between smoking and cognitive impairment given the differential high mortality of smokers especially among the elderly population [<xref ref-type="bibr" rid="B85">85</xref>]. After controlling for a range of socioeconomic and health status indicators (both physical and mental), they found that smokers who survive into later life may be at risk of clinically significant cognitive decline. However, these effects were accounted for largely by heavy smokers, i.e. those who smoked 20 cigarettes per day or more. Earlier research on middle aged adults suggested that current smoking and number of pack-years of smoking were related to reduced performance on tests of psychomotor speed and cognitive flexibility assessed approximately five years later [<xref ref-type="bibr" rid="B83">83</xref>]. Similar results were shown for cognitive decline in a large cohort study (Rotterdam study) conducted in multiple European countries [<xref ref-type="bibr" rid="B89">89</xref>] and in another more recent study conducted in the United States [<xref ref-type="bibr" rid="B92">92</xref>].</p><p>Among studies that examined incidence of AD in relation to smoking status, two of the largest European cohort studies reported conflicting results. While one found no relationship between smoking status and incident AD among a large sample of 34,439 older UK men (mean age: 81) [<xref ref-type="bibr" rid="B82">82</xref>], the recent 2011 study found that heavy smoking increased the risk of dementia and AD in a younger sample of 21,123 older Finnish adults (Mean age:60.1) that comprised both men and women [<xref ref-type="bibr" rid="B104">104</xref>].</p><p>In sum, 16 (55.2%) out of the 29 selected cohort studies linking smoking to the various cognitive outcomes found the relationship to be in the hypothesized direction in the entire population that was studied and for most outcomes of interest [<xref ref-type="bibr" rid="B75">75</xref>,<xref ref-type="bibr" rid="B81">81</xref>,<xref ref-type="bibr" rid="B83">83</xref>,<xref ref-type="bibr" rid="B85">85</xref>,<xref ref-type="bibr" rid="B86">86</xref>,<xref ref-type="bibr" rid="B88">88</xref>,<xref ref-type="bibr" rid="B89">89</xref>,<xref ref-type="bibr" rid="B92">92</xref>-<xref ref-type="bibr" rid="B96">96</xref>,<xref ref-type="bibr" rid="B98">98</xref>,<xref ref-type="bibr" rid="B99">99</xref>,<xref ref-type="bibr" rid="B101">101</xref>,<xref ref-type="bibr" rid="B104">104</xref>], while 2 found this relationship for some outcomes but not others [<xref ref-type="bibr" rid="B97">97</xref>,<xref ref-type="bibr" rid="B103">103</xref>] and 2 detected it for a sub-group of the total population [<xref ref-type="bibr" rid="B78">78</xref>,<xref ref-type="bibr" rid="B105">105</xref>], while the remaining 9 studies did not find an association [<xref ref-type="bibr" rid="B63">63</xref>,<xref ref-type="bibr" rid="B72">72</xref>,<xref ref-type="bibr" rid="B74">74</xref>,<xref ref-type="bibr" rid="B76">76</xref>,<xref ref-type="bibr" rid="B77">77</xref>,<xref ref-type="bibr" rid="B82">82</xref>,<xref ref-type="bibr" rid="B84">84</xref>,<xref ref-type="bibr" rid="B90">90</xref>] or found an association in the opposite direction [<xref ref-type="bibr" rid="B102">102</xref>]. (See Table&#x000a0;<xref ref-type="table" rid="T2">2</xref> and Figure&#x000a0;<xref ref-type="fig" rid="F2">2</xref>A).</p><p>Only 2 (28.6%) of the 7 cross-sectional studies found an association in the hypothesized direction [<xref ref-type="bibr" rid="B36">36</xref>,<xref ref-type="bibr" rid="B87">87</xref>], while 2 detected it for a sub-group of the total population [<xref ref-type="bibr" rid="B79">79</xref>,<xref ref-type="bibr" rid="B100">100</xref>], and the remaining 3 did not detect a significant association [<xref ref-type="bibr" rid="B73">73</xref>,<xref ref-type="bibr" rid="B80">80</xref>,<xref ref-type="bibr" rid="B91">91</xref>], (See Table&#x000a0;<xref ref-type="table" rid="T2">2</xref> and Figure&#x000a0;<xref ref-type="fig" rid="F2">2</xref>B).</p></sec><sec><title>Alcohol</title><p>Alcohol consumption in moderation was hypothesized to be protective against cognitive decline and impairment in old age. Several mechanisms may be involved in explaining the potential protective effect of moderate alcohol consumption on various cognitive outcomes. First, this effect might be mediated through cardiovascular risk factor reduction, partly through a dampening effect of ethanol on platelet aggregation, or through a modification of the serum lipid profile. Second, another potential mechanism in which alcohol can have a direct effect on cognitive function is through acetylcholine release in the hippocampus, which in turn enhances learning and memory [<xref ref-type="bibr" rid="B273">273</xref>].</p><p>The Rotterdam study [<xref ref-type="bibr" rid="B83">83</xref>] also examined the effect of alcohol use on cognition. They found that past alcohol consumption&#x02019;s effect on speed and flexibility appeared to be slightly U-shaped, with the best performance observed among those who drank 1&#x02013;4 glasses of alcohol per day, although this association was stronger among women than among men. Other studies also detected sex differences [<xref ref-type="bibr" rid="B106">106</xref>,<xref ref-type="bibr" rid="B107">107</xref>,<xref ref-type="bibr" rid="B111">111</xref>]. Light to moderate alcohol consumption was also found beneficial based on findings of other cohort and cross-sectional studies with a U- or J-shaped pattern observed [<xref ref-type="bibr" rid="B108">108</xref>-<xref ref-type="bibr" rid="B110">110</xref>,<xref ref-type="bibr" rid="B113">113</xref>,<xref ref-type="bibr" rid="B114">114</xref>,<xref ref-type="bibr" rid="B116">116</xref>,<xref ref-type="bibr" rid="B117">117</xref>,<xref ref-type="bibr" rid="B119">119</xref>-<xref ref-type="bibr" rid="B121">121</xref>,<xref ref-type="bibr" rid="B124">124</xref>-<xref ref-type="bibr" rid="B127">127</xref>]. However, in other studies, a linear dose&#x02013;response relationship between alcohol use and improved cognition was noted, though the authors cautioned that these should not encourage increased alcohol consumption without an upper bound to this consumption [<xref ref-type="bibr" rid="B114">114</xref>,<xref ref-type="bibr" rid="B115">115</xref>,<xref ref-type="bibr" rid="B122">122</xref>,<xref ref-type="bibr" rid="B131">131</xref>].</p><p>In one cross-sectional study, a linear relationship between alcohol consumption and cognitive function was found in women but a U-shaped pattern was found in men [<xref ref-type="bibr" rid="B109">109</xref>]. One cohort study found that overall, moderate consumption was protective against poor cognitive function, but had an opposite relationship with cognitive function among ApoE4<sup>+</sup> individuals [<xref ref-type="bibr" rid="B113">113</xref>], while another found that alcohol use in general was related to better cognition without effect modification by ApoE4 status [<xref ref-type="bibr" rid="B123">123</xref>]. Slower memory decline with increased alcohol consumption in men was found in one study, though the opposite relationship was found in the case of psychomotor speed among women [<xref ref-type="bibr" rid="B118">118</xref>]. The positive association between alcohol intake and memory was also noted in at least one other cross-sectional study for both men and women combined [<xref ref-type="bibr" rid="B128">128</xref>]. Moreover, heavy alcohol use was linked to poorer cognitive outcomes in a few studies [<xref ref-type="bibr" rid="B87">87</xref>,<xref ref-type="bibr" rid="B127">127</xref>,<xref ref-type="bibr" rid="B129">129</xref>,<xref ref-type="bibr" rid="B130">130</xref>]. Finally, only a few studies among those that were selected found no associations between alcohol consumption and cognitive outcomes [<xref ref-type="bibr" rid="B76">76</xref>,<xref ref-type="bibr" rid="B77">77</xref>,<xref ref-type="bibr" rid="B112">112</xref>].</p><p>In fact, 8 out of the 18 selected cohort studies (44%) linking alcohol consumption to the various cognitive outcomes, found the relationship to be in the hypothesized direction (but were U-shaped, J-shaped or linear) in the entire population that was studied and for most outcomes of interest [<xref ref-type="bibr" rid="B108">108</xref>,<xref ref-type="bibr" rid="B114">114</xref>,<xref ref-type="bibr" rid="B116">116</xref>,<xref ref-type="bibr" rid="B117">117</xref>,<xref ref-type="bibr" rid="B122">122</xref>,<xref ref-type="bibr" rid="B124">124</xref>,<xref ref-type="bibr" rid="B125">125</xref>,<xref ref-type="bibr" rid="B131">131</xref>], while 2 found this relationship for some outcomes but not others [<xref ref-type="bibr" rid="B115">115</xref>,<xref ref-type="bibr" rid="B120">120</xref>] and 4 detected it for a sub-group of the total population [<xref ref-type="bibr" rid="B83">83</xref>,<xref ref-type="bibr" rid="B111">111</xref>,<xref ref-type="bibr" rid="B113">113</xref>,<xref ref-type="bibr" rid="B118">118</xref>]. Moreover, 1 cohort studies have indicated that alcohol use was generally linked to poor cognitive outcomes for the total population [<xref ref-type="bibr" rid="B87">87</xref>]. Finally, 3 did not find any significant associations between alcohol consumption and the various cognitive outcomes that were under study [<xref ref-type="bibr" rid="B76">76</xref>,<xref ref-type="bibr" rid="B77">77</xref>,<xref ref-type="bibr" rid="B129">129</xref>]. (See Table&#x000a0;<xref ref-type="table" rid="T2">2</xref> and Figure&#x000a0;<xref ref-type="fig" rid="F2">2</xref>A).</p><p>9 of the 12 cross-sectional studies (75%) found an association in the hypothesized direction for the entire study population and for most outcomes of interest [<xref ref-type="bibr" rid="B106">106</xref>,<xref ref-type="bibr" rid="B109">109</xref>,<xref ref-type="bibr" rid="B110">110</xref>,<xref ref-type="bibr" rid="B119">119</xref>,<xref ref-type="bibr" rid="B121">121</xref>,<xref ref-type="bibr" rid="B123">123</xref>,<xref ref-type="bibr" rid="B126">126</xref>-<xref ref-type="bibr" rid="B128">128</xref>]. The remaining 3 studies either found this U-shaped or J-shaped association in a sub-group [<xref ref-type="bibr" rid="B107">107</xref>], and either failed to detect any association [<xref ref-type="bibr" rid="B112">112</xref>] or detected one that was not in line with the hypothesis, whereby alcohol use was generally found to result in poor cognitive outcomes [<xref ref-type="bibr" rid="B130">130</xref>]. (See Table&#x000a0;<xref ref-type="table" rid="T2">2</xref> and Figure&#x000a0;<xref ref-type="fig" rid="F2">2</xref>B).</p></sec><sec><title>Physical activity</title><p>Physical activity has many well-known benefits for preventing a number of chronic disorders, including coronary heart disease, stroke, diabetes mellitus and osteoporosis. However, its impact on cognitive functioning has not been studied extensively. Several mechanisms may underlie the potentially protective effects of physical activity on cognitive function, including sustained cerebral blood flow [<xref ref-type="bibr" rid="B274">274</xref>], improved aerobic capacity and cerebral nutrient supply [<xref ref-type="bibr" rid="B275">275</xref>,<xref ref-type="bibr" rid="B276">276</xref>] as well as growth factors, specifically the brain-derived neurotropic factor, which is a molecule that increases neuronal survival, enhances learning, and protects against cognitive decline [<xref ref-type="bibr" rid="B277">277</xref>,<xref ref-type="bibr" rid="B278">278</xref>].</p><p>Currently, 24 cohort and 4 cross-sectional studies have examined the hypothesized relationship. For instance, a recent cohort study of 716 dementia-free older adults from the Rush Memory and Aging Project who were followed-up for an average of 4&#x000a0;years found an inverse relationship between total daily physical activity and incident AD after controlling for age, sex, education, self-report physical, social, and cognitive activities, as well as current level of motor function, depressive symptoms, chronic health conditions, and ApoE4 allele status [<xref ref-type="bibr" rid="B156">156</xref>]. Furthermore, a recent cross-sectional study of 9344 women, 65&#x000a0;years and older, found a lower prevalence of cognitive impairment among those who reported being physically active versus those who reported being physically inactive at different stages of their lives [<xref ref-type="bibr" rid="B155">155</xref>].</p><p>These findings suggested that physical activity could represent an important and potent protective factor for cognitive decline and dementia in elderly persons. Significant findings were obtained by other recent cohort [<xref ref-type="bibr" rid="B132">132</xref>-<xref ref-type="bibr" rid="B145">145</xref>,<xref ref-type="bibr" rid="B147">147</xref>,<xref ref-type="bibr" rid="B148">148</xref>,<xref ref-type="bibr" rid="B150">150</xref>-<xref ref-type="bibr" rid="B154">154</xref>,<xref ref-type="bibr" rid="B156">156</xref>-<xref ref-type="bibr" rid="B158">158</xref>] and cross-sectional studies [<xref ref-type="bibr" rid="B100">100</xref>,<xref ref-type="bibr" rid="B146">146</xref>,<xref ref-type="bibr" rid="B149">149</xref>]. Only one cohort study resulted in non-significant findings [<xref ref-type="bibr" rid="B143">143</xref>].</p><p>In sum, of the 24 selected cohort studies linking physical activity to the various cognitive outcomes, 21(87.5%) found the relationship in the hypothesized direction in the entire population that was studied and for most outcomes of interest [<xref ref-type="bibr" rid="B132">132</xref>,<xref ref-type="bibr" rid="B133">133</xref>,<xref ref-type="bibr" rid="B135">135</xref>-<xref ref-type="bibr" rid="B140">140</xref>,<xref ref-type="bibr" rid="B142">142</xref>,<xref ref-type="bibr" rid="B144">144</xref>,<xref ref-type="bibr" rid="B145">145</xref>,<xref ref-type="bibr" rid="B147">147</xref>,<xref ref-type="bibr" rid="B148">148</xref>,<xref ref-type="bibr" rid="B150">150</xref>-<xref ref-type="bibr" rid="B154">154</xref>,<xref ref-type="bibr" rid="B156">156</xref>-<xref ref-type="bibr" rid="B158">158</xref>,<xref ref-type="bibr" rid="B279">279</xref>], while 1 found this relationship in ApoE4 carriers [<xref ref-type="bibr" rid="B134">134</xref>] and 1 in non-carriers [<xref ref-type="bibr" rid="B141">141</xref>]. In one cohort study, the association was against its hypothesized direction [<xref ref-type="bibr" rid="B143">143</xref>]. (See Table&#x000a0;<xref ref-type="table" rid="T2">2</xref> and Figure&#x000a0;<xref ref-type="fig" rid="F2">2</xref>A).</p><p>In addition, all 4 of the selected cross-sectional studies (100%) found an association in the hypothesized direction for the entire study population and for most outcomes of interest (See Table&#x000a0;<xref ref-type="table" rid="T2">2</xref> and Figure&#x000a0;<xref ref-type="fig" rid="F2">2</xref>B).</p></sec></sec><sec><title>Nutritional factors</title><p>Nutritional factors being studied in relation to cognitive outcomes included caffeine consumpion, antioxidant nutrients and Hcy. In addition, special attention was devoted recently to one class of essential fatty acids, namely <italic>n</italic>-3 fatty acids.</p><sec><title>Caffeine</title><p>Caffeine is known to be the most widely used psychoactive drug worldwide. Its main source is coffee particularly in Western diets. Acting as a stimulant of the central nervous system, caffeine causes heightened alertness and arousal [<xref ref-type="bibr" rid="B280">280</xref>]. Previous literature yielded inconsistent findings about the effects of caffeine consumption on cognitive processes. In fact, caffeine improved perceptual speed and vigilance, as well as more complex functions such as memory [<xref ref-type="bibr" rid="B281">281</xref>]. Caffeine is one type of compound known as methylxanthines whose effects are mainly to block adenosine receptors in the brain, resulting in cholinergic stimulation. It was hypothesized that such stimulation would lead to improved memory [<xref ref-type="bibr" rid="B282">282</xref>]. The earliest large cross-sectional study conducted by Jarvis and colleagues found that caffeine improved cognitive performance [<xref ref-type="bibr" rid="B159">159</xref>]. Later on, other cross-sectional studies focusing on tea consumption found similar results [<xref ref-type="bibr" rid="B100">100</xref>,<xref ref-type="bibr" rid="B162">162</xref>,<xref ref-type="bibr" rid="B167">167</xref>,<xref ref-type="bibr" rid="B170">170</xref>]. Others, however, did not show evidence of a significant protective effect [<xref ref-type="bibr" rid="B160">160</xref>,<xref ref-type="bibr" rid="B168">168</xref>]. In sum, 4 of 7 selected cross-sectional studies linking caffeine consumption to various cognitive outcomes found the relationship to be in the hypothesized direction in the study population and for most outcomes of interest (57.1%), one found this association in men [<xref ref-type="bibr" rid="B100">100</xref>] and two failed to find a significant association [<xref ref-type="bibr" rid="B160">160</xref>,<xref ref-type="bibr" rid="B168">168</xref>]. (See Table&#x000a0;<xref ref-type="table" rid="T2">2</xref> and Figure&#x000a0;<xref ref-type="fig" rid="F2">2</xref>B).</p><p>Of 11 cohort studies, positive findings pertained to 3 (27.3%) [<xref ref-type="bibr" rid="B163">163</xref>,<xref ref-type="bibr" rid="B164">164</xref>,<xref ref-type="bibr" rid="B175">175</xref>], though this was found only for coffee intake in two studies [<xref ref-type="bibr" rid="B165">165</xref>,<xref ref-type="bibr" rid="B169">169</xref>], while 5 recent studies detected this association only among women or for specific exposures [<xref ref-type="bibr" rid="B165">165</xref>,<xref ref-type="bibr" rid="B169">169</xref>,<xref ref-type="bibr" rid="B171">171</xref>-<xref ref-type="bibr" rid="B173">173</xref>]. The remaining cohort studies (3 of 11, 27%) did not find an association between caffeine intake and cognitive change [<xref ref-type="bibr" rid="B161">161</xref>] or incident dementia [<xref ref-type="bibr" rid="B166">166</xref>,<xref ref-type="bibr" rid="B174">174</xref>]. Given the paucity of large cohort studies, more research is needed to establish causality (See Table&#x000a0;<xref ref-type="table" rid="T2">2</xref> and Figure&#x000a0;<xref ref-type="fig" rid="F2">2</xref>A).</p></sec><sec><title>Antioxidants: focus on vitamin E</title><p>Several findings suggest that oxidative stress may play an important role in the pathogenesis of AD. First, the brains of AD patients have lesions that are associated with exposure to free radicals. Moreover, oxidative stress among these patients is also marked by an increased level of antioxidants in the brain that act as free radical scavengers. Finally, in vitro studies suggest that exogenous antioxidants may reduce the toxicity of &#x003b2;-amyloids in the brains of AD patients [<xref ref-type="bibr" rid="B283">283</xref>-<xref ref-type="bibr" rid="B285">285</xref>]. Based on these findings, it may be hypothesized that dietary antioxidants may help reduce the risk of AD.</p><p>Those epidemiologic studies examined the longitudinal relationship between <italic>supplemental antioxidants</italic> and risk of AD and other dementias found conflicting results: While vitamin C supplement use was related to lower AD risk in one cohort study [<xref ref-type="bibr" rid="B178">178</xref>], combined supplementation of vitamin E and vitamin C was associated with reduced prevalence and incidence of AD and cognitive decline in three other cohort studies [<xref ref-type="bibr" rid="B189">189</xref>,<xref ref-type="bibr" rid="B193">193</xref>,<xref ref-type="bibr" rid="B198">198</xref>], whereas another study found this effect to be specific to Vitamin E supplements [<xref ref-type="bibr" rid="B186">186</xref>]. These findings of a protective effect of supplemental antioxidant use against cognitive impairment and decline was replicated in a large cohort study [<xref ref-type="bibr" rid="B185">185</xref>]. However, there were only borderline or little evidence of a cognitive benefit from use of antioxidant supplements, particularly vitamins C and E, according to at least five independent cohort studies [<xref ref-type="bibr" rid="B177">177</xref>,<xref ref-type="bibr" rid="B180">180</xref>,<xref ref-type="bibr" rid="B187">187</xref>,<xref ref-type="bibr" rid="B192">192</xref>,<xref ref-type="bibr" rid="B199">199</xref>].</p><p>There are several prospective cohort studies on the effect of <italic>dietary antioxidants</italic> on the risk of dementia. One study found that high dietary intake of vitamins C and E may reduce the risk of AD [<xref ref-type="bibr" rid="B182">182</xref>] with the relationship most pronounced among smokers. Morris and colleagues [<xref ref-type="bibr" rid="B183">183</xref>] found that dietary intake of vitamin E, but not other antioxidants, was associated with a reduced risk of incident AD, although this association was restricted to individuals without the Apolipoprotein E &#x003f5;4 genotype. Similar findings were reported with cognitive decline as an outcome [<xref ref-type="bibr" rid="B184">184</xref>]. In a later study when both outcomes were considered it was concluded that certain forms of tocopherols not found in dietary supplements but found only in foods may be at play [<xref ref-type="bibr" rid="B194">194</xref>]. This observation was corroborated by at least one recent study [<xref ref-type="bibr" rid="B197">197</xref>]. Another study, however, suggested that dietary antioxidants were not able to reduce AD risk [<xref ref-type="bibr" rid="B187">187</xref>]. Similarly, Laurin and colleagues [<xref ref-type="bibr" rid="B188">188</xref>] found no association between midlife dietary intake of vitamins E and C and dementia incidence. At least five other cohort studies came to a similar conclusion [<xref ref-type="bibr" rid="B176">176</xref>,<xref ref-type="bibr" rid="B181">181</xref>,<xref ref-type="bibr" rid="B201">201</xref>,<xref ref-type="bibr" rid="B202">202</xref>]. In addition to examining associations of cognition with vitamins C and E, other studies found that carotenoids, particularly &#x003b2;-carotene intake, may be have beneficial effects of various cognitive outcomes [<xref ref-type="bibr" rid="B176">176</xref>], though others were not able to detect such an association [<xref ref-type="bibr" rid="B184">184</xref>,<xref ref-type="bibr" rid="B201">201</xref>,<xref ref-type="bibr" rid="B202">202</xref>].</p><p>Irrespective of the source of antioxidants, <italic>plasma concentration</italic> may be a good biomarker for oxidative stress status. In particular, an inverse association between plasma vitamin E among others and poor cognitive outcomes was found in at least two cross-sectional studies [<xref ref-type="bibr" rid="B179">179</xref>,<xref ref-type="bibr" rid="B190">190</xref>] and two cohort studies [<xref ref-type="bibr" rid="B196">196</xref>,<xref ref-type="bibr" rid="B200">200</xref>]. Another cross-sectional study, however, did not find evidence of an association between plasma antioxidants, including vitamin E and prevalent AD [<xref ref-type="bibr" rid="B191">191</xref>]. In addition, among studies that examined the influence of plasma carotenoids [<xref ref-type="bibr" rid="B179">179</xref>,<xref ref-type="bibr" rid="B195">195</xref>], only one detected a significant potential protective effect against cognitive impairment [<xref ref-type="bibr" rid="B195">195</xref>]. While these results are mixed, they suggest that at least one antioxidant has a protective effect against adverse cognitive outcomes.</p><p>In sum, of the 21 selected cohort studies linking antioxidants, with focus on vitamin E, to the various cognitive outcomes, 9 (42.9%) found the relationship to be in the hypothesized direction in the entire population that was studied and for most outcomes of interest [<xref ref-type="bibr" rid="B176">176</xref>,<xref ref-type="bibr" rid="B178">178</xref>,<xref ref-type="bibr" rid="B182">182</xref>,<xref ref-type="bibr" rid="B184">184</xref>,<xref ref-type="bibr" rid="B189">189</xref>,<xref ref-type="bibr" rid="B193">193</xref>,<xref ref-type="bibr" rid="B194">194</xref>,<xref ref-type="bibr" rid="B197">197</xref>,<xref ref-type="bibr" rid="B198">198</xref>], while 5 found this relationship for specific antioxidants or some outcomes but not others [<xref ref-type="bibr" rid="B180">180</xref>,<xref ref-type="bibr" rid="B183">183</xref>,<xref ref-type="bibr" rid="B186">186</xref>,<xref ref-type="bibr" rid="B196">196</xref>,<xref ref-type="bibr" rid="B200">200</xref>,<xref ref-type="bibr" rid="B201">201</xref>] and 1 detected it for a sub-group of the total population [<xref ref-type="bibr" rid="B183">183</xref>]. The remaining selected cohort studies (n&#x02009;=&#x02009;6) did not find a significant association [<xref ref-type="bibr" rid="B177">177</xref>,<xref ref-type="bibr" rid="B185">185</xref>,<xref ref-type="bibr" rid="B187">187</xref>,<xref ref-type="bibr" rid="B188">188</xref>,<xref ref-type="bibr" rid="B192">192</xref>,<xref ref-type="bibr" rid="B199">199</xref>]. (See Table&#x000a0;<xref ref-type="table" rid="T2">2</xref> and Figure&#x000a0;<xref ref-type="fig" rid="F2">2</xref>A).</p><p>Similarly, of the 6 cross-sectional studies that were selected, 2 (33.3%) found an association in the hypothesized direction for the entire study population and for most outcomes of interest [<xref ref-type="bibr" rid="B190">190</xref>,<xref ref-type="bibr" rid="B195">195</xref>], 1 found the association to hold only for vitamin E [<xref ref-type="bibr" rid="B179">179</xref>], whereas 3 found no significant association [<xref ref-type="bibr" rid="B181">181</xref>,<xref ref-type="bibr" rid="B191">191</xref>,<xref ref-type="bibr" rid="B202">202</xref>]. (See Table&#x000a0;<xref ref-type="table" rid="T2">2</xref> and Figure&#x000a0;<xref ref-type="fig" rid="F2">2</xref>B).</p></sec><sec><title>Homocysteine</title><p>An elevated level of plasma concentration of the sulfur amino acid Hcy (hyperhomocysteinemia) is recognized as an independent risk factor for cardiovascular, peripheral vascular, and cerebrovascular disease [<xref ref-type="bibr" rid="B286">286</xref>]. Accordingly, a potential influence of hyperhomocysteinemia on cognitive functioning among older adults was postulated and several studies were able to associate high levels of Hcy with increased risk of incident AD or all-cause dementia [<xref ref-type="bibr" rid="B206">206</xref>,<xref ref-type="bibr" rid="B217">217</xref>,<xref ref-type="bibr" rid="B224">224</xref>,<xref ref-type="bibr" rid="B228">228</xref>,<xref ref-type="bibr" rid="B233">233</xref>,<xref ref-type="bibr" rid="B234">234</xref>]. Studies have pointed to selective effect of Hcy on specific domains of cognition [<xref ref-type="bibr" rid="B214">214</xref>,<xref ref-type="bibr" rid="B287">287</xref>,<xref ref-type="bibr" rid="B288">288</xref>]. One explanation could be that Hcy might be affecting certain parts of the brain to a greater extent than others, and studies have linked Hcy to higher degree of white matter hyperintensities and with brain atrophy [<xref ref-type="bibr" rid="B289">289</xref>-<xref ref-type="bibr" rid="B293">293</xref>].</p><p>Even though blood Hcy levels increase with age and diminished renal function, it is largely determined by dietary intake of B-vitamins (mainly B-6 and B-12) and folate which are needed to convert Hcy into methionine and cysteine, through the methylation reactions [<xref ref-type="bibr" rid="B294">294</xref>]. Thus, Hcy status in plasma can be modified by dietary interventions. Moreover, vitamin B-12 plasma level has been shown to be inversely related to that of Hcy [<xref ref-type="bibr" rid="B295">295</xref>] and studies looking at Hcy levels and cognitive functioning also examined the effect of B-vitamins. In particular, vitamin B-12 was found to be protective against decline in at least three recent studies [<xref ref-type="bibr" rid="B204">204</xref>,<xref ref-type="bibr" rid="B213">213</xref>,<xref ref-type="bibr" rid="B219">219</xref>]. At least five other studies [<xref ref-type="bibr" rid="B204">204</xref>,<xref ref-type="bibr" rid="B213">213</xref>,<xref ref-type="bibr" rid="B214">214</xref>,<xref ref-type="bibr" rid="B216">216</xref>,<xref ref-type="bibr" rid="B217">217</xref>,<xref ref-type="bibr" rid="B219">219</xref>,<xref ref-type="bibr" rid="B221">221</xref>] concluded that fotate was protective against cognitive impairment or decline. For Vitamin B-6, two other studies suggested a protective effect [<xref ref-type="bibr" rid="B213">213</xref>,<xref ref-type="bibr" rid="B219">219</xref>]. An antagonistic interaction of folate and Vitamin B-12 with Hcy&#x02019;s effect on cognition was noted in other studies [<xref ref-type="bibr" rid="B224">224</xref>,<xref ref-type="bibr" rid="B296">296</xref>,<xref ref-type="bibr" rid="B297">297</xref>]. Aside from its link to cardiovascular disease, Hcy was shown to have neurotoxic and excitotoxic properties <italic>in vitro</italic>[<xref ref-type="bibr" rid="B298">298</xref>,<xref ref-type="bibr" rid="B299">299</xref>], suggesting a direct influence on cognition.</p><p>Overall, of the 19 selected cohort studies linking Hcy to the various cognitive outcomes, 12(63.2%) found the relationship in the hypothesized direction in the entire population that was studied and for most outcomes of interest [<xref ref-type="bibr" rid="B206">206</xref>,<xref ref-type="bibr" rid="B215">215</xref>,<xref ref-type="bibr" rid="B217">217</xref>,<xref ref-type="bibr" rid="B219">219</xref>,<xref ref-type="bibr" rid="B222">222</xref>-<xref ref-type="bibr" rid="B224">224</xref>,<xref ref-type="bibr" rid="B228">228</xref>,<xref ref-type="bibr" rid="B231">231</xref>,<xref ref-type="bibr" rid="B233">233</xref>-<xref ref-type="bibr" rid="B235">235</xref>], while 2 found this relationship for some outcomes but not others or a sub-group [<xref ref-type="bibr" rid="B213">213</xref>,<xref ref-type="bibr" rid="B214">214</xref>] and 5 were not able to detect a significant association [<xref ref-type="bibr" rid="B203">203</xref>,<xref ref-type="bibr" rid="B209">209</xref>,<xref ref-type="bibr" rid="B210">210</xref>,<xref ref-type="bibr" rid="B229">229</xref>,<xref ref-type="bibr" rid="B230">230</xref>]. (See Table&#x000a0;<xref ref-type="table" rid="T2">2</xref> and Figure&#x000a0;<xref ref-type="fig" rid="F2">2</xref>A).</p><p>Similarly, of the 14 cross-sectional studies that were selected, 11(78%) found an association in the hypothesized direction for the entire study population and for most outcomes of interest [<xref ref-type="bibr" rid="B204">204</xref>,<xref ref-type="bibr" rid="B205">205</xref>,<xref ref-type="bibr" rid="B207">207</xref>,<xref ref-type="bibr" rid="B208">208</xref>,<xref ref-type="bibr" rid="B216">216</xref>,<xref ref-type="bibr" rid="B218">218</xref>,<xref ref-type="bibr" rid="B220">220</xref>,<xref ref-type="bibr" rid="B221">221</xref>,<xref ref-type="bibr" rid="B225">225</xref>,<xref ref-type="bibr" rid="B227">227</xref>,<xref ref-type="bibr" rid="B232">232</xref>], 1 found an association only among older adults above age 60y [<xref ref-type="bibr" rid="B212">212</xref>], 1 detected it among ApoE4<sup>+</sup> individuals [<xref ref-type="bibr" rid="B226">226</xref>], and 1 found no significant relationship [<xref ref-type="bibr" rid="B211">211</xref>]. (See Table&#x000a0;<xref ref-type="table" rid="T2">2</xref> and Figure&#x000a0;<xref ref-type="fig" rid="F2">2</xref>B).</p></sec><sec><title>n-3 fatty acids</title><p>Another nutritional factor hypothesized to be protective against cognitive decline is higher intake of <italic>n-</italic>3 fatty acids and/or a better balance of <italic>n</italic>-3/<italic>n</italic>-6 fatty acids. Linoleic(LA&#x02009;~&#x02009;18:2<italic>n</italic>-6) and &#x003b1;-linolenic (LNA&#x02009;~&#x02009;18:3<italic>n</italic>-3) are two types of fatty acids that are essential for all members of the animal kingdom. These fatty acids and their respective derivatives are also commonly referred to as <italic>n</italic>-6 and <italic>n</italic>-3 fatty acids. Their essentiality lies in the fact that they cannot be synthesized <italic>de novo</italic> within the human or animal organism [<xref ref-type="bibr" rid="B300">300</xref>].</p><p>In the past, <italic>n</italic>-3 fatty acids were classified only as essential because of their ability to alleviate deficiency symptoms that include dermatitis, growth retardation and reproductive failure. However, <italic>n</italic>-3 fatty acids have other important neurological functions, which explain their high concentrations in neural and retinal tissues [<xref ref-type="bibr" rid="B301">301</xref>-<xref ref-type="bibr" rid="B303">303</xref>]. Some of the longer chain fatty acids that are synthesized from &#x003b1;-linolenic acid include Eicosapentanoic acid (EPA&#x02009;~&#x02009;20:5 <italic>n</italic>-3), which through further elongation, desaturation and &#x003b2;-oxidation produces Docosahexaenoic acid (DHA&#x02009;~&#x02009;22:6 <italic>n</italic>-3). On the other hand, products of linoleic acid which are also termed long-chain <italic>n</italic>-6 fatty acids include gamma-linoleic (GLA&#x02009;~&#x02009;18:3 <italic>n</italic>-6), dihomogammalinolenic acid (DGLA&#x02009;~&#x02009;20:3 <italic>n</italic>-6) and Arachidonic acid (AA&#x02009;~&#x02009;20:4 <italic>n</italic>-6) [<xref ref-type="bibr" rid="B304">304</xref>]. Of all organs in the human body (excluding adipose tissue), the nervous system has the highest lipid content. The dry weight of an adult brain is 50% to 60% lipid, and 35% of the lipid content is accounted for by polyunsaturated fatty acids (PUFAs) [<xref ref-type="bibr" rid="B305">305</xref>].</p><p>A review of scientific articles and biochemistry textbooks [<xref ref-type="bibr" rid="B306">306</xref>] suggested that the fatty acid composition of neuronal cell membrane phospholipids reflects their intake in the diet. Fish oils, which contain high levels of C20 and C22 PUFA, exert the most profound influence on brain PUFA concentrations [<xref ref-type="bibr" rid="B306">306</xref>]. The ratio between <italic>n</italic>-3 and <italic>n</italic>-6 PUFA may influence various aspects of serotoninergic and catecholaminergic neurotransmission, and it has been shown that by increasing the density of neurotransmitter receptors for acetylcholine and dopamine, dietary <italic>n</italic>-3 PUFA can improve learning and memory processes [<xref ref-type="bibr" rid="B307">307</xref>].</p><p>Previous observational studies suggested that the biochemical composition of blood components in terms of fatty acids differs significantly between subjects with normal cognitive functioning and patients with some form of cognitive impairment. While the majority of these studies showed an inverse association of plasma and erythrocyte <italic>n</italic>-3 fatty acids with cognition among older adults [<xref ref-type="bibr" rid="B243">243</xref>-<xref ref-type="bibr" rid="B245">245</xref>,<xref ref-type="bibr" rid="B248">248</xref>,<xref ref-type="bibr" rid="B255">255</xref>,<xref ref-type="bibr" rid="B258">258</xref>], at least one found no association between biochemical markers of <italic>n</italic>-3 fatty acids and cognition [<xref ref-type="bibr" rid="B251">251</xref>].</p><p>Epidemiological studies involving self-reported dietary data of <italic>n</italic>-3 fatty acids had suggestive but slightly controversial results. One study by Morris and colleagues used cohort data on 815 subjects who were initially unaffected by AD (age range: 65-94y, mean follow-up period&#x02009;=&#x02009;2.3y). Using standardized criteria, AD incidence was compared across <italic>n</italic>-3 fatty acid consumption groups, with those eating fish once per week compared to those who rarely or never eat fish having considerably lower incidence (RR&#x02009;=&#x02009;0.4; 95% CI: 0.2, 0.9). Total <italic>n</italic>-3 fatty acid consumption was also associated with a reduced AD risk even after controlling for intake of other dietary fats, vitamin E and for cardiovascular conditions [<xref ref-type="bibr" rid="B239">239</xref>]. A similar finding was reported later on for a larger but comparable cohort when looking at fish consumption and cognitive decline over time [<xref ref-type="bibr" rid="B241">241</xref>].</p><p>In the Zutphen Elderly Study, cognitive functioning and decline over three years were assessed in a cohort of 476 men aged 69-89y using the Mini-Mental State Examination (MMSE). Findings indicated that high linoleic acid intake (the main <italic>n</italic>-6 fatty acid in the diet) was associated with cognitive impairment, even after controlling for age, education, cigarette smoking, alcohol consumption and energy intake (OR&#x02009;=&#x02009;1.76, 95% CI: 1.04-3.01, comparing highest to lowest tertile). However, there was no distinctive association for <italic>n</italic>-3 fatty acids. Nevertheless, total fish consumption was suggestive of a protective effect, even though it did not reach significance [<xref ref-type="bibr" rid="B236">236</xref>].</p><p>Another larger cohort study&#x02013;The Rotterdam Study&#x02013; recruited 5,386 non-institutionalized participants, aged 55&#x02009;+&#x02009;y at baseline, who had normal cognition and assessed their complete dietary intake with a semi-quantitative food-frequency questionnaire. After an average 2.1y of follow-up, lower risk of incident dementia and AD was found among fish consumers and therefore among those with higher intake of <italic>n</italic>-3 fatty acids (RR&#x02009;=&#x02009;0.3; 95% CI: 0.1-0.9) [<xref ref-type="bibr" rid="B237">237</xref>]. However, when the study was conducted later with a longer follow-up (mean follow-up period of 6.0&#x000a0;years), it was concluded that high intake of total, saturated, trans fat, cholesterol and low intake of monounsatured fatty acids (MUFA), total PUFA, <italic>n</italic>-6 PUFA and <italic>n</italic>-3 PUFA were not associated with increased risk of dementia or its subtypes [<xref ref-type="bibr" rid="B238">238</xref>].</p><p>A cross-sectional study of 1,613 subjects aged 45&#x02013;70 years that examined the association between fatty acid and fish intake with cognitive function, found that the risk of cognitive impairment was reduced with increased consumption of fatty fish and marine <italic>n</italic>-3 PUFA. per Standard Deviation (SD) increased intake, the ORs were 0.81 (95% CI: 0.66, 1.00) and 0.72 (95% CI: 0.57, 0.90), respectively [<xref ref-type="bibr" rid="B240">240</xref>]. Another recent study using the Athersclerosis Risk in Communities (ARIC) cohort data suggested that dietary intake of <italic>n</italic>-3 fatty acids (mainly DHA&#x02009;+&#x02009;EPA) reduced the risk of cognitive decline in verbal fluency but not other cognitive domains (i.e. delayed word recall and psychomotor speed). This protective effect was particularly strong among hypertensive subjects [<xref ref-type="bibr" rid="B246">246</xref>]. The potentially protective effect of dietary <italic>n</italic>-3 fatty acid was also reported in several other large epidemiological studies [<xref ref-type="bibr" rid="B242">242</xref>,<xref ref-type="bibr" rid="B247">247</xref>,<xref ref-type="bibr" rid="B249">249</xref>,<xref ref-type="bibr" rid="B253">253</xref>,<xref ref-type="bibr" rid="B254">254</xref>,<xref ref-type="bibr" rid="B256">256</xref>-<xref ref-type="bibr" rid="B258">258</xref>], but not in others [<xref ref-type="bibr" rid="B250">250</xref>-<xref ref-type="bibr" rid="B252">252</xref>].</p><p>In sum, 7 out of the 18 (39%) selected cohort studies linking <italic>n</italic>-3 fatty acids to the various cognitive outcomes found the relationship in the hypothesized direction in the entire population that was studied and for most outcomes of interest [<xref ref-type="bibr" rid="B237">237</xref>,<xref ref-type="bibr" rid="B239">239</xref>,<xref ref-type="bibr" rid="B247">247</xref>,<xref ref-type="bibr" rid="B248">248</xref>,<xref ref-type="bibr" rid="B250">250</xref>,<xref ref-type="bibr" rid="B253">253</xref>,<xref ref-type="bibr" rid="B257">257</xref>], while 1 found this relationship for some outcomes but not others [<xref ref-type="bibr" rid="B245">245</xref>], 4 detected it for a sub-group of the total population [<xref ref-type="bibr" rid="B242">242</xref>,<xref ref-type="bibr" rid="B243">243</xref>,<xref ref-type="bibr" rid="B246">246</xref>,<xref ref-type="bibr" rid="B258">258</xref>], and 6 found no association [<xref ref-type="bibr" rid="B236">236</xref>,<xref ref-type="bibr" rid="B238">238</xref>,<xref ref-type="bibr" rid="B241">241</xref>,<xref ref-type="bibr" rid="B250">250</xref>-<xref ref-type="bibr" rid="B252">252</xref>] (See Table&#x000a0;<xref ref-type="table" rid="T2">2</xref> and Figure&#x000a0;<xref ref-type="fig" rid="F2">2</xref>A). In addition, all of the 5 (100%) cross-sectional studies that were selected found an association in the hypothesized direction for the entire study population and for most outcomes of interest [<xref ref-type="bibr" rid="B240">240</xref>,<xref ref-type="bibr" rid="B244">244</xref>,<xref ref-type="bibr" rid="B249">249</xref>,<xref ref-type="bibr" rid="B254">254</xref>,<xref ref-type="bibr" rid="B255">255</xref>] (See Table&#x000a0;<xref ref-type="table" rid="T2">2</xref> and Figure&#x000a0;<xref ref-type="fig" rid="F2">2</xref>B).</p></sec></sec><sec><title>Description of study-level characteristics and comparison by risk factor</title><p>Table&#x000a0;<xref ref-type="table" rid="T3">3</xref> shows descriptive findings of study-level characteristics and compares their distributions across risk factors. Out of the 247 selected studies, 98 were conducted in the US (39.7%), while 104 were carried out in a European country (42.1%), and the remaining 45 studies originated from Asia, Canada and Australia among others (18.2%). The majority of the selected studies were cohort studies (n&#x02009;=&#x02009;167). Most had only one type of cognitive outcome (72.5%), whereas 24.3% had two, and the remaining 3.2% had 3 or 4 outcomes. 152 studies had confirmed positive findings for most outcomes, exposures and for all study sub-groups (61.5%), while 18.2% (n&#x02009;=&#x02009;45) had null findings. Partially positive findings were found in around 18.2% while 2% had a finding against the hypothesized direction. Around 40.5% of studies included participants with ages &#x0003c;65y, and the majority had both men and women (84.2%). Incident AD as an outcome was available in 47 studies, while 47 studies included incident dementia as a main outcome of interest. On the other hand, cognitive function as an outcome was found in 83 of included studies, while 62 of those studies had cognitive decline or change as a primary outcome of interest (data not shown). In general, there was an almost even split between studies focusing on cognitive function/decline/change (51.0%) and studies focused on AD/dementia/impairment as outcomes (46.2%). Only 2.8% of the studies examined both categories. When comparing the distribution of those study-level characteristics by risk factor, we found some significant differences for year of publication, country, age group inclusion/exclusion, study design, cognitive outcome type and study finding. In particular, studies on education and cognitive outcomes tended to be published earlier than studies of other risk factors, there were significantly more European studies of n-3 FA compared to other risk factors, while most studies with PA excluded middle aged adults unlike other risk factors. The highest proportion of cohort studies was also found for PA. The vast majority of studies on alcohol and cognitive outcomes used cognitive function/decline as their primary outcome of interest, unlike other risk factors which were more balanced in terms of cognitive outcome type. The percent positive finding was highest among PA studies (89.3%) and lowest for caffeine studies (38.9%). The significant difference in percent &#x0201c;positive finding&#x0201d; was found in cohort studies (p&#x02009;=&#x02009;0.043) rather than cross-sectional studies (p&#x02009;=&#x02009;0.09) (See Figure&#x000a0;<xref ref-type="fig" rid="F2">2</xref>A-B).</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Study-level characteristics distribution, overall and comparison across risk factors</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead valign="top"><tr><th rowspan="2" align="left">&#x000a0;</th><th colspan="2" align="left" valign="bottom"><bold>Overall</bold><hr/></th><th colspan="2" align="left" valign="bottom"><bold>EDU</bold><hr/></th><th colspan="2" align="left" valign="bottom"><bold>SMOK</bold><hr/></th><th colspan="2" align="left" valign="bottom"><bold>ALCO</bold><hr/></th><th colspan="2" align="left" valign="bottom"><bold>PA</bold><hr/></th><th colspan="2" align="left" valign="bottom"><bold>CAFF</bold><hr/></th><th colspan="2" align="left" valign="bottom"><bold>ANTIOX</bold><hr/></th><th colspan="2" align="left" valign="bottom"><bold>HCY</bold><hr/></th><th colspan="2" align="left" valign="bottom"><bold>N-FA</bold><hr/></th><th rowspan="2" align="left"><bold>
<italic>P</italic>
</bold><bold>*</bold></th></tr><tr><th colspan="2" align="left"><bold>N&#x02009;=&#x02009;247</bold></th><th colspan="2" align="left"><bold>N&#x02009;=&#x02009;52</bold></th><th colspan="2" align="left"><bold>N&#x02009;=&#x02009;36</bold></th><th colspan="2" align="left"><bold>N&#x02009;=&#x02009;30</bold></th><th colspan="2" align="left"><bold>N&#x02009;=&#x02009;28</bold></th><th colspan="2" align="left"><bold>N&#x02009;=&#x02009;18</bold></th><th colspan="2" align="left"><bold>N&#x02009;=&#x02009;27</bold></th><th colspan="2" align="left"><bold>N&#x02009;=&#x02009;33</bold></th><th colspan="2" align="left"><bold>N&#x02009;=&#x02009;23</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="bottom">Year, Mean (SD)<hr/></td><td align="left" valign="bottom">2004.5<hr/></td><td align="left" valign="bottom">(5.1)<hr/></td><td align="left" valign="bottom">2001.3<hr/></td><td align="left" valign="bottom">(6.3)<hr/></td><td align="left" valign="bottom">2003.6<hr/></td><td align="left" valign="bottom">(5.2)<hr/></td><td align="left" valign="bottom">2004.5<hr/></td><td align="left" valign="bottom">(4.5)<hr/></td><td align="left" valign="bottom">2006.7<hr/></td><td align="left" valign="bottom">(3.6)<hr/></td><td align="left" valign="bottom">2007.7<hr/></td><td align="left" valign="bottom">(4.5)<hr/></td><td align="left" valign="bottom">2003.8<hr/></td><td align="left" valign="bottom">(3.8)<hr/></td><td align="left" valign="bottom">2006.2<hr/></td><td align="left" valign="bottom">(3.1)<hr/></td><td align="left" valign="bottom">2006.9<hr/></td><td align="left" valign="bottom">(4.0)<hr/></td><td align="left" valign="bottom">&#x0003c;0.001<hr/></td></tr><tr><td align="left" valign="bottom">Country, N (%)<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">98<hr/></td><td align="left" valign="bottom">(39.7)<hr/></td><td align="left" valign="bottom">16<hr/></td><td align="left" valign="bottom">(30.8)<hr/></td><td align="left" valign="bottom">12<hr/></td><td align="left" valign="bottom">(33.3)<hr/></td><td align="left" valign="bottom">15<hr/></td><td align="left" valign="bottom">(50.0)<hr/></td><td align="left" valign="bottom">17<hr/></td><td align="left" valign="bottom">(63.0)<hr/></td><td align="left" valign="bottom">3<hr/></td><td align="left" valign="bottom">(16.7)<hr/></td><td align="left" valign="bottom">17<hr/></td><td align="left" valign="bottom">(63.0)<hr/></td><td align="left" valign="bottom">13<hr/></td><td align="left" valign="bottom">(39.4)<hr/></td><td align="left" valign="bottom">5<hr/></td><td align="left" valign="bottom">(21.7)<hr/></td><td align="left" valign="bottom">0.020<hr/></td></tr><tr><td align="left" valign="bottom">Europe<hr/></td><td align="left" valign="bottom">104<hr/></td><td align="left" valign="bottom">(42.1)<hr/></td><td align="left" valign="bottom">22<hr/></td><td align="left" valign="bottom">(42.3)<hr/></td><td align="left" valign="bottom">18<hr/></td><td align="left" valign="bottom">(50.0)<hr/></td><td align="left" valign="bottom">9<hr/></td><td align="left" valign="bottom">(30.0)<hr/></td><td align="left" valign="bottom">8<hr/></td><td align="left" valign="bottom">(28.6)<hr/></td><td align="left" valign="bottom">10<hr/></td><td align="left" valign="bottom">(55.6)<hr/></td><td align="left" valign="bottom">8<hr/></td><td align="left" valign="bottom">(29.6)<hr/></td><td align="left" valign="bottom">14<hr/></td><td align="left" valign="bottom">(42.4)<hr/></td><td align="left" valign="bottom">15<hr/></td><td align="left" valign="bottom">(65.2)<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">Other<hr/></td><td align="left" valign="bottom">45<hr/></td><td align="left" valign="bottom">(18.2)<hr/></td><td align="left" valign="bottom">14<hr/></td><td align="left" valign="bottom">(26.9)<hr/></td><td align="left" valign="bottom">6<hr/></td><td align="left" valign="bottom">(16.7)<hr/></td><td align="left" valign="bottom">6<hr/></td><td align="left" valign="bottom">(20.0)<hr/></td><td align="left" valign="bottom">3<hr/></td><td align="left" valign="bottom">(10.7)<hr/></td><td align="left" valign="bottom">5<hr/></td><td align="left" valign="bottom">(27.8)<hr/></td><td align="left" valign="bottom">2<hr/></td><td align="left" valign="bottom">(7.4)<hr/></td><td align="left" valign="bottom">6<hr/></td><td align="left" valign="bottom">(18.2)<hr/></td><td align="left" valign="bottom">3<hr/></td><td align="left" valign="bottom">(13.00<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">Age group, N (%)<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">Excludes&#x02009;&#x0003c;&#x02009;65y<hr/></td><td align="left" valign="bottom">147<hr/></td><td align="left" valign="bottom">(59.5)<hr/></td><td align="left" valign="bottom">31<hr/></td><td align="left" valign="bottom">(59.6)<hr/></td><td align="left" valign="bottom">17<hr/></td><td align="left" valign="bottom">(47.2)<hr/></td><td align="left" valign="bottom">13<hr/></td><td align="left" valign="bottom">(43.3)<hr/></td><td align="left" valign="bottom">24<hr/></td><td align="left" valign="bottom">(85.7)<hr/></td><td align="left" valign="bottom">12<hr/></td><td align="left" valign="bottom">(66.7)<hr/></td><td align="left" valign="bottom">20<hr/></td><td align="left" valign="bottom">(74.1)<hr/></td><td align="left" valign="bottom">16<hr/></td><td align="left" valign="bottom">(48.5)<hr/></td><td align="left" valign="bottom">14<hr/></td><td align="left" valign="bottom">(60.9)<hr/></td><td align="left" valign="bottom">0.012<hr/></td></tr><tr><td align="left" valign="bottom">Includes&#x02009;&#x0003c;&#x02009;65y<hr/></td><td align="left" valign="bottom">100<hr/></td><td align="left" valign="bottom">(40.5)<hr/></td><td align="left" valign="bottom">21<hr/></td><td align="left" valign="bottom">(40.4)<hr/></td><td align="left" valign="bottom">19<hr/></td><td align="left" valign="bottom">(52.8)<hr/></td><td align="left" valign="bottom">17<hr/></td><td align="left" valign="bottom">(56.7)<hr/></td><td align="left" valign="bottom">4<hr/></td><td align="left" valign="bottom">(14.3)<hr/></td><td align="left" valign="bottom">6<hr/></td><td align="left" valign="bottom">(33.3)<hr/></td><td align="left" valign="bottom">7<hr/></td><td align="left" valign="bottom">(25.9)<hr/></td><td align="left" valign="bottom">17<hr/></td><td align="left" valign="bottom">(51.5)<hr/></td><td align="left" valign="bottom">9<hr/></td><td align="left" valign="bottom">(39.1)<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">Sex, N (%)<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">Both<hr/></td><td align="left" valign="bottom">208<hr/></td><td align="left" valign="bottom">(84.2)<hr/></td><td align="left" valign="bottom">47<hr/></td><td align="left" valign="bottom">(90.4)<hr/></td><td align="left" valign="bottom">28<hr/></td><td align="left" valign="bottom">(77.8)<hr/></td><td align="left" valign="bottom">28<hr/></td><td align="left" valign="bottom">(93.4)<hr/></td><td align="left" valign="bottom">19<hr/></td><td align="left" valign="bottom">(67.9)<hr/></td><td align="left" valign="bottom">16<hr/></td><td align="left" valign="bottom">(88.9)<hr/></td><td align="left" valign="bottom">22<hr/></td><td align="left" valign="bottom">(81.5)<hr/></td><td align="left" valign="bottom">28<hr/></td><td align="left" valign="bottom">(84.8)<hr/></td><td align="left" valign="bottom">20<hr/></td><td align="left" valign="bottom">(87.0)<hr/></td><td align="left" valign="bottom">0.12<hr/></td></tr><tr><td align="left" valign="bottom">Men only<hr/></td><td align="left" valign="bottom">26<hr/></td><td align="left" valign="bottom">(10.5)<hr/></td><td align="left" valign="bottom">3<hr/></td><td align="left" valign="bottom">(5.8)<hr/></td><td align="left" valign="bottom">8<hr/></td><td align="left" valign="bottom">(22.2)<hr/></td><td align="left" valign="bottom">1<hr/></td><td align="left" valign="bottom">(3.3)<hr/></td><td align="left" valign="bottom">5<hr/></td><td align="left" valign="bottom">(17.9)<hr/></td><td align="left" valign="bottom">2<hr/></td><td align="left" valign="bottom">(11.1)<hr/></td><td align="left" valign="bottom">2<hr/></td><td align="left" valign="bottom">(7.4)<hr/></td><td align="left" valign="bottom">3<hr/></td><td align="left" valign="bottom">(9.1)<hr/></td><td align="left" valign="bottom">2<hr/></td><td align="left" valign="bottom">(8.7)<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">Women only<hr/></td><td align="left" valign="bottom">13<hr/></td><td align="left" valign="bottom">(5.3)<hr/></td><td align="left" valign="bottom">2<hr/></td><td align="left" valign="bottom">(3.8)<hr/></td><td align="left" valign="bottom">0<hr/></td><td align="left" valign="bottom">(0.0)<hr/></td><td align="left" valign="bottom">1<hr/></td><td align="left" valign="bottom">(3.3)<hr/></td><td align="left" valign="bottom">4<hr/></td><td align="left" valign="bottom">(14.3)<hr/></td><td align="left" valign="bottom">0<hr/></td><td align="left" valign="bottom">(0.0)<hr/></td><td align="left" valign="bottom">3<hr/></td><td align="left" valign="bottom">(11.1)<hr/></td><td align="left" valign="bottom">2<hr/></td><td align="left" valign="bottom">(6.1)<hr/></td><td align="left" valign="bottom">1<hr/></td><td align="left" valign="bottom">(4.3)<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">Study design, N (%)<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">80<hr/></td><td align="left" valign="bottom">(32.4)<hr/></td><td align="left" valign="bottom">25<hr/></td><td align="left" valign="bottom">(48.1)<hr/></td><td align="left" valign="bottom">7<hr/></td><td align="left" valign="bottom">(19.4)<hr/></td><td align="left" valign="bottom">12<hr/></td><td align="left" valign="bottom">(40.0)<hr/></td><td align="left" valign="bottom">4<hr/></td><td align="left" valign="bottom">(14.3)<hr/></td><td align="left" valign="bottom">7<hr/></td><td align="left" valign="bottom">(38.9)<hr/></td><td align="left" valign="bottom">6<hr/></td><td align="left" valign="bottom">(22.2)<hr/></td><td align="left" valign="bottom">14<hr/></td><td align="left" valign="bottom">(42.4)<hr/></td><td align="left" valign="bottom">5<hr/></td><td align="left" valign="bottom">(21.7)<hr/></td><td align="left" valign="bottom">0.012<hr/></td></tr><tr><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">167<hr/></td><td align="left" valign="bottom">(67.6)<hr/></td><td align="left" valign="bottom">27<hr/></td><td align="left" valign="bottom">(51.9)<hr/></td><td align="left" valign="bottom">29<hr/></td><td align="left" valign="bottom">(80.6)<hr/></td><td align="left" valign="bottom">18<hr/></td><td align="left" valign="bottom">(60.0)<hr/></td><td align="left" valign="bottom">24<hr/></td><td align="left" valign="bottom">(85.7)<hr/></td><td align="left" valign="bottom">11<hr/></td><td align="left" valign="bottom">(61.1)<hr/></td><td align="left" valign="bottom">21<hr/></td><td align="left" valign="bottom">(77.8)<hr/></td><td align="left" valign="bottom">19<hr/></td><td align="left" valign="bottom">(57.6)<hr/></td><td align="left" valign="bottom">18<hr/></td><td align="left" valign="bottom">(78.3)<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">Sample size, Mean (SD)<hr/></td><td align="left" valign="bottom">3,561<hr/></td><td align="left" valign="bottom">(5,128)<hr/></td><td align="left" valign="bottom">4,345<hr/></td><td align="left" valign="bottom">(6,066)<hr/></td><td align="left" valign="bottom">4,745<hr/></td><td align="left" valign="bottom">(6,859)<hr/></td><td align="left" valign="bottom">4,745<hr/></td><td align="left" valign="bottom">(6,808)<hr/></td><td align="left" valign="bottom">3,322<hr/></td><td align="left" valign="bottom">(3,927)<hr/></td><td align="left" valign="bottom">2,408<hr/></td><td align="left" valign="bottom">(2,385)<hr/></td><td align="left" valign="bottom">3,643<hr/></td><td align="left" valign="bottom">(4,191)<hr/></td><td align="left" valign="bottom">1,074<hr/></td><td align="left" valign="bottom">(769)<hr/></td><td align="left" valign="bottom">3,061<hr/></td><td align="left" valign="bottom">(3,389)<hr/></td><td align="left" valign="bottom">0.05<hr/></td></tr><tr><td align="left" valign="bottom">Cognitive outcome count, N (%)<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">1<hr/></td><td align="left" valign="bottom">179<hr/></td><td align="left" valign="bottom">(72.5)<hr/></td><td align="left" valign="bottom">34<hr/></td><td align="left" valign="bottom">(65.4)<hr/></td><td align="left" valign="bottom">26<hr/></td><td align="left" valign="bottom">(86.7)<hr/></td><td align="left" valign="bottom">26<hr/></td><td align="left" valign="bottom">(86.7)<hr/></td><td align="left" valign="bottom">20<hr/></td><td align="left" valign="bottom">(71.4)<hr/></td><td align="left" valign="bottom">14<hr/></td><td align="left" valign="bottom">(77.8)<hr/></td><td align="left" valign="bottom">22<hr/></td><td align="left" valign="bottom">(81.5)<hr/></td><td align="left" valign="bottom">21<hr/></td><td align="left" valign="bottom">(63.6)<hr/></td><td align="left" valign="bottom">15<hr/></td><td align="left" valign="bottom">(65.2)<hr/></td><td align="left" valign="bottom">0.77<hr/></td></tr><tr><td align="left" valign="bottom">2<hr/></td><td align="left" valign="bottom">60<hr/></td><td align="left" valign="bottom">(24.3)<hr/></td><td align="left" valign="bottom">15<hr/></td><td align="left" valign="bottom">(28.8)<hr/></td><td align="left" valign="bottom">4<hr/></td><td align="left" valign="bottom">(13.3)<hr/></td><td align="left" valign="bottom">4<hr/></td><td align="left" valign="bottom">(13.3)<hr/></td><td align="left" valign="bottom">7<hr/></td><td align="left" valign="bottom">(25.0)<hr/></td><td align="left" valign="bottom">3<hr/></td><td align="left" valign="bottom">(16.7)<hr/></td><td align="left" valign="bottom">4<hr/></td><td align="left" valign="bottom">(14.8)<hr/></td><td align="left" valign="bottom">10<hr/></td><td align="left" valign="bottom">(30.3)<hr/></td><td align="left" valign="bottom">8<hr/></td><td align="left" valign="bottom">(34.8)<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">3<hr/></td><td align="left" valign="bottom">5<hr/></td><td align="left" valign="bottom">(2.0)<hr/></td><td align="left" valign="bottom">2<hr/></td><td align="left" valign="bottom">(3.9)<hr/></td><td align="left" valign="bottom">0<hr/></td><td align="left" valign="bottom">(0.0)<hr/></td><td align="left" valign="bottom">0<hr/></td><td align="left" valign="bottom">(0.0)<hr/></td><td align="left" valign="bottom">1<hr/></td><td align="left" valign="bottom">(3.6)<hr/></td><td align="left" valign="bottom">1<hr/></td><td align="left" valign="bottom">(5.6)<hr/></td><td align="left" valign="bottom">0<hr/></td><td align="left" valign="bottom">(0.0)<hr/></td><td align="left" valign="bottom">1<hr/></td><td align="left" valign="bottom">(3.0)<hr/></td><td align="left" valign="bottom">0<hr/></td><td align="left" valign="bottom">(0.0)<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">4<hr/></td><td align="left" valign="bottom">2<hr/></td><td align="left" valign="bottom">(1.2)<hr/></td><td align="left" valign="bottom">1<hr/></td><td align="left" valign="bottom">(1.9)<hr/></td><td align="left" valign="bottom">0<hr/></td><td align="left" valign="bottom">(0.0)<hr/></td><td align="left" valign="bottom">0<hr/></td><td align="left" valign="bottom">(0.0)<hr/></td><td align="left" valign="bottom">0<hr/></td><td align="left" valign="bottom">(0.0)<hr/></td><td align="left" valign="bottom">0<hr/></td><td align="left" valign="bottom">(0.0)<hr/></td><td align="left" valign="bottom">1<hr/></td><td align="left" valign="bottom">(3.7)<hr/></td><td align="left" valign="bottom">1<hr/></td><td align="left" valign="bottom">(3.0)<hr/></td><td align="left" valign="bottom">0<hr/></td><td align="left" valign="bottom">(0.0)<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">Cognitive outcome type, N (%)<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">0.042<hr/></td></tr><tr><td align="left" valign="bottom">AD/dementia/impairment<hr/></td><td align="left" valign="bottom">114<hr/></td><td align="left" valign="bottom">(46.2)<hr/></td><td align="left" valign="bottom">26<hr/></td><td align="left" valign="bottom">(50.0)<hr/></td><td align="left" valign="bottom">20<hr/></td><td align="left" valign="bottom">(55.6)<hr/></td><td align="left" valign="bottom">6<hr/></td><td align="left" valign="bottom">(20.0)<hr/></td><td align="left" valign="bottom">16<hr/></td><td align="left" valign="bottom">(57.1)<hr/></td><td align="left" valign="bottom">5<hr/></td><td align="left" valign="bottom">(27.8)<hr/></td><td align="left" valign="bottom">15<hr/></td><td align="left" valign="bottom">(55.6)<hr/></td><td align="left" valign="bottom">15<hr/></td><td align="left" valign="bottom">(45.5)<hr/></td><td align="left" valign="bottom">11<hr/></td><td align="left" valign="bottom">(47.8)<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">Cognitive function/decline<hr/></td><td align="left" valign="bottom">126<hr/></td><td align="left" valign="bottom">(51.0)<hr/></td><td align="left" valign="bottom">25<hr/></td><td align="left" valign="bottom">(48.1)<hr/></td><td align="left" valign="bottom">16<hr/></td><td align="left" valign="bottom">(44.4)<hr/></td><td align="left" valign="bottom">24<hr/></td><td align="left" valign="bottom">(80.0)<hr/></td><td align="left" valign="bottom">10<hr/></td><td align="left" valign="bottom">(35.7)<hr/></td><td align="left" valign="bottom">11<hr/></td><td align="left" valign="bottom">(61.1)<hr/></td><td align="left" valign="bottom">12<hr/></td><td align="left" valign="bottom">(44.4)<hr/></td><td align="left" valign="bottom">17<hr/></td><td align="left" valign="bottom">(51.5)<hr/></td><td align="left" valign="bottom">11<hr/></td><td align="left" valign="bottom">(47.8)<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">Both<hr/></td><td align="left" valign="bottom">7<hr/></td><td align="left" valign="bottom">(2.8)<hr/></td><td align="left" valign="bottom">1<hr/></td><td align="left" valign="bottom">(1.9)<hr/></td><td align="left" valign="bottom">0<hr/></td><td align="left" valign="bottom">(0.0)<hr/></td><td align="left" valign="bottom">0<hr/></td><td align="left" valign="bottom">(0.0)<hr/></td><td align="left" valign="bottom">2<hr/></td><td align="left" valign="bottom">(7.1)<hr/></td><td align="left" valign="bottom">2<hr/></td><td align="left" valign="bottom">(11.1)<hr/></td><td align="left" valign="bottom">0<hr/></td><td align="left" valign="bottom">(0.0)<hr/></td><td align="left" valign="bottom">1<hr/></td><td align="left" valign="bottom">(3.0)<hr/></td><td align="left" valign="bottom">1<hr/></td><td align="left" valign="bottom">(4.4)<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">Study finding, N(%)<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">0.004<hr/></td></tr><tr><td align="left" valign="bottom">Against hypothesis<hr/></td><td align="left" valign="bottom">5<hr/></td><td align="left" valign="bottom">(2.0)<hr/></td><td align="left" valign="bottom">1<hr/></td><td align="left" valign="bottom">(1.9)<hr/></td><td align="left" valign="bottom">1<hr/></td><td align="left" valign="bottom">(2.8)<hr/></td><td align="left" valign="bottom">2<hr/></td><td align="left" valign="bottom">(6.7)<hr/></td><td align="left" valign="bottom">1<hr/></td><td align="left" valign="bottom">(3.6)<hr/></td><td align="left" valign="bottom">0<hr/></td><td align="left" valign="bottom">(0.0)<hr/></td><td align="left" valign="bottom">0<hr/></td><td align="left" valign="bottom">(0.0)<hr/></td><td align="left" valign="bottom">0<hr/></td><td align="left" valign="bottom">(0.0)<hr/></td><td align="left" valign="bottom">0<hr/></td><td align="left" valign="bottom">(0.0)<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">Null<hr/></td><td align="left" valign="bottom">45<hr/></td><td align="left" valign="bottom">(18.2)<hr/></td><td align="left" valign="bottom">4<hr/></td><td align="left" valign="bottom">(7.7)<hr/></td><td align="left" valign="bottom">11<hr/></td><td align="left" valign="bottom">(30.6)<hr/></td><td align="left" valign="bottom">4<hr/></td><td align="left" valign="bottom">(13.3)<hr/></td><td align="left" valign="bottom">0<hr/></td><td align="left" valign="bottom">(0.0)<hr/></td><td align="left" valign="bottom">5<hr/></td><td align="left" valign="bottom">(27.8)<hr/></td><td align="left" valign="bottom">9<hr/></td><td align="left" valign="bottom">(33.3)<hr/></td><td align="left" valign="bottom">6<hr/></td><td align="left" valign="bottom">(18.2)<hr/></td><td align="left" valign="bottom">6<hr/></td><td align="left" valign="bottom">(26.1)<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">Positive<hr/></td><td align="left" valign="bottom">152<hr/></td><td align="left" valign="bottom">(61.5)<hr/></td><td align="left" valign="bottom">39<hr/></td><td align="left" valign="bottom">(75.0)<hr/></td><td align="left" valign="bottom">18<hr/></td><td align="left" valign="bottom">(50.0)<hr/></td><td align="left" valign="bottom">17<hr/></td><td align="left" valign="bottom">(56.7)<hr/></td><td align="left" valign="bottom">25<hr/></td><td align="left" valign="bottom">(89.3)<hr/></td><td align="left" valign="bottom">7<hr/></td><td align="left" valign="bottom">(38.9)<hr/></td><td align="left" valign="bottom">11<hr/></td><td align="left" valign="bottom">(40.7)<hr/></td><td align="left" valign="bottom">23<hr/></td><td align="left" valign="bottom">(69.7)<hr/></td><td align="left" valign="bottom">12<hr/></td><td align="left" valign="bottom">(52.2)<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">Partially positive (outcomes/exposures)<hr/></td><td align="left" valign="bottom">21<hr/></td><td align="left" valign="bottom">(8.5)<hr/></td><td align="left" valign="bottom">6<hr/></td><td align="left" valign="bottom">(11.5)<hr/></td><td align="left" valign="bottom">2<hr/></td><td align="left" valign="bottom">(5.6)<hr/></td><td align="left" valign="bottom">2<hr/></td><td align="left" valign="bottom">(6.7)<hr/></td><td align="left" valign="bottom">0<hr/></td><td align="left" valign="bottom">(0.0)<hr/></td><td align="left" valign="bottom">3<hr/></td><td align="left" valign="bottom">(16.7)<hr/></td><td align="left" valign="bottom">2<hr/></td><td align="left" valign="bottom">(7.4)<hr/></td><td align="left" valign="bottom">1<hr/></td><td align="left" valign="bottom">(3.0)<hr/></td><td align="left" valign="bottom">1<hr/></td><td align="left" valign="bottom">(4.3)<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left">Partially positive (sub-groups)</td><td align="left">24</td><td align="left">(9.7)</td><td align="left">2</td><td align="left">(7.7)</td><td align="left">4</td><td align="left">(11.1)</td><td align="left">5</td><td align="left">(16.7)</td><td align="left">2</td><td align="left">(7.1)</td><td align="left">3</td><td align="left">(16.7)</td><td align="left">5</td><td align="left">(27.8)</td><td align="left">3</td><td align="left">(9.1)</td><td align="left">4</td><td align="left">(17.4)</td><td align="left">&#x000a0;</td></tr></tbody></table><table-wrap-foot><p>*P-value for difference across risk/protective factors was obtained from one-way ANOVA test when variable is continuous and <italic>&#x003c7;</italic><sup>2</sup> test when variable is categorical.</p></table-wrap-foot></table-wrap></sec><sec><title>Consistency analysis: study-level characteristics and risk factor as predictors of study finding</title><p>In an attempt to examine heterogeneity in findings across risk factors and study-level characteristics, we conducted a consistency analysis using a logistic regression model (Table&#x000a0;<xref ref-type="table" rid="T4">4</xref>). Examining the odds ratios and their 95% CI, taking &#x0201c;null finding/against hypothesis finding&#x0201d; as the referent category for the outcome, we found that in general, a positive or partially positive finding was significantly more likely when the risk factor was &#x0201c;education&#x0201d; particularly when compared to smoking, caffeine and antioxidants/vitamin E (p&#x02009;&#x0003c;&#x02009;0.05). None of the other study-level characteristics were associated with the study finding.</p><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>Multiple logistic regression: study-level predictors of study finding*</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead valign="top"><tr><th align="left">&#x000a0;</th><th align="left"><bold>Odds Ratio</bold></th><th align="left"><bold>(95% CI)</bold></th><th align="left"><bold>P-value</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="bottom"><italic>Year</italic><hr/></td><td align="left" valign="bottom">1.06<hr/></td><td align="left" valign="bottom">(0.98;1.14)<hr/></td><td align="left" valign="bottom">0.13<hr/></td></tr><tr><td align="left" valign="bottom"><italic>Country</italic><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">US<hr/></td><td align="left" valign="bottom">1.00<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">Europe<hr/></td><td align="left" valign="bottom">0.96<hr/></td><td align="left" valign="bottom">(0.45;2.06)<hr/></td><td align="left" valign="bottom">0.92<hr/></td></tr><tr><td align="left" valign="bottom">Other<hr/></td><td align="left" valign="bottom">0.99<hr/></td><td align="left" valign="bottom">(0.35;2.80)<hr/></td><td align="left" valign="bottom">0.99<hr/></td></tr><tr><td align="left" valign="bottom"><italic>Age group</italic><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">Excludes&#x02009;&#x0003c;&#x02009;65y<hr/></td><td align="left" valign="bottom">1.00<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">Includes&#x02009;&#x0003c;&#x02009;65y<hr/></td><td align="left" valign="bottom">0.80<hr/></td><td align="left" valign="bottom">(0.40;1.60)<hr/></td><td align="left" valign="bottom">0.53<hr/></td></tr><tr><td align="left" valign="bottom"><italic>Study design</italic><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">Cross-sectional<hr/></td><td align="left" valign="bottom">1.00<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">Cohort<hr/></td><td align="left" valign="bottom">0.60<hr/></td><td align="left" valign="bottom">(0.27;1.33)<hr/></td><td align="left" valign="bottom">0.21<hr/></td></tr><tr><td align="left" valign="bottom"><italic>Sample size</italic><hr/></td><td align="left" valign="bottom">1.00<hr/></td><td align="left" valign="bottom">(0.99;1.00)<hr/></td><td align="left" valign="bottom">0.25<hr/></td></tr><tr><td align="left" valign="bottom"><italic>Cognitive outcome count</italic><hr/></td><td align="left" valign="bottom">1.03<hr/></td><td align="left" valign="bottom">(0.54;1.98)<hr/></td><td align="left" valign="bottom">0.92<hr/></td></tr><tr><td align="left" valign="bottom"><italic>Cognitive outcome type</italic><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">AD/dementia/impairment<hr/></td><td align="left" valign="bottom">1.00<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">Cognitive function/decline<hr/></td><td align="left" valign="bottom">1.52<hr/></td><td align="left" valign="bottom">(0.72;3.22)<hr/></td><td align="left" valign="bottom">0.27<hr/></td></tr><tr><td align="left" valign="bottom">Both<hr/></td><td align="left" valign="bottom">1.78<hr/></td><td align="left" valign="bottom">(0.16;19.7)<hr/></td><td align="left" valign="bottom">0.64<hr/></td></tr><tr><td align="left" valign="bottom"><italic>Risk factor</italic><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">EDU<hr/></td><td align="left" valign="bottom">1.00<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">SMOK<hr/></td><td align="left" valign="bottom">0.21<hr/></td><td align="left" valign="bottom">(0.06;0.70)<hr/></td><td align="left" valign="bottom">0.012<hr/></td></tr><tr><td align="left" valign="bottom">ALCO<hr/></td><td align="left" valign="bottom">0.33<hr/></td><td align="left" valign="bottom">(0.08;1.29)<hr/></td><td align="left" valign="bottom">0.11<hr/></td></tr><tr><td align="left" valign="bottom">PA<hr/></td><td align="left" valign="bottom">2.49<hr/></td><td align="left" valign="bottom">(0.26;24.29)<hr/></td><td align="left" valign="bottom">0.43<hr/></td></tr><tr><td align="left" valign="bottom">CAFF<hr/></td><td align="left" valign="bottom">0.18<hr/></td><td align="left" valign="bottom">(0.04;0.84)<hr/></td><td align="left" valign="bottom">0.029<hr/></td></tr><tr><td align="left" valign="bottom">ANTIOX<hr/></td><td align="left" valign="bottom">0.20<hr/></td><td align="left" valign="bottom">(0.06;0.75)<hr/></td><td align="left" valign="bottom">0.016<hr/></td></tr><tr><td align="left" valign="bottom">HCY<hr/></td><td align="left" valign="bottom">0.41<hr/></td><td align="left" valign="bottom">(0.10;1.67)<hr/></td><td align="left" valign="bottom">0.22<hr/></td></tr><tr><td align="left">N-3 FA</td><td align="left">0.25</td><td align="left">(0.06;1.05)</td><td align="left">0.06</td></tr></tbody></table><table-wrap-foot><p>*Positive or partially positive finding coded as &#x0201c;1&#x0201d;, Null or against hypothesized finding coded as &#x0201c;0&#x0201d; (referent category).</p><p>Gender composition of the sample was excluded as a predictor due to lack of variability.</p></table-wrap-foot></table-wrap></sec><sec><title>Meta-analysis: selected risk factors for incident AD</title><p>Using random effects models, we pooled findings of 31 selected data points from 31 studies in which the outcome was incident AD and for which exposure data was adequate and comparable across studies (Figure&#x000a0;<xref ref-type="fig" rid="F3">3</xref>A-E<bold>)</bold>. Among studies used to summarize the association between low education and incident AD, the largest study (N&#x02009;=&#x02009;3,675) found a HR&#x02009;=&#x02009;1.81 with 95% CI: 1.30&#x02013;2.53, with a prevalence of low education being ~32% [<xref ref-type="bibr" rid="B43">43</xref>]. In all four studies, the exposure definition was standardized as a comparison between &#x0003c;8y of education vs. &#x02265;8y. In contrast, for all other exposures, definitions differed to some extent between studies but were assumed to operationalize the same concept. For instance, high vs. low physical activity was defined as a frequency of 3 times or more per week by two studies, 2 times of more per week by one, 4 activities per week by one, &#x02265;2 vs. &#x0003c;2 mile walk/day by another study, and other comparable definitions by the remaining four studies combining frequency and intensity of activity. A full description of how various exposures were defined under Figure&#x000a0;<xref ref-type="fig" rid="F3">3</xref>A-E notes.</p><fig id="F3" position="float"><label>Figure 3</label><caption><p><bold>Meta-analysis of selected risk and protective factors for incident AD (n = 31). (A)</bold> Education. <bold>(B)</bold> Smoking status. <bold>(C)</bold> Physical activity. <bold>(D)</bold> Homocysteine. <bold>(E)</bold> n3 fatty acids.</p></caption><graphic xlink:href="1471-2458-14-643-3"/></fig><p><italic>Sources:</italic>[<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B33">33</xref>,<xref ref-type="bibr" rid="B43">43</xref>,<xref ref-type="bibr" rid="B46">46</xref>,<xref ref-type="bibr" rid="B78">78</xref>,<xref ref-type="bibr" rid="B82">82</xref>,<xref ref-type="bibr" rid="B86">86</xref>,<xref ref-type="bibr" rid="B88">88</xref>,<xref ref-type="bibr" rid="B93">93</xref>,<xref ref-type="bibr" rid="B95">95</xref>,<xref ref-type="bibr" rid="B101">101</xref>,<xref ref-type="bibr" rid="B103">103</xref>,<xref ref-type="bibr" rid="B104">104</xref>,<xref ref-type="bibr" rid="B133">133</xref>,<xref ref-type="bibr" rid="B137">137</xref>,<xref ref-type="bibr" rid="B141">141</xref>,<xref ref-type="bibr" rid="B142">142</xref>,<xref ref-type="bibr" rid="B145">145</xref>,<xref ref-type="bibr" rid="B148">148</xref>,<xref ref-type="bibr" rid="B150">150</xref>,<xref ref-type="bibr" rid="B156">156</xref>,<xref ref-type="bibr" rid="B206">206</xref>,<xref ref-type="bibr" rid="B209">209</xref>,<xref ref-type="bibr" rid="B215">215</xref>,<xref ref-type="bibr" rid="B217">217</xref>,<xref ref-type="bibr" rid="B233">233</xref>,<xref ref-type="bibr" rid="B237">237</xref>,<xref ref-type="bibr" rid="B239">239</xref>,<xref ref-type="bibr" rid="B242">242</xref>,<xref ref-type="bibr" rid="B250">250</xref>,<xref ref-type="bibr" rid="B251">251</xref>]: <italic>Notes</italic>: Only studies with available data points on incident AD were selected. Moreover, risk factors/protective factors needed to be measured in a comparable manner across studies to allow for estimating a pooled RR with a 95% CI. For education, only four studies out of 27 cohort studies had the required inclusion criteria. For smoking status, the common referent category was non-smoking or never smoking or &#x000ab; never or former &#x000bb; whereas exposed group consisted of either &#x000ab; ever smokers &#x000bb; [<xref ref-type="bibr" rid="B78">78</xref>,<xref ref-type="bibr" rid="B93">93</xref>], or a pooled value for RR to obtain an approximate &#x000ab; ever smoker &#x000bb; category [<xref ref-type="bibr" rid="B86">86</xref>], or current smokers [<xref ref-type="bibr" rid="B82">82</xref>,<xref ref-type="bibr" rid="B88">88</xref>,<xref ref-type="bibr" rid="B95">95</xref>], or mid-life smoking or heavy smoking [<xref ref-type="bibr" rid="B101">101</xref>,<xref ref-type="bibr" rid="B103">103</xref>,<xref ref-type="bibr" rid="B104">104</xref>]. For high vs. low physical activity level, two studies used the cut-point of 3 or more times per week [<xref ref-type="bibr" rid="B133">133</xref>,<xref ref-type="bibr" rid="B145">145</xref>], one used 2 times or more per week [<xref ref-type="bibr" rid="B142">142</xref>], one used the criterion of 4 activities per week vs. none [<xref ref-type="bibr" rid="B141">141</xref>], one used&#x02009;&#x0003e;&#x02009;=2 vs. &#x0003c;2 miles walking/day [<xref ref-type="bibr" rid="B137">137</xref>], and the remaining four studies used other definitions related to both frequency and intensity [<xref ref-type="bibr" rid="B148">148</xref>,<xref ref-type="bibr" rid="B150">150</xref>,<xref ref-type="bibr" rid="B156">156</xref>]. For high vs. low n-3 fatty acids, one study had fish consumption (yes vs. no) as the exposure of interest [<xref ref-type="bibr" rid="B237">237</xref>], another examined quintiles of total <italic>n</italic>-3 PUFA and compared the fifth to the first quintile in terms of risk for AD [<xref ref-type="bibr" rid="B239">239</xref>], a third study had one main exposure as &#x000ab; weekly consumption of fish vs. not &#x000bb; [<xref ref-type="bibr" rid="B242">242</xref>], a fourth study contrast high <italic>vs</italic>. no fish intake, 0-8y follow-up [<xref ref-type="bibr" rid="B250">250</xref>], and finally upper quartile vs. lowest quartile for total n-3 PUFA in erythrocyte membranes [<xref ref-type="bibr" rid="B251">251</xref>]. For high vs. low Hcy, two studies used a cut-point of 14.6&#x000a0;&#x003bc;mol/L [<xref ref-type="bibr" rid="B206">206</xref>,<xref ref-type="bibr" rid="B215">215</xref>], one study used a cut-point of 15&#x000a0;&#x003bc;mol/L [<xref ref-type="bibr" rid="B217">217</xref>], one study used upper vs. lowest quartile [<xref ref-type="bibr" rid="B209">209</xref>] and one study used upper tertile vs. lowest tertile [<xref ref-type="bibr" rid="B233">233</xref>].</p><p>Tests of heterogeneity, including the Q-tests, determined whether to use fixed-effects or random-effects models to pool the RR. Findings indicated that, with the exception of education and smoking as main exposures, RR estimates obtained from individual studies were largely homogenous. In sum, the pooled RRs were: 1.99 (1.30, 3.04) for low vs. higher educational attainment (n&#x02009;=&#x02009;4 data points; Q&#x02009;=&#x02009;11.33, p&#x02009;=&#x02009;0.010); 1.37(1.23-1.52) for smoking status (current or ever vs. never smokers (n&#x02009;=&#x02009;9 data points, Q&#x02009;=&#x02009;36.2, p&#x02009;&#x0003c;&#x02009;0.001); 0.58(0.49, 0.70) for physical activity (n&#x02009;=&#x02009;8 data points, Q&#x02009;=&#x02009;3.2, p&#x02009;=&#x02009;0.867), 0.67(0.47,0.96) for high intake of <italic>n</italic>-3 fatty acids (n&#x02009;=&#x02009;5, Q&#x02009;=&#x02009;7.4, p&#x02009;=&#x02009;0.116), and RR&#x02009;=&#x02009;1.93(1.50, 2.49) for high levels of plasma Hcy (n&#x02009;=&#x02009;5 data points; Q&#x02009;=&#x02009;2.64, p&#x02009;=&#x02009;0.620).</p><p>Taking the largest study for each as a means to obtain an estimate of exposure prevalence, the following was found: low education (32%) [<xref ref-type="bibr" rid="B43">43</xref>], mid-life smoking (59.8%) [<xref ref-type="bibr" rid="B93">93</xref>], <italic>lower</italic> physical activity (62%) [<xref ref-type="bibr" rid="B150">150</xref>], <italic>lower n</italic>-3 fatty acids (49.4%) [<xref ref-type="bibr" rid="B242">242</xref>], elevated Hcy (30%) [<xref ref-type="bibr" rid="B206">206</xref>]. From these exposure prevalence estimates (Prev<sub>exp</sub>), we computed the PAR% and its 95% CI to assess the proportion of AD that is attributable to each exposure in a typical adult population and thus the % that can be averted if that exposure was eliminated from that population. Our findings indicated that the PAR% for low education was 24.0% with a 95% CI: 8.4-39.6; for mid-life smoking it was 31.0% with a 95% CI: 17.9-44.3; for physical activity (lower vs. higher) it was 31.9% with 95% CI: 22.7-41.2; for high vs. low Hcy, it was 21.7% with a 95% CI: 12.8-30.6; for lower vs. higher fish consumption (&#x0003c;weekly vs. &#x02265;weekly), it was 21.9% with 95% CI:4.7-39.1.</p><p>Publication bias for the meta-analysis data points (n&#x02009;=&#x02009;31) was assessed using primarily the funnel plot which plotted point estimates of RR for all exposures combined on the Log<sub>e</sub> scale against their standard errors. This plot indicated that estimates obtained from those 31 studies lay within the pseudo 95% confidence limits, an indication of non-appreciable publication bias. This finding was reinforced by a non-significant Begg-adjusted rank correlation test (<italic>Z</italic>&#x02009;=&#x02009;0.25; <italic>P</italic>&#x02009;=&#x02009;0.80), and by Egger&#x02019;s regression asymmetry test (bias (SE): -0.43 (0.98); p&#x02009;=&#x02009;0.66) (Additional file <xref ref-type="supplementary-material" rid="S1">1</xref>: Figure S1).</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>As stated earlier, this is the first study to systematically review those selected modifiable risk and protective factors for cognitive health outcomes in cross-sectional and cohort studies while comparing the consistency of association between those factors and across study-level characteristics. It is also among few recent studies to compare the strength of association across those factors in relation to incident AD using a similar approach [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref>]. However, our study has a few limitations. First, the literature search was limited to published articles in English available in the Medline database. Second, comparing all included studies in a quantitative meta-analytic manner was not possible due to the diversity of the cognitive outcome measurements between original studies included. In fact, cognitive measures included scores from batteries of different cognitive tests, single global cognitive test scores such as the MMSE total score, as well as the use of a factor analytic approach to combine test scores into various domains of interest (e.g. memory, spatial, psychomotor, executive function, attention). Thus, meta-analysis was only possible for measures of cognitive impairment (i.e. MCI, all-cause dementia, AD, VaD) from which we selected incident AD as the most comparable outcome across studies. However, in order to measure consistency across the selected studies and compare risk factors in terms of consistency, we conducted another type of analysis in which a qualitative outcome of &#x0201c;study finding&#x0201d; was modeled against study-level characteristics. The qualification of a finding as null or positive was based on the main conclusion of each study that was included. This type of analysis does not necessarily discriminate between null findings due to low power, poor quality study <italic>vs</italic>. actual null finding. However, our logistic regression analysis indicated that overall, sample size was not a determining factor for the study finding outcome. Combining findings from meta-analysis and the consistency analyses, we compared evidence level for each risk and protective factor of cognitive health. Other limitations include the lack of comparability in measurements of risk or protective factors in studies with incident AD, which resulted in the exclusion of a few data points in our meta-analysis. However, the datapoints that were included in the meta-analysis were relatively comparable as described in the footnotes of Figure&#x000a0;<xref ref-type="fig" rid="F3">3</xref>A-E. Finally, our study was limited by the inability to create a common quality measure for all studies given the diversity of the exposure variables and the relative importance of having a large sample size given the type of exposure (e.g., a larger sample size is needed for a questionnaire-based exposure <italic>vs</italic>. a blood level based exposure).</p><p>Our review shows that over the past several decades many risk or protective factors have been studied in relation to cognitive impairment, dementia (including AD) and cognitive decline. Overall, these studies indicate that modifiable factors including individuals&#x02019; socio-economic, behavioral characteristics and dietary intake seem to affect people&#x02019;s cognitive ability and change over time, as well as the incidence of cognitive impairment, all-cause dementia and AD. It is worth noting, however, that some of the diagnostic criteria for dementia, AD and MCI have changed over time, particularly between the 1990s and the more recent years, as shown in Table&#x000a0;<xref ref-type="table" rid="T1">1</xref>.</p><p>In total, 247 studies were retrieved for systematic review. When conducting consistency analysis for each risk factor/design dyad, we found the % of studies with positive finding, given hypothesis, for most outcomes and study participants to range from ~38.9% for caffeine (27.3 for cohort studies (n&#x02009;=&#x02009;11), 57.1% for cross-sectional studies(n&#x02009;=&#x02009;7)) to ~89% for physical activity(87.5% for cohort studies(n&#x02009;=&#x02009;24); 100% for cross-sectional studies(n&#x02009;=&#x02009;4)). Consistency analysis confirmed that education-related studies had a significantly higher propensity for a positive or partially positive finding compared to caffeine, smoking and antioxidant-related studies. Meta-analysis of 31 studies with incident AD and selected risk/protective factors yielded pooled RR and 95% CI as follows: RR&#x02009;=&#x02009;1.99(1.30, 3.04) for low(risk factor) vs. higher education (n&#x02009;=&#x02009;4 studies; Q&#x02009;=&#x02009;11.33, p&#x02009;=&#x02009;0.010); RR&#x02009;=&#x02009;1.37(1.23, 1.52) for smoking status (current or ever(risk factor) vs. never smokers (n&#x02009;=&#x02009;9 studies, Q&#x02009;=&#x02009;36.2, p&#x02009;&#x0003c;&#x02009;0.001); RR&#x02009;=&#x02009;0.58(0.49, 0.70) for higher physical activity(protective factor) vs. lower (n&#x02009;=&#x02009;8 studies, Q&#x02009;=&#x02009;3.2, p&#x02009;=&#x02009;0.867), RR&#x02009;=&#x02009;0.67(0.47,0.96) for higher intake of <italic>n</italic>-3 fatty acids(protective factor) vs. lower (n&#x02009;=&#x02009;5, Q&#x02009;=&#x02009;7.4, p&#x02009;=&#x02009;0.116), and RR&#x02009;=&#x02009;1.93(1.50, 2.49) for high levels of plasma Hcy(risk factor) vs. lower (n&#x02009;=&#x02009;6 data points; Q&#x02009;=&#x02009;2.64, p&#x02009;=&#x02009;0.620). Given the observed prevalence of exposure from the largest study per risk factor included in each meta-analysis, the population attributable risk percent (PAR%) with its 95% CI was estimated as follows: for low education: 24.0% with a 95% CI: 8.4-39.6; for mid-life smoking it was 31.0% with a 95% CI: 17.9-44.3; for physical activity (lower vs. higher) it was 31.9% with 95% CI: 22.7-41.2; for high vs. low Hcy, it was 21.7% with a 95% CI: 12.8-30.6; for lower vs. higher fish consumption (&#x0003c;weekly vs. &#x02265;weekly), it was 21.9% with 95% CI:4.7-39.1. There was no significant publication bias, taking all selected risk factors for incident AD together.</p><p>A large number of epidemiologic studies were initially conducted to examine the effects of socio-economic factors, mainly educational attainment, and were later used to assess the validity of alternative hypotheses regarding the presence of behavioral or health-related mediating factors. To this end, several behavioral and nutritional risk factors were studied in relation to various cognitive outcomes. For instance, it was hypothesized that low SES was associated with higher prevalence of smoking which in turn may affect cognitive performance and change over time. While few studies found weak or no association between smoking and cognitive decline, many others found a positive association whereby smoking increased the risk of decline. Alcohol was found in general to have a U-shaped association with the risk of decline, while caffeine was shown to increase perceptual speed and vigilance as well as memory and other more complex functions in at least two cohort studies and one cross-sectional study. Physical activity was shown to protect against cognitive decline as corroborated by a number of prospective cohort studies.</p><p>Among nutritional factors, dietary and supplemental antioxidants were shown in some studies to reduce the risk of cognitive decline while in others they showed no appreciable effect. Other micronutrients including B-Vitamins and folate were shown to be protective against cognitive decline, through their dampening effect on plasma Hcy which was shown to consistently increase the risk of dementia, particularly of the AD type. In addition, studies show that <italic>n</italic>-3 fatty acids with their anti-inflammatory and cardio-protective properties can help reduce the risk of cognitive decline and impairment in some studies but not in others. Among nutritional factors, caffeine seems to be the factor hypothesized to have a protective effect with the smallest number of current studies.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>In conclusion, the consistency of findings between studies varied for each selected risk or protective modifiable factors (highest consistency observed for physical activity). Secondly, a moderate to strong association was observed between some selected factors and incident AD (strongest for low education and elevated Hcy). Combining both criteria (strength of association in the case of incident AD and consistency overall), the strongest evidence thus far is an increased risk with elevated plasma Hcy levels or lower educational attainment and a lowered risk with increased physical activity. Nevertheless, more studies are needed to verify the consistency, particularly regarding caffeine. A comprehensive meta-analysis requires additional research for certain risk factors of incident AD or dementia. For incident AD, selected risk factors may potentially account on average for 21.7%-31.9% of AD cases for each risk factor considered (with 95% CI: 8.4%-44.3%) (highest for mid-life smoking and physical activity), given the estimated prevalence of those factors from the largest available study. Thus, on average, one in five to one in three cases of AD can potentially be averted if those risk factors were eliminated from populations with comparable exposure prevalence.</p></sec><sec><title>Abbreviations</title><p>AD: Alzheimer&#x02019;s disease; VaD: Vascular dementia; DLB: Dementia with Lewy bodies; PD-D: Parkinson&#x02019;s disease with dementia; MD: Mixed dementia; FTD: Fronot-parietal dementia; OD: Other dementia; MCI: Mild cognitive impairment; ADDTC: Alzheimer's disease diagnostic and treatment centers; DSM-IV: Diagnostic and statistical manual, 4<sup>th</sup> edition; ICD-10: International classification of disease, 10<sup>th</sup> edition; NINCDS-ADRDA: National Institute of neurological and communicative disorders and stroke -- the Alzheimer's disease and related disorders association; NINDS-AIREN: National institute of neurological and communicative disorders and stroke--Association Internationale pour la Recherche et l&#x02019;Enseignement en Neurosciences; ApoE: Apolipoprotein E; PAR%: Population attributable risk percent; OR: Odd ratio; RR: Relative risk; HR: Hazard ratio; CI: Confidence interval; Pr<sub>exp</sub>: Prevalence of each exposure; SE: Standard errors; SD: Standard deviation; Edu: Education; Smok: Smoking status; Alco: Alcohol consumption; PA: Physical activity; CAFF: Caffeine consumption; Antiox: Antioxidants; N-3 Fa: n-3 fatty acids; SES: Socio-economic status; SEP: Socio-economic position; Hcy: Homocysteine; EPA: Eicosapentanoic acid; DHA: Docosahexaenoic acid; DGLA: Dihomogaminalinolenic acid; GLA: Gamma-linoleic acid; AA: Arachidonic acid; PUFA: Polyunsaturated fatty acid; MUFA: monounsaturated fatty acid; MMSE: Mini-mental state examination; B: Both; M: Men; W: Women; UK: United Kingdom; US: United States.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors&#x02019; contributions</title><p>MAB: conceptualization, literature search and review, plan of analysis, data management, statistical analysis (including meta-analysis), writing of the manuscript, revision of the manuscript. HAB: Literature search and review, plan of analysis, writing of parts of the manuscript, revision of the manuscript. AG: Literature search and review, plan of analysis, writing of parts of the manuscript, revision of the manuscript. AT: Literature search and reivew, writing of parts of the manuscript, revision of the manuscript. ABZ: Plan of analysis, write-up of parts of the manuscript, revision of the manuscript. YW: Plan of analysis, write-up of parts of the manuscript, revision of the manuscript. All authors read and approved the final manuscript.</p></sec><sec><title>Authors&#x02019; information</title><p>Youfa Wang and Alan B Zonderman are senior authors.</p></sec><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2458/14/643/prepub">http://www.biomedcentral.com/1471-2458/14/643/prepub</ext-link></p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="S1"><caption><title>Additional file 1: Figure S1</title><p>Begg&#x02019;s funnel plot with pseudo 95% confidence limits.</p></caption><media xlink:href="1471-2458-14-643-S1.jpeg"><caption><p>Click here for file</p></caption></media></supplementary-material></sec></body><back><sec><title>Acknowledgments</title><p>This study was supported by the Intramural Research Program of the National Institute on Aging, NIA/NIH/IRP. The authors would like to thank Mr. James Byrnes, NIA/NIH/IRP, for help with literature search and retrieval. Special thanks also go to Drs. Lori L. Beason-Held and Madhav Thambisetty, NIA/NIH/IRP, for their review and comments on the manuscript.</p></sec><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>de Champlain</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>R</given-names></name><name><surname>Girouard</surname><given-names>H</given-names></name><name><surname>Karas</surname><given-names>M</given-names></name><name><surname>ELM</surname><given-names>A</given-names></name><name><surname>Laplante</surname><given-names>MA</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><article-title>Oxidative stress in hypertension</article-title><source>Clin Exp Hypertens</source><year>2004</year><volume>26</volume><fpage>593</fpage><lpage>601</lpage><pub-id pub-id-type="pmid">15702613</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Verhaeghen</surname><given-names>P</given-names></name><name><surname>Salthouse</surname><given-names>TA</given-names></name><article-title>Meta-analyses of age-cognition relations in adulthood: estimates of linear and nonlinear age effects and structural models</article-title><source>Psychol Bull</source><year>1997</year><volume>122</volume><fpage>231</fpage><lpage>249</lpage><pub-id pub-id-type="pmid">9354147</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Moritz</surname><given-names>DJ</given-names></name><name><surname>Kasl</surname><given-names>SV</given-names></name><name><surname>Berkman</surname><given-names>LF</given-names></name><article-title>Cognitive functioning and the incidence of limitations in activities of daily living in an elderly community sample</article-title><source>Am J Epidemiol</source><year>1995</year><volume>141</volume><fpage>41</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">7801965</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Lobo</surname><given-names>A</given-names></name><name><surname>Launer</surname><given-names>LJ</given-names></name><name><surname>Fratiglioni</surname><given-names>L</given-names></name><name><surname>Andersen</surname><given-names>K</given-names></name><name><surname>Di Carlo</surname><given-names>A</given-names></name><name><surname>Breteler</surname><given-names>MM</given-names></name><name><surname>Copeland</surname><given-names>JR</given-names></name><name><surname>Dartigues</surname><given-names>JF</given-names></name><name><surname>Jagger</surname><given-names>C</given-names></name><name><surname>Martinez-Lage</surname><given-names>J</given-names></name><name><surname>Soininen</surname><given-names>H</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><article-title>Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group</article-title><source>Neurology</source><year>2000</year><volume>54</volume><fpage>S4</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">10854354</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Shen</surname><given-names>YC</given-names></name><name><surname>Chen</surname><given-names>CH</given-names></name><name><surname>Zhao</surname><given-names>YW</given-names></name><name><surname>Li</surname><given-names>SR</given-names></name><name><surname>Lu</surname><given-names>M</given-names></name><article-title>An epidemiological survey of age-related dementia in an urban area of Beijing</article-title><source>Acta Psychiatr Scand</source><year>1989</year><volume>79</volume><fpage>557</fpage><lpage>563</lpage><pub-id pub-id-type="pmid">2788352</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Fichter</surname><given-names>MM</given-names></name><name><surname>Meller</surname><given-names>I</given-names></name><name><surname>Schroppel</surname><given-names>H</given-names></name><name><surname>Steinkirchner</surname><given-names>R</given-names></name><article-title>Dementia and cognitive impairment in the oldest old in the community. Prevalence and comorbidity</article-title><source>Br J Psychiatry</source><year>1995</year><volume>166</volume><fpage>621</fpage><lpage>629</lpage><pub-id pub-id-type="pmid">7620747</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>Ankri</surname><given-names>J</given-names></name><name><surname>Poupard</surname><given-names>M</given-names></name><article-title>Prevalence and incidence of dementia among the very old. Review of the literature</article-title><source>Rev Epidemiol Sante Publique</source><year>2003</year><volume>51</volume><fpage>349</fpage><lpage>360</lpage><pub-id pub-id-type="pmid">13130215</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name><surname>Jorm</surname><given-names>AF</given-names></name><name><surname>Jolley</surname><given-names>D</given-names></name><article-title>The incidence of dementia: a meta-analysis</article-title><source>Neurology</source><year>1998</year><volume>51</volume><fpage>728</fpage><lpage>733</lpage><pub-id pub-id-type="pmid">9748017</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Ott</surname><given-names>A</given-names></name><name><surname>Breteler</surname><given-names>MM</given-names></name><name><surname>van Harskamp</surname><given-names>F</given-names></name><name><surname>Claus</surname><given-names>JJ</given-names></name><name><surname>van der Cammen</surname><given-names>TJ</given-names></name><name><surname>Grobbee</surname><given-names>DE</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><article-title>Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study</article-title><source>BMJ</source><year>1995</year><volume>310</volume><fpage>970</fpage><lpage>973</lpage><pub-id pub-id-type="pmid">7728032</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>HC</given-names></name><name><surname>Lin</surname><given-names>KN</given-names></name><name><surname>Teng</surname><given-names>EL</given-names></name><name><surname>Wang</surname><given-names>SJ</given-names></name><name><surname>Fuh</surname><given-names>JL</given-names></name><name><surname>Guo</surname><given-names>NW</given-names></name><name><surname>Chou</surname><given-names>P</given-names></name><name><surname>Hu</surname><given-names>HH</given-names></name><name><surname>Chiang</surname><given-names>BN</given-names></name><article-title>Prevalence and subtypes of dementia in Taiwan: a community survey of 5297 individuals</article-title><source>J Am Geriatr Soc</source><year>1995</year><volume>43</volume><fpage>144</fpage><lpage>149</lpage><pub-id pub-id-type="pmid">7836638</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><name><surname>McKhann</surname><given-names>G</given-names></name><name><surname>Drachman</surname><given-names>D</given-names></name><name><surname>Folstein</surname><given-names>M</given-names></name><name><surname>Katzman</surname><given-names>R</given-names></name><name><surname>Price</surname><given-names>D</given-names></name><name><surname>Stadlan</surname><given-names>EM</given-names></name><article-title>Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of health and human services task force on Alzheimer's disease</article-title><source>Neurology</source><year>1984</year><volume>34</volume><fpage>939</fpage><lpage>944</lpage><pub-id pub-id-type="pmid">6610841</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><name><surname>McKhann</surname><given-names>GM</given-names></name><name><surname>Knopman</surname><given-names>DS</given-names></name><name><surname>Chertkow</surname><given-names>H</given-names></name><name><surname>Hyman</surname><given-names>BT</given-names></name><name><surname>Jack</surname><given-names>CR</given-names><suffix>Jr</suffix></name><name><surname>Kawas</surname><given-names>CH</given-names></name><name><surname>Klunk</surname><given-names>WE</given-names></name><name><surname>Koroshetz</surname><given-names>WJ</given-names></name><name><surname>Manly</surname><given-names>JJ</given-names></name><name><surname>Mayeux</surname><given-names>R</given-names></name><name><surname>Mohs</surname><given-names>RC</given-names></name><name><surname>Morris</surname><given-names>JC</given-names></name><name><surname>Rossor</surname><given-names>MN</given-names></name><name><surname>Scheltens</surname><given-names>P</given-names></name><name><surname>Carrillo</surname><given-names>MC</given-names></name><name><surname>Thies</surname><given-names>B</given-names></name><name><surname>Weintraub</surname><given-names>S</given-names></name><name><surname>Phelps</surname><given-names>CH</given-names></name><article-title>The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease</article-title><source>Alzheimers Dement</source><year>2011</year><volume>7</volume><fpage>263</fpage><lpage>269</lpage><pub-id pub-id-type="pmid">21514250</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><name><surname>Roman</surname><given-names>GC</given-names></name><name><surname>Tatemichi</surname><given-names>TK</given-names></name><name><surname>Erkinjuntti</surname><given-names>T</given-names></name><name><surname>Cummings</surname><given-names>JL</given-names></name><name><surname>Masdeu</surname><given-names>JC</given-names></name><name><surname>Garcia</surname><given-names>JH</given-names></name><name><surname>Amaducci</surname><given-names>L</given-names></name><name><surname>Orgogozo</surname><given-names>JM</given-names></name><name><surname>Brun</surname><given-names>A</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><etal/><article-title>Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN international workshop</article-title><source>Neurology</source><year>1993</year><volume>43</volume><fpage>250</fpage><lpage>260</lpage><pub-id pub-id-type="pmid">8094895</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name><surname>Hachinski</surname><given-names>VC</given-names></name><name><surname>Iliff</surname><given-names>LD</given-names></name><name><surname>Zilhka</surname><given-names>E</given-names></name><name><surname>Du Boulay</surname><given-names>GH</given-names></name><name><surname>McAllister</surname><given-names>VL</given-names></name><name><surname>Marshall</surname><given-names>J</given-names></name><name><surname>Russell</surname><given-names>RW</given-names></name><name><surname>Symon</surname><given-names>L</given-names></name><article-title>Cerebral blood flow in dementia</article-title><source>Arch Neurol</source><year>1975</year><volume>32</volume><fpage>632</fpage><lpage>637</lpage><pub-id pub-id-type="pmid">1164215</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><collab>The Lund and Manchester Groups</collab><article-title>Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester groups</article-title><source>J Neurol Neurosurg Psychiatry</source><year>1994</year><volume>57</volume><fpage>416</fpage><lpage>418</lpage><pub-id pub-id-type="pmid">8163988</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><name><surname>McKeith</surname><given-names>IG</given-names></name><name><surname>Galasko</surname><given-names>D</given-names></name><name><surname>Kosaka</surname><given-names>K</given-names></name><name><surname>Perry</surname><given-names>EK</given-names></name><name><surname>Dickson</surname><given-names>DW</given-names></name><name><surname>Hansen</surname><given-names>LA</given-names></name><name><surname>Salmon</surname><given-names>DP</given-names></name><name><surname>Lowe</surname><given-names>J</given-names></name><name><surname>Mirra</surname><given-names>SS</given-names></name><name><surname>Byrne</surname><given-names>EJ</given-names></name><name><surname>Lennox</surname><given-names>G</given-names></name><name><surname>Quinn</surname><given-names>NP</given-names></name><name><surname>Edwardson</surname><given-names>JA</given-names></name><name><surname>Ince</surname><given-names>PG</given-names></name><name><surname>Bergeron</surname><given-names>C</given-names></name><name><surname>Burns</surname><given-names>A</given-names></name><name><surname>Miller</surname><given-names>BL</given-names></name><name><surname>Lovestone</surname><given-names>S</given-names></name><name><surname>Collerton</surname><given-names>D</given-names></name><name><surname>Jansen</surname><given-names>EN</given-names></name><name><surname>Ballard</surname><given-names>C</given-names></name><name><surname>de Vos</surname><given-names>RA</given-names></name><name><surname>Wilcock</surname><given-names>GK</given-names></name><name><surname>Jellinger</surname><given-names>KA</given-names></name><name><surname>Perry</surname><given-names>RH</given-names></name><article-title>Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop</article-title><source>Neurology</source><year>1996</year><volume>47</volume><fpage>1113</fpage><lpage>1124</lpage><pub-id pub-id-type="pmid">8909416</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><name><surname>Crecelius</surname><given-names>C</given-names></name><article-title>Diagnosis and treatment of non-Alzheimer's dementias</article-title><source>J Am Med Dir Assoc</source><year>2003</year><volume>4</volume><fpage>H25</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">12857366</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><name><surname>Zekry</surname><given-names>D</given-names></name><name><surname>Hauw</surname><given-names>JJ</given-names></name><name><surname>Gold</surname><given-names>G</given-names></name><article-title>Mixed dementia: epidemiology, diagnosis, and treatment</article-title><source>J Am Geriatr Soc</source><year>2002</year><volume>50</volume><fpage>1431</fpage><lpage>1438</lpage><pub-id pub-id-type="pmid">12165002</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><name><surname>Gorelick</surname><given-names>PB</given-names></name><name><surname>Scuteri</surname><given-names>A</given-names></name><name><surname>Black</surname><given-names>SE</given-names></name><name><surname>Decarli</surname><given-names>C</given-names></name><name><surname>Greenberg</surname><given-names>SM</given-names></name><name><surname>Iadecola</surname><given-names>C</given-names></name><name><surname>Launer</surname><given-names>LJ</given-names></name><name><surname>Laurent</surname><given-names>S</given-names></name><name><surname>Lopez</surname><given-names>OL</given-names></name><name><surname>Nyenhuis</surname><given-names>D</given-names></name><name><surname>Petersen</surname><given-names>RC</given-names></name><name><surname>Schneider</surname><given-names>JA</given-names></name><name><surname>Tzourio</surname><given-names>C</given-names></name><name><surname>Arnett</surname><given-names>DK</given-names></name><name><surname>Bennett</surname><given-names>DA</given-names></name><name><surname>Chui</surname><given-names>HC</given-names></name><name><surname>Higashida</surname><given-names>RT</given-names></name><name><surname>Lindquist</surname><given-names>R</given-names></name><name><surname>Nilsson</surname><given-names>PM</given-names></name><name><surname>Roman</surname><given-names>GC</given-names></name><name><surname>Sellke</surname><given-names>FW</given-names></name><name><surname>Seshadri</surname><given-names>S</given-names></name><collab>American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia</collab><article-title>Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association</article-title><source>Stroke</source><year>2011</year><volume>42</volume><fpage>2672</fpage><lpage>2713</lpage><pub-id pub-id-type="pmid">21778438</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><name><surname>Barnes</surname><given-names>DE</given-names></name><name><surname>Yaffe</surname><given-names>K</given-names></name><article-title>The projected effect of risk factor reduction on Alzheimer's disease prevalence</article-title><source>Lancet Neurol</source><year>2011</year><volume>10</volume><fpage>819</fpage><lpage>828</lpage><pub-id pub-id-type="pmid">21775213</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>MY</given-names></name><name><surname>Katzman</surname><given-names>R</given-names></name><name><surname>Salmon</surname><given-names>D</given-names></name><name><surname>Jin</surname><given-names>H</given-names></name><name><surname>Cai</surname><given-names>GJ</given-names></name><name><surname>Wang</surname><given-names>ZY</given-names></name><name><surname>Qu</surname><given-names>GY</given-names></name><name><surname>Grant</surname><given-names>I</given-names></name><name><surname>Yu</surname><given-names>E</given-names></name><name><surname>Levy</surname><given-names>P</given-names></name><etal/><article-title>The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender, and education</article-title><source>Ann Neurol</source><year>1990</year><volume>27</volume><fpage>428</fpage><lpage>437</lpage><pub-id pub-id-type="pmid">2353798</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><name><surname>Ogunniyi</surname><given-names>A</given-names></name><name><surname>Lekwauwa</surname><given-names>UG</given-names></name><name><surname>Osuntokun</surname><given-names>BO</given-names></name><article-title>Influence of education on aspects of cognitive functions in non-demented elderly Nigerians</article-title><source>Neuroepidemiology</source><year>1991</year><volume>10</volume><fpage>246</fpage><lpage>250</lpage><pub-id pub-id-type="pmid">1798426</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name><surname>Dealberto</surname><given-names>MJ</given-names></name><name><surname>Gagnon</surname><given-names>M</given-names></name><name><surname>Barberger-Gateau</surname><given-names>P</given-names></name><name><surname>Dartigues</surname><given-names>JF</given-names></name><name><surname>Alperovitch</surname><given-names>A</given-names></name><article-title>[Influence of educational status on a screening test for dementia, the mini-mental state examination]</article-title><source>Rev Epidemiol Sante Publique</source><year>1992</year><volume>40</volume><fpage>93</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">1631382</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name><surname>Koivisto</surname><given-names>K</given-names></name><name><surname>Helkala</surname><given-names>EL</given-names></name><name><surname>Reinikainen</surname><given-names>KJ</given-names></name><name><surname>Hanninen</surname><given-names>T</given-names></name><name><surname>Mykkanen</surname><given-names>L</given-names></name><name><surname>Laakso</surname><given-names>M</given-names></name><name><surname>Pyorala</surname><given-names>K</given-names></name><name><surname>Riekkinen</surname><given-names>PJ</given-names></name><article-title>Population-based dementia screening program in Kuopio: the effect of education, age, and sex on brief neuropsychological tests</article-title><source>J Geriatr Psychiatry Neurol</source><year>1992</year><volume>5</volume><fpage>162</fpage><lpage>171</lpage><pub-id pub-id-type="pmid">1497793</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><name><surname>Evans</surname><given-names>DA</given-names></name><name><surname>Beckett</surname><given-names>LA</given-names></name><name><surname>Albert</surname><given-names>MS</given-names></name><name><surname>Hebert</surname><given-names>LE</given-names></name><name><surname>Scherr</surname><given-names>PA</given-names></name><name><surname>Funkenstein</surname><given-names>HH</given-names></name><name><surname>Taylor</surname><given-names>JO</given-names></name><article-title>Level of education and change in cognitive function in a community population of older persons</article-title><source>Ann Epidemiol</source><year>1993</year><volume>3</volume><fpage>71</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">8287159</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><name><surname>Paykel</surname><given-names>ES</given-names></name><name><surname>Brayne</surname><given-names>C</given-names></name><name><surname>Huppert</surname><given-names>FA</given-names></name><name><surname>Gill</surname><given-names>C</given-names></name><name><surname>Barkley</surname><given-names>C</given-names></name><name><surname>Gehlhaar</surname><given-names>E</given-names></name><name><surname>Beardsall</surname><given-names>L</given-names></name><name><surname>Girling</surname><given-names>DM</given-names></name><name><surname>Pollitt</surname><given-names>P</given-names></name><name><surname>O'Connor</surname><given-names>D</given-names></name><article-title>Incidence of dementia in a population older than 75&#x000a0;years in the United Kingdom</article-title><source>Arch Gen Psychiatry</source><year>1994</year><volume>51</volume><fpage>325</fpage><lpage>332</lpage><pub-id pub-id-type="pmid">8161293</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><name><surname>White</surname><given-names>L</given-names></name><name><surname>Katzman</surname><given-names>R</given-names></name><name><surname>Losonczy</surname><given-names>K</given-names></name><name><surname>Salive</surname><given-names>M</given-names></name><name><surname>Wallace</surname><given-names>R</given-names></name><name><surname>Berkman</surname><given-names>L</given-names></name><name><surname>Taylor</surname><given-names>J</given-names></name><name><surname>Fillenbaum</surname><given-names>G</given-names></name><name><surname>Havlik</surname><given-names>R</given-names></name><article-title>Association of education with incidence of cognitive impairment in three established populations for epidemiologic studies of the elderly</article-title><source>J Clin Epidemiol</source><year>1994</year><volume>47</volume><fpage>363</fpage><lpage>374</lpage><pub-id pub-id-type="pmid">7730861</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><name><surname>Cobb</surname><given-names>JL</given-names></name><name><surname>Wolf</surname><given-names>PA</given-names></name><name><surname>Au</surname><given-names>R</given-names></name><name><surname>White</surname><given-names>R</given-names></name><name><surname>D'Agostino</surname><given-names>RB</given-names></name><article-title>The effect of education on the incidence of dementia and Alzheimer's disease in the Framingham Study</article-title><source>Neurology</source><year>1995</year><volume>45</volume><fpage>1707</fpage><lpage>1712</lpage><pub-id pub-id-type="pmid">7675231</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><name><surname>Farmer</surname><given-names>ME</given-names></name><name><surname>Kittner</surname><given-names>SJ</given-names></name><name><surname>Rae</surname><given-names>DS</given-names></name><name><surname>Bartko</surname><given-names>JJ</given-names></name><name><surname>Regier</surname><given-names>DA</given-names></name><article-title>Education and change in cognitive function. The epidemiologic catchment area study</article-title><source>Ann Epidemiol</source><year>1995</year><volume>5</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">7728280</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><name><surname>Callahan</surname><given-names>CM</given-names></name><name><surname>Hall</surname><given-names>KS</given-names></name><name><surname>Hui</surname><given-names>SL</given-names></name><name><surname>Musick</surname><given-names>BS</given-names></name><name><surname>Unverzagt</surname><given-names>FW</given-names></name><name><surname>Hendrie</surname><given-names>HC</given-names></name><article-title>Relationship of age, education, and occupation with dementia among a community-based sample of African Americans</article-title><source>Arch Neurol</source><year>1996</year><volume>53</volume><fpage>134</fpage><lpage>140</lpage><pub-id pub-id-type="pmid">8639062</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><name><surname>Hanninen</surname><given-names>T</given-names></name><name><surname>Koivisto</surname><given-names>K</given-names></name><name><surname>Reinikainen</surname><given-names>KJ</given-names></name><name><surname>Helkala</surname><given-names>EL</given-names></name><name><surname>Soininen</surname><given-names>H</given-names></name><name><surname>Mykkanen</surname><given-names>L</given-names></name><name><surname>Laakso</surname><given-names>M</given-names></name><name><surname>Riekkinen</surname><given-names>PJ</given-names></name><article-title>Prevalence of ageing-associated cognitive decline in an elderly population</article-title><source>Age Ageing</source><year>1996</year><volume>25</volume><fpage>201</fpage><lpage>205</lpage><pub-id pub-id-type="pmid">8670552</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><name><surname>Christensen</surname><given-names>H</given-names></name><name><surname>Korten</surname><given-names>AE</given-names></name><name><surname>Jorm</surname><given-names>AF</given-names></name><name><surname>Henderson</surname><given-names>AS</given-names></name><name><surname>Jacomb</surname><given-names>PA</given-names></name><name><surname>Rodgers</surname><given-names>B</given-names></name><name><surname>Mackinnon</surname><given-names>AJ</given-names></name><article-title>Education and decline in cognitive performance: compensatory but not protective</article-title><source>Int J Geriatr Psychiatry</source><year>1997</year><volume>12</volume><fpage>323</fpage><lpage>330</lpage><pub-id pub-id-type="pmid">9152716</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><name><surname>Evans</surname><given-names>DA</given-names></name><name><surname>Hebert</surname><given-names>LE</given-names></name><name><surname>Beckett</surname><given-names>LA</given-names></name><name><surname>Scherr</surname><given-names>PA</given-names></name><name><surname>Albert</surname><given-names>MS</given-names></name><name><surname>Chown</surname><given-names>MJ</given-names></name><name><surname>Pilgrim</surname><given-names>DM</given-names></name><name><surname>Taylor</surname><given-names>JO</given-names></name><article-title>Education and other measures of socioeconomic status and risk of incident Alzheimer disease in a defined population of older persons</article-title><source>Arch Neurol</source><year>1997</year><volume>54</volume><fpage>1399</fpage><lpage>1405</lpage><pub-id pub-id-type="pmid">9362989</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><name><surname>Freidl</surname><given-names>W</given-names></name><name><surname>Schmidt</surname><given-names>R</given-names></name><name><surname>Stronegger</surname><given-names>WJ</given-names></name><name><surname>Reinhart</surname><given-names>B</given-names></name><article-title>The impact of sociodemographic, environmental, and behavioral factors, and cerebrovascular risk factors as potential predictors of the mattis dementia rating scale</article-title><source>J Gerontol A Biol Sci Med Sci</source><year>1997</year><volume>52</volume><fpage>M111</fpage><lpage>116</lpage><pub-id pub-id-type="pmid">9060979</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><name><surname>Kalmijn</surname><given-names>S</given-names></name><name><surname>Feskens</surname><given-names>EJ</given-names></name><name><surname>Launer</surname><given-names>LJ</given-names></name><name><surname>Kromhout</surname><given-names>D</given-names></name><article-title>Longitudinal study of the effect of apolipoprotein e4 allele on the association between education and cognitive decline in elderly men</article-title><source>BMJ</source><year>1997</year><volume>314</volume><fpage>34</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">9001477</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><name><surname>Kilander</surname><given-names>L</given-names></name><name><surname>Nyman</surname><given-names>H</given-names></name><name><surname>Boberg</surname><given-names>M</given-names></name><name><surname>Lithell</surname><given-names>H</given-names></name><article-title>Cognitive function, vascular risk factors and education. A cross-sectional study based on a cohort of 70-year-old men</article-title><source>J Intern Med</source><year>1997</year><volume>242</volume><fpage>313</fpage><lpage>321</lpage><pub-id pub-id-type="pmid">9366810</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><name><surname>Schmand</surname><given-names>B</given-names></name><name><surname>Smit</surname><given-names>J</given-names></name><name><surname>Lindeboom</surname><given-names>J</given-names></name><name><surname>Smits</surname><given-names>C</given-names></name><name><surname>Hooijer</surname><given-names>C</given-names></name><name><surname>Jonker</surname><given-names>C</given-names></name><name><surname>Deelman</surname><given-names>B</given-names></name><article-title>Low education is a genuine risk factor for accelerated memory decline and dementia</article-title><source>J Clin Epidemiol</source><year>1997</year><volume>50</volume><fpage>1025</fpage><lpage>1033</lpage><pub-id pub-id-type="pmid">9363037</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><name><surname>Schmand</surname><given-names>B</given-names></name><name><surname>Smit</surname><given-names>JH</given-names></name><name><surname>Geerlings</surname><given-names>MI</given-names></name><name><surname>Lindeboom</surname><given-names>J</given-names></name><article-title>The effects of intelligence and education on the development of dementia. A test of the brain reserve hypothesis</article-title><source>Psychol Med</source><year>1997</year><volume>27</volume><fpage>1337</fpage><lpage>1344</lpage><pub-id pub-id-type="pmid">9403905</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><name><surname>Cerhan</surname><given-names>JR</given-names></name><name><surname>Folsom</surname><given-names>AR</given-names></name><name><surname>Mortimer</surname><given-names>JA</given-names></name><name><surname>Shahar</surname><given-names>E</given-names></name><name><surname>Knopman</surname><given-names>DS</given-names></name><name><surname>McGovern</surname><given-names>PG</given-names></name><name><surname>Hays</surname><given-names>MA</given-names></name><name><surname>Crum</surname><given-names>LD</given-names></name><name><surname>Heiss</surname><given-names>G</given-names></name><article-title>
Correlates of cognitive function in middle-aged adults. Atherosclerosis risk in communities (ARIC) study investigators</article-title><source>Gerontology</source><year>1998</year><volume>44</volume><fpage>95</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">9523221</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><name><surname>De Ronchi</surname><given-names>D</given-names></name><name><surname>Fratiglioni</surname><given-names>L</given-names></name><name><surname>Rucci</surname><given-names>P</given-names></name><name><surname>Paternico</surname><given-names>A</given-names></name><name><surname>Graziani</surname><given-names>S</given-names></name><name><surname>Dalmonte</surname><given-names>E</given-names></name><article-title>The effect of education on dementia occurrence in an Italian population with middle to high socioeconomic status</article-title><source>Neurology</source><year>1998</year><volume>50</volume><fpage>1231</fpage><lpage>1238</lpage><pub-id pub-id-type="pmid">9595968</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><name><surname>Lin</surname><given-names>RT</given-names></name><name><surname>Lai</surname><given-names>CL</given-names></name><name><surname>Tai</surname><given-names>CT</given-names></name><name><surname>Liu</surname><given-names>CK</given-names></name><name><surname>Yen</surname><given-names>YY</given-names></name><name><surname>Howng</surname><given-names>SL</given-names></name><article-title>Prevalence and subtypes of dementia in southern Taiwan: impact of age, sex, education, and urbanization</article-title><source>J Neurol Sci</source><year>1998</year><volume>160</volume><fpage>67</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">9804120</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><name><surname>Lyketsos</surname><given-names>CG</given-names></name><name><surname>Chen</surname><given-names>LS</given-names></name><name><surname>Anthony</surname><given-names>JC</given-names></name><article-title>Cognitive decline in adulthood: an 11.5-year follow-up of the Baltimore epidemiologic catchment area study</article-title><source>Am J Psychiatry</source><year>1999</year><volume>156</volume><fpage>58</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">9892298</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><name><surname>Letenneur</surname><given-names>L</given-names></name><name><surname>Gilleron</surname><given-names>V</given-names></name><name><surname>Commenges</surname><given-names>D</given-names></name><name><surname>Helmer</surname><given-names>C</given-names></name><name><surname>Orgogozo</surname><given-names>JM</given-names></name><name><surname>Dartigues</surname><given-names>JF</given-names></name><article-title>Are sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project</article-title><source>J Neurol Neurosurg Psychiatry</source><year>1999</year><volume>66</volume><fpage>177</fpage><lpage>183</lpage><pub-id pub-id-type="pmid">10071096</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><name><surname>Ott</surname><given-names>A</given-names></name><name><surname>van Rossum</surname><given-names>CT</given-names></name><name><surname>van Harskamp</surname><given-names>F</given-names></name><name><surname>van de Mheen</surname><given-names>H</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Breteler</surname><given-names>MM</given-names></name><article-title>Education and the incidence of dementia in a large population-based study: the Rotterdam study</article-title><source>Neurology</source><year>1999</year><volume>52</volume><fpage>663</fpage><lpage>666</lpage><pub-id pub-id-type="pmid">10025813</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><name><surname>Aevarsson</surname><given-names>O</given-names></name><name><surname>Skoog</surname><given-names>I</given-names></name><article-title>A longitudinal population study of the mini-mental state examination in the very old: relation to dementia and education</article-title><source>Dement Geriatr Cogn Disord</source><year>2000</year><volume>11</volume><fpage>166</fpage><lpage>175</lpage><pub-id pub-id-type="pmid">10765048</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><name><surname>Qiu</surname><given-names>C</given-names></name><name><surname>Backman</surname><given-names>L</given-names></name><name><surname>Winblad</surname><given-names>B</given-names></name><name><surname>Aguero-Torres</surname><given-names>H</given-names></name><name><surname>Fratiglioni</surname><given-names>L</given-names></name><article-title>The influence of education on clinically diagnosed dementia incidence and mortality data from the Kungsholmen project</article-title><source>Arch Neurol</source><year>2001</year><volume>58</volume><fpage>2034</fpage><lpage>2039</lpage><pub-id pub-id-type="pmid">11735777</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><name><surname>Alvarado</surname><given-names>BE</given-names></name><name><surname>Zunzunegui</surname><given-names>MV</given-names></name><name><surname>Del Ser</surname><given-names>T</given-names></name><name><surname>Beland</surname><given-names>F</given-names></name><article-title>Cognitive decline is related to education and occupation in a Spanish elderly cohort</article-title><source>Aging Clin Exp Res</source><year>2002</year><volume>14</volume><fpage>132</fpage><lpage>142</lpage><pub-id pub-id-type="pmid">12092786</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><name><surname>Cagney</surname><given-names>KA</given-names></name><name><surname>Lauderdale</surname><given-names>DS</given-names></name><article-title>Education, wealth, and cognitive function in later life</article-title><source>J Gerontol B Psychol Sci Soc Sci</source><year>2002</year><volume>57</volume><fpage>P163</fpage><lpage>172</lpage><pub-id pub-id-type="pmid">11867664</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><name><surname>Herrera</surname><given-names>E</given-names><suffix>Jr</suffix></name><name><surname>Caramelli</surname><given-names>P</given-names></name><name><surname>Silveira</surname><given-names>AS</given-names></name><name><surname>Nitrini</surname><given-names>R</given-names></name><article-title>Epidemiologic survey of dementia in a community-dwelling Brazilian population</article-title><source>Alzheimer Dis Assoc Disord</source><year>2002</year><volume>16</volume><fpage>103</fpage><lpage>108</lpage><pub-id pub-id-type="pmid">12040305</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><name><surname>Ravaglia</surname><given-names>G</given-names></name><name><surname>Forti</surname><given-names>P</given-names></name><name><surname>Maioli</surname><given-names>F</given-names></name><name><surname>Sacchetti</surname><given-names>L</given-names></name><name><surname>Mariani</surname><given-names>E</given-names></name><name><surname>Nativio</surname><given-names>V</given-names></name><name><surname>Talerico</surname><given-names>T</given-names></name><name><surname>Vettori</surname><given-names>C</given-names></name><name><surname>Macini</surname><given-names>PL</given-names></name><article-title>Education, occupation, and prevalence of dementia: findings from the Conselice study</article-title><source>Dement Geriatr Cogn Disord</source><year>2002</year><volume>14</volume><fpage>90</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">12145456</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><name><surname>Wight</surname><given-names>RG</given-names></name><name><surname>Aneshensel</surname><given-names>CS</given-names></name><name><surname>Seeman</surname><given-names>TE</given-names></name><article-title>Educational attainment, continued learning experience, and cognitive function among older men</article-title><source>J Aging Health</source><year>2002</year><volume>14</volume><fpage>211</fpage><lpage>236</lpage><pub-id pub-id-type="pmid">11995741</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Kawachi</surname><given-names>I</given-names></name><name><surname>Berkman</surname><given-names>LF</given-names></name><name><surname>Grodstein</surname><given-names>F</given-names></name><article-title>Education, other socioeconomic indicators, and cognitive function</article-title><source>Am J Epidemiol</source><year>2003</year><volume>157</volume><fpage>712</fpage><lpage>720</lpage><pub-id pub-id-type="pmid">12697575</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><name><surname>Seeman</surname><given-names>TE</given-names></name><name><surname>Huang</surname><given-names>MH</given-names></name><name><surname>Bretsky</surname><given-names>P</given-names></name><name><surname>Crimmins</surname><given-names>E</given-names></name><name><surname>Launer</surname><given-names>L</given-names></name><name><surname>Guralnik</surname><given-names>JM</given-names></name><article-title>Education and APOE-e4 in longitudinal cognitive decline: MacArthur studies of successful aging</article-title><source>J Gerontol B Psychol Sci Soc Sci</source><year>2005</year><volume>60</volume><fpage>P74</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">15746021</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Buring</surname><given-names>JE</given-names></name><name><surname>Cook</surname><given-names>NR</given-names></name><name><surname>Grodstein</surname><given-names>F</given-names></name><article-title>The relation of education and income to cognitive function among professional women</article-title><source>Neuroepidemiology</source><year>2006</year><volume>26</volume><fpage>93</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">16352912</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><name><surname>Shadlen</surname><given-names>MF</given-names></name><name><surname>Siscovick</surname><given-names>D</given-names></name><name><surname>Fitzpatrick</surname><given-names>AL</given-names></name><name><surname>Dulberg</surname><given-names>C</given-names></name><name><surname>Kuller</surname><given-names>LH</given-names></name><name><surname>Jackson</surname><given-names>S</given-names></name><article-title>Education, cognitive test scores, and black-white differences in dementia risk</article-title><source>J Am Geriatr Soc</source><year>2006</year><volume>54</volume><fpage>898</fpage><lpage>905</lpage><pub-id pub-id-type="pmid">16776783</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>ZX</given-names></name><name><surname>Zahner</surname><given-names>GE</given-names></name><name><surname>Rom&#x000e1;n</surname><given-names>GC</given-names></name><name><surname>Liu</surname><given-names>XH</given-names></name><name><surname>Wu</surname><given-names>CB</given-names></name><name><surname>Hong</surname><given-names>Z</given-names></name><name><surname>Hong</surname><given-names>X</given-names></name><name><surname>Tang</surname><given-names>MN</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Qu</surname><given-names>QM</given-names></name><name><surname>Zhang</surname><given-names>XJ</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><article-title>Socio-demographic variation of dementia subtypes in china: methodology and results of a prevalence study in Beijing, Chengdu, Shanghai, and Xian</article-title><source>Neuroepidemiology</source><year>2006</year><volume>27</volume><fpage>177</fpage><lpage>187</lpage><pub-id pub-id-type="pmid">17035714</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><name><surname>Zhou</surname><given-names>DF</given-names></name><name><surname>Wu</surname><given-names>CS</given-names></name><name><surname>Qi</surname><given-names>H</given-names></name><name><surname>Fan</surname><given-names>JH</given-names></name><name><surname>Sun</surname><given-names>XD</given-names></name><name><surname>Como</surname><given-names>P</given-names></name><name><surname>Qiao</surname><given-names>YL</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Kieburtz</surname><given-names>K</given-names></name><article-title>Prevalence of dementia in rural China: impact of age, gender and education</article-title><source>Acta Neurol Scand</source><year>2006</year><volume>114</volume><fpage>273</fpage><lpage>280</lpage><pub-id pub-id-type="pmid">16942548</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><name><surname>Galasko</surname><given-names>D</given-names></name><name><surname>Salmon</surname><given-names>D</given-names></name><name><surname>Gamst</surname><given-names>A</given-names></name><name><surname>Olichney</surname><given-names>J</given-names></name><name><surname>Thal</surname><given-names>LJ</given-names></name><name><surname>Silbert</surname><given-names>L</given-names></name><name><surname>Kaye</surname><given-names>J</given-names></name><name><surname>Brooks</surname><given-names>P</given-names></name><name><surname>Adonay</surname><given-names>R</given-names></name><name><surname>Craig</surname><given-names>UK</given-names></name><name><surname>Schellenberg</surname><given-names>G</given-names></name><name><surname>Borenstein</surname><given-names>AR</given-names></name><article-title>Prevalence of dementia in Chamorros on Guam: relationship to age, gender, education, and APOE</article-title><source>Neurology</source><year>2007</year><volume>68</volume><fpage>1772</fpage><lpage>1781</lpage><pub-id pub-id-type="pmid">17515539</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><name><surname>van Hooren</surname><given-names>SA</given-names></name><name><surname>Valentijn</surname><given-names>AM</given-names></name><name><surname>Bosma</surname><given-names>H</given-names></name><name><surname>Ponds</surname><given-names>RW</given-names></name><name><surname>van Boxtel</surname><given-names>MP</given-names></name><name><surname>Jolles</surname><given-names>J</given-names></name><article-title>Cognitive functioning in healthy older adults aged 64&#x02013;81: a cohort study into the effects of age, sex, and education</article-title><source>Neuropsychol Dev Cogn B Aging Neuropsychol Cogn</source><year>2007</year><volume>14</volume><fpage>40</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">17164189</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><name><surname>Christensen</surname><given-names>H</given-names></name><name><surname>Batterham</surname><given-names>PJ</given-names></name><name><surname>Mackinnon</surname><given-names>AJ</given-names></name><name><surname>Anstey</surname><given-names>KJ</given-names></name><name><surname>Wen</surname><given-names>W</given-names></name><name><surname>Sachdev</surname><given-names>PS</given-names></name><article-title>Education, atrophy, and cognitive change in an epidemiological sample in early old age</article-title><source>Am J Geriatr Psychiatry</source><year>2009</year><volume>17</volume><fpage>218</fpage><lpage>226</lpage><pub-id pub-id-type="pmid">19454848</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><name><surname>Dotson</surname><given-names>VM</given-names></name><name><surname>Kitner-Triolo</surname><given-names>MH</given-names></name><name><surname>Evans</surname><given-names>MK</given-names></name><name><surname>Zonderman</surname><given-names>AB</given-names></name><article-title>Effects of race and socioeconomic status on the relative influence of education and literacy on cognitive functioning</article-title><source>J Int Neuropsychol Soc</source><year>2009</year><volume>15</volume><fpage>580</fpage><lpage>589</lpage><pub-id pub-id-type="pmid">19573276</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><name><surname>Gavrila</surname><given-names>D</given-names></name><name><surname>Antunez</surname><given-names>C</given-names></name><name><surname>Tormo</surname><given-names>MJ</given-names></name><name><surname>Carles</surname><given-names>R</given-names></name><name><surname>Garcia Santos</surname><given-names>JM</given-names></name><name><surname>Parrilla</surname><given-names>G</given-names></name><name><surname>Fortuna</surname><given-names>L</given-names></name><name><surname>Jimenez</surname><given-names>J</given-names></name><name><surname>Salmeron</surname><given-names>D</given-names></name><name><surname>Navarro</surname><given-names>C</given-names></name><article-title>Prevalence of dementia and cognitive impairment in Southeastern Spain: the Ariadna study</article-title><source>Acta Neurol Scand</source><year>2009</year><volume>120</volume><fpage>300</fpage><lpage>307</lpage><pub-id pub-id-type="pmid">19832772</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><name><surname>Peters</surname><given-names>R</given-names></name><name><surname>Beckett</surname><given-names>N</given-names></name><name><surname>Geneva</surname><given-names>M</given-names></name><name><surname>Tzekova</surname><given-names>M</given-names></name><name><surname>Lu</surname><given-names>FH</given-names></name><name><surname>Poulter</surname><given-names>R</given-names></name><name><surname>Gainsborough</surname><given-names>N</given-names></name><name><surname>Williams</surname><given-names>B</given-names></name><name><surname>de Vernejoul</surname><given-names>MC</given-names></name><name><surname>Fletcher</surname><given-names>A</given-names></name><name><surname>Bulpitt</surname><given-names>C</given-names></name><article-title>Sociodemographic and lifestyle risk factors for incident dementia and cognitive decline in the HYVET</article-title><source>Age Ageing</source><year>2009</year><volume>38</volume><fpage>521</fpage><lpage>527</lpage><pub-id pub-id-type="pmid">19553357</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><name><surname>Wilson</surname><given-names>RS</given-names></name><name><surname>Hebert</surname><given-names>LE</given-names></name><name><surname>Scherr</surname><given-names>PA</given-names></name><name><surname>Barnes</surname><given-names>LL</given-names></name><name><surname>de Leon CF</surname><given-names>M</given-names></name><name><surname>Evans</surname><given-names>DA</given-names></name><article-title>Educational attainment and cognitive decline in old age</article-title><source>Neurology</source><year>2009</year><volume>72</volume><fpage>460</fpage><lpage>465</lpage><pub-id pub-id-type="pmid">19188578</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><name><surname>Hamid</surname><given-names>TA</given-names></name><name><surname>Krishnaswamy</surname><given-names>S</given-names></name><name><surname>Abdullah</surname><given-names>SS</given-names></name><name><surname>Momtaz</surname><given-names>YA</given-names></name><article-title>Sociodemographic risk factors and correlates of dementia in older Malaysians</article-title><source>Dement Geriatr Cogn Disord</source><year>2010</year><volume>30</volume><fpage>533</fpage><lpage>539</lpage><pub-id pub-id-type="pmid">21252548</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><name><surname>Mathuranath</surname><given-names>PS</given-names></name><name><surname>Cherian</surname><given-names>PJ</given-names></name><name><surname>Mathew</surname><given-names>R</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>George</surname><given-names>A</given-names></name><name><surname>Alexander</surname><given-names>A</given-names></name><name><surname>Ranjith</surname><given-names>N</given-names></name><name><surname>Sarma</surname><given-names>PS</given-names></name><article-title>Dementia in Kerala, South India: prevalence and influence of age, education and gender</article-title><source>Int J Geriatr Psychiatry</source><year>2010</year><volume>25</volume><fpage>290</fpage><lpage>297</lpage><pub-id pub-id-type="pmid">19621355</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><name><surname>Scazufca</surname><given-names>M</given-names></name><name><surname>Almeida</surname><given-names>OP</given-names></name><name><surname>Menezes</surname><given-names>PR</given-names></name><article-title>The role of literacy, occupation and income in dementia prevention: the Sao Paulo ageing &#x00026; health study (SPAH)</article-title><source>Int Psychogeriatr</source><year>2010</year><volume>22</volume><fpage>1209</fpage><lpage>1215</lpage><pub-id pub-id-type="pmid">20678301</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><name><surname>Castro-Costa</surname><given-names>E</given-names></name><name><surname>Dewey</surname><given-names>ME</given-names></name><name><surname>Uchoa</surname><given-names>E</given-names></name><name><surname>Firmo</surname><given-names>JO</given-names></name><name><surname>Lima-Costa</surname><given-names>MF</given-names></name><name><surname>Stewart</surname><given-names>R</given-names></name><article-title>Trajectories of cognitive decline over 10&#x000a0;years in a Brazilian elderly population: the Bambui cohort study of aging</article-title><source>Cad Saude Publica</source><year>2011</year><volume>27</volume><issue>Suppl 3</issue><fpage>S345</fpage><lpage>350</lpage><pub-id pub-id-type="pmid">21952855</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><name><surname>Marengoni</surname><given-names>A</given-names></name><name><surname>Fratiglioni</surname><given-names>L</given-names></name><name><surname>Bandinelli</surname><given-names>S</given-names></name><name><surname>Ferrucci</surname><given-names>L</given-names></name><article-title>Socioeconomic status during lifetime and cognitive impairment no-dementia in late life: the population-based aging in the Chianti area (InCHIANTI) study</article-title><source>J Alzheimers Dis</source><year>2011</year><volume>24</volume><fpage>559</fpage><lpage>568</lpage><pub-id pub-id-type="pmid">21297261</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><name><surname>Mejia-Arango</surname><given-names>S</given-names></name><name><surname>Gutierrez</surname><given-names>LM</given-names></name><article-title>Prevalence and incidence rates of dementia and cognitive impairment no dementia in the Mexican population: data from the Mexican health and aging study</article-title><source>J Aging Health</source><year>2011</year><volume>23</volume><fpage>1050</fpage><lpage>1074</lpage><pub-id pub-id-type="pmid">21948770</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><name><surname>Zahodne</surname><given-names>LB</given-names></name><name><surname>Glymour</surname><given-names>MM</given-names></name><name><surname>Sparks</surname><given-names>C</given-names></name><name><surname>Bontempo</surname><given-names>D</given-names></name><name><surname>Dixon</surname><given-names>RA</given-names></name><name><surname>MacDonald</surname><given-names>SW</given-names></name><name><surname>Manly</surname><given-names>JJ</given-names></name><article-title>Education does not slow cognitive decline with aging: 12-year evidence from the victoria longitudinal study</article-title><source>J Int Neuropsychol Soc</source><year>2011</year><volume>17</volume><fpage>1039</fpage><lpage>1046</lpage><pub-id pub-id-type="pmid">21923980</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><name><surname>Herbert</surname><given-names>LE</given-names></name><name><surname>Scherr</surname><given-names>PA</given-names></name><name><surname>Beckett</surname><given-names>LA</given-names></name><name><surname>Albert</surname><given-names>MS</given-names></name><name><surname>Rosner</surname><given-names>B</given-names></name><name><surname>Taylor</surname><given-names>JO</given-names></name><name><surname>Evans</surname><given-names>DA</given-names></name><article-title>Relation of smoking and low-to-moderate alcohol consumption to change in cognitive function: a longitudinal study in a defined community of older persons</article-title><source>Am J Epidemiol</source><year>1993</year><volume>137</volume><fpage>881</fpage><lpage>891</lpage><pub-id pub-id-type="pmid">8484379</pub-id></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal"><name><surname>Letenneur</surname><given-names>L</given-names></name><name><surname>Dartigues</surname><given-names>JF</given-names></name><name><surname>Commenges</surname><given-names>D</given-names></name><name><surname>Barberger-Gateau</surname><given-names>P</given-names></name><name><surname>Tessier</surname><given-names>JF</given-names></name><name><surname>Orgogozo</surname><given-names>JM</given-names></name><article-title>Tobacco consumption and cognitive impairment in elderly people. A population-based study</article-title><source>Ann Epidemiol</source><year>1994</year><volume>4</volume><fpage>449</fpage><lpage>454</lpage><pub-id pub-id-type="pmid">7804499</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><name><surname>Ford</surname><given-names>AB</given-names></name><name><surname>Mefrouche</surname><given-names>Z</given-names></name><name><surname>Friedland</surname><given-names>RP</given-names></name><name><surname>Debanne</surname><given-names>SM</given-names></name><article-title>Smoking and cognitive impairment: a population-based study</article-title><source>J Am Geriatr Soc</source><year>1996</year><volume>44</volume><fpage>905</fpage><lpage>909</lpage><pub-id pub-id-type="pmid">8708298</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><name><surname>Galanis</surname><given-names>DJ</given-names></name><name><surname>Petrovitch</surname><given-names>H</given-names></name><name><surname>Launer</surname><given-names>LJ</given-names></name><name><surname>Harris</surname><given-names>TB</given-names></name><name><surname>Foley</surname><given-names>DJ</given-names></name><name><surname>White</surname><given-names>LR</given-names></name><article-title>
Smoking history in middle age and subsequent cognitive performance in elderly Japanese-American men. The Honolulu-Asia Aging Study</article-title><source>Am J Epidemiol</source><year>1997</year><volume>145</volume><fpage>507</fpage><lpage>515</lpage><pub-id pub-id-type="pmid">9063340</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><name><surname>Broe</surname><given-names>GA</given-names></name><name><surname>Creasey</surname><given-names>H</given-names></name><name><surname>Jorm</surname><given-names>AF</given-names></name><name><surname>Bennett</surname><given-names>HP</given-names></name><name><surname>Casey</surname><given-names>B</given-names></name><name><surname>Waite</surname><given-names>LM</given-names></name><name><surname>Grayson</surname><given-names>DA</given-names></name><name><surname>Cullen</surname><given-names>J</given-names></name><article-title>Health habits and risk of cognitive impairment and dementia in old age: a prospective study on the effects of exercise, smoking and alcohol consumption</article-title><source>Aust N Z J Public Health</source><year>1998</year><volume>22</volume><fpage>621</fpage><lpage>623</lpage><pub-id pub-id-type="pmid">9744220</pub-id></mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><name><surname>Edelstein</surname><given-names>SL</given-names></name><name><surname>Kritz-Silverstein</surname><given-names>D</given-names></name><name><surname>Barrett-Connor</surname><given-names>E</given-names></name><article-title>Prospective association of smoking and alcohol use with cognitive function in an elderly cohort</article-title><source>J Womens Health</source><year>1998</year><volume>7</volume><fpage>1271</fpage><lpage>1281</lpage><pub-id pub-id-type="pmid">9929860</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><name><surname>Ott</surname><given-names>A</given-names></name><name><surname>Slooter</surname><given-names>AJ</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>van Harskamp</surname><given-names>F</given-names></name><name><surname>Witteman</surname><given-names>JC</given-names></name><name><surname>Van Broeckhoven</surname><given-names>C</given-names></name><name><surname>van Duijn</surname><given-names>CM</given-names></name><name><surname>Breteler</surname><given-names>MM</given-names></name><article-title>Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam study</article-title><source>Lancet</source><year>1998</year><volume>351</volume><fpage>1840</fpage><lpage>1843</lpage><pub-id pub-id-type="pmid">9652667</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><name><surname>Carmelli</surname><given-names>D</given-names></name><name><surname>Swan</surname><given-names>GE</given-names></name><name><surname>Reed</surname><given-names>T</given-names></name><name><surname>Schellenberg</surname><given-names>GD</given-names></name><name><surname>Christian</surname><given-names>JC</given-names></name><article-title>The effect of apolipoprotein E epsilon4 in the relationships of smoking and drinking to cognitive function</article-title><source>Neuroepidemiology</source><year>1999</year><volume>18</volume><fpage>125</fpage><lpage>133</lpage><pub-id pub-id-type="pmid">10202267</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><name><surname>Elwood</surname><given-names>PC</given-names></name><name><surname>Gallacher</surname><given-names>JE</given-names></name><name><surname>Hopkinson</surname><given-names>CA</given-names></name><name><surname>Pickering</surname><given-names>J</given-names></name><name><surname>Rabbitt</surname><given-names>P</given-names></name><name><surname>Stollery</surname><given-names>B</given-names></name><name><surname>Brayne</surname><given-names>C</given-names></name><name><surname>Huppert</surname><given-names>FA</given-names></name><name><surname>Bayer</surname><given-names>A</given-names></name><article-title>Smoking, drinking, and other life style factors and cognitive function in men in the Caerphilly cohort</article-title><source>J Epidemiol Community Health</source><year>1999</year><volume>53</volume><fpage>9</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">10326046</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal"><name><surname>Cervilla</surname><given-names>JA</given-names></name><name><surname>Prince</surname><given-names>M</given-names></name><name><surname>Mann</surname><given-names>A</given-names></name><article-title>Smoking, drinking, and incident cognitive impairment: a cohort community based study included in the Gospel Oak project</article-title><source>J Neurol Neurosurg Psychiatry</source><year>2000</year><volume>68</volume><fpage>622</fpage><lpage>626</lpage><pub-id pub-id-type="pmid">10766894</pub-id></mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal"><name><surname>Doll</surname><given-names>R</given-names></name><name><surname>Peto</surname><given-names>R</given-names></name><name><surname>Boreham</surname><given-names>J</given-names></name><name><surname>Sutherland</surname><given-names>I</given-names></name><article-title>Smoking and dementia in male British doctors: prospective study</article-title><source>BMJ</source><year>2000</year><volume>320</volume><fpage>1097</fpage><lpage>1102</lpage><pub-id pub-id-type="pmid">10775216</pub-id></mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal"><name><surname>Kalmijn</surname><given-names>S</given-names></name><name><surname>van Boxtel</surname><given-names>MP</given-names></name><name><surname>Verschuren</surname><given-names>MW</given-names></name><name><surname>Jolles</surname><given-names>J</given-names></name><name><surname>Launer</surname><given-names>LJ</given-names></name><article-title>Cigarette smoking and alcohol consumption in relation to cognitive performance in middle age</article-title><source>Am J Epidemiol</source><year>2002</year><volume>156</volume><fpage>936</fpage><lpage>944</lpage><pub-id pub-id-type="pmid">12419766</pub-id></mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>WT</given-names></name><name><surname>Wang</surname><given-names>PN</given-names></name><name><surname>Wang</surname><given-names>SJ</given-names></name><name><surname>Fuh</surname><given-names>JL</given-names></name><name><surname>Lin</surname><given-names>KN</given-names></name><name><surname>Liu</surname><given-names>HC</given-names></name><article-title>Smoking and cognitive performance in the community elderly: a longitudinal study</article-title><source>J Geriatr Psychiatry Neurol</source><year>2003</year><volume>16</volume><fpage>18</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">12641368</pub-id></mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal"><name><surname>Richards</surname><given-names>M</given-names></name><name><surname>Jarvis</surname><given-names>MJ</given-names></name><name><surname>Thompson</surname><given-names>N</given-names></name><name><surname>Wadsworth</surname><given-names>ME</given-names></name><article-title>Cigarette smoking and cognitive decline in midlife: evidence from a prospective birth cohort study</article-title><source>Am J Public Health</source><year>2003</year><volume>93</volume><fpage>994</fpage><lpage>998</lpage><pub-id pub-id-type="pmid">12773367</pub-id></mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal"><name><surname>Tyas</surname><given-names>SL</given-names></name><name><surname>White</surname><given-names>LR</given-names></name><name><surname>Petrovitch</surname><given-names>H</given-names></name><name><surname>Webster Ross</surname><given-names>G</given-names></name><name><surname>Foley</surname><given-names>DJ</given-names></name><name><surname>Heimovitz</surname><given-names>HK</given-names></name><name><surname>Launer</surname><given-names>LJ</given-names></name><article-title>Mid-life smoking and late-life dementia: the Honolulu-Asia aging study</article-title><source>Neurobiol Aging</source><year>2003</year><volume>24</volume><fpage>589</fpage><lpage>596</lpage><pub-id pub-id-type="pmid">12714116</pub-id></mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal"><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Deng</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>He</surname><given-names>H</given-names></name><article-title>Study of the relationship between cigarette smoking, alcohol drinking and cognitive impairment among elderly people in China</article-title><source>Age Ageing</source><year>2003</year><volume>32</volume><fpage>205</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">12615566</pub-id></mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal"><name><surname>Juan</surname><given-names>D</given-names></name><name><surname>Zhou</surname><given-names>DH</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>JY</given-names></name><name><surname>Gao</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><article-title>A 2-year follow-up study of cigarette smoking and risk of dementia</article-title><source>Eur J Neurol</source><year>2004</year><volume>11</volume><fpage>277</fpage><lpage>282</lpage><pub-id pub-id-type="pmid">15061830</pub-id></mixed-citation></ref><ref id="B89"><mixed-citation publication-type="journal"><name><surname>Ott</surname><given-names>A</given-names></name><name><surname>Andersen</surname><given-names>K</given-names></name><name><surname>Dewey</surname><given-names>ME</given-names></name><name><surname>Letenneur</surname><given-names>L</given-names></name><name><surname>Brayne</surname><given-names>C</given-names></name><name><surname>Copeland</surname><given-names>JR</given-names></name><name><surname>Dartigues</surname><given-names>JF</given-names></name><name><surname>Kragh-Sorensen</surname><given-names>P</given-names></name><name><surname>Lobo</surname><given-names>A</given-names></name><name><surname>Martinez-Lage</surname><given-names>JM</given-names></name><name><surname>Stijnen</surname><given-names>T</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Launer</surname><given-names>LJ</given-names></name><collab>EURODEM Incidence Research Group</collab><article-title>Effect of smoking on global cognitive function in nondemented elderly</article-title><source>Neurology</source><year>2004</year><volume>62</volume><fpage>920</fpage><lpage>924</lpage><pub-id pub-id-type="pmid">15037693</pub-id></mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal"><name><surname>Solfrizzi</surname><given-names>V</given-names></name><name><surname>Panza</surname><given-names>F</given-names></name><name><surname>Colacicco</surname><given-names>AM</given-names></name><name><surname>D'Introno</surname><given-names>A</given-names></name><name><surname>Capurso</surname><given-names>C</given-names></name><name><surname>Torres</surname><given-names>F</given-names></name><name><surname>Grigoletto</surname><given-names>F</given-names></name><name><surname>Maggi</surname><given-names>S</given-names></name><name><surname>Del Parigi</surname><given-names>A</given-names></name><name><surname>Reiman</surname><given-names>EM</given-names></name><name><surname>Caselli</surname><given-names>RJ</given-names></name><name><surname>Scafato</surname><given-names>E</given-names></name><name><surname>Farchi</surname><given-names>G</given-names></name><name><surname>Capurso</surname><given-names>A</given-names></name><collab>Italian Longitudinal Study on Aging Working Group</collab><article-title>Vascular risk factors, incidence of MCI, and rates of progression to dementia</article-title><source>Neurology</source><year>2004</year><volume>63</volume><fpage>1882</fpage><lpage>1891</lpage><pub-id pub-id-type="pmid">15557506</pub-id></mixed-citation></ref><ref id="B91"><mixed-citation publication-type="journal"><name><surname>Aleman</surname><given-names>A</given-names></name><name><surname>Muller</surname><given-names>M</given-names></name><name><surname>de Haan</surname><given-names>EH</given-names></name><name><surname>van der Schouw</surname><given-names>YT</given-names></name><article-title>Vascular risk factors and cognitive function in a sample of independently living men</article-title><source>Neurobiol Aging</source><year>2005</year><volume>26</volume><fpage>485</fpage><lpage>490</lpage><pub-id pub-id-type="pmid">15653177</pub-id></mixed-citation></ref><ref id="B92"><mixed-citation publication-type="journal"><name><surname>Reitz</surname><given-names>C</given-names></name><name><surname>Luchsinger</surname><given-names>J</given-names></name><name><surname>Tang</surname><given-names>MX</given-names></name><name><surname>Mayeux</surname><given-names>R</given-names></name><article-title>Effect of smoking and time on cognitive function in the elderly without dementia</article-title><source>Neurology</source><year>2005</year><volume>65</volume><fpage>870</fpage><lpage>875</lpage><pub-id pub-id-type="pmid">16186526</pub-id></mixed-citation></ref><ref id="B93"><mixed-citation publication-type="journal"><name><surname>Whitmer</surname><given-names>RA</given-names></name><name><surname>Sidney</surname><given-names>S</given-names></name><name><surname>Selby</surname><given-names>J</given-names></name><name><surname>Johnston</surname><given-names>SC</given-names></name><name><surname>Yaffe</surname><given-names>K</given-names></name><article-title>Midlife cardiovascular risk factors and risk of dementia in late life</article-title><source>Neurology</source><year>2005</year><volume>64</volume><fpage>277</fpage><lpage>281</lpage><pub-id pub-id-type="pmid">15668425</pub-id></mixed-citation></ref><ref id="B94"><mixed-citation publication-type="journal"><name><surname>Stewart</surname><given-names>MC</given-names></name><name><surname>Deary</surname><given-names>IJ</given-names></name><name><surname>Fowkes</surname><given-names>FG</given-names></name><name><surname>Price</surname><given-names>JF</given-names></name><article-title>Relationship between lifetime smoking, smoking status at older age and human cognitive function</article-title><source>Neuroepidemiology</source><year>2006</year><volume>26</volume><fpage>83</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">16352911</pub-id></mixed-citation></ref><ref id="B95"><mixed-citation publication-type="journal"><name><surname>Reitz</surname><given-names>C</given-names></name><name><surname>den Heijer</surname><given-names>T</given-names></name><name><surname>van Duijn</surname><given-names>C</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Breteler</surname><given-names>MM</given-names></name><article-title>Relation between smoking and risk of dementia and Alzheimer disease: the Rotterdam study</article-title><source>Neurology</source><year>2007</year><volume>69</volume><fpage>998</fpage><lpage>1005</lpage><pub-id pub-id-type="pmid">17785668</pub-id></mixed-citation></ref><ref id="B96"><mixed-citation publication-type="journal"><name><surname>Nooyens</surname><given-names>AC</given-names></name><name><surname>van Gelder</surname><given-names>BM</given-names></name><name><surname>Verschuren</surname><given-names>WM</given-names></name><article-title>Smoking and cognitive decline among middle-aged men and women: the Doetinchem cohort study</article-title><source>Am J Public Health</source><year>2008</year><volume>98</volume><fpage>2244</fpage><lpage>2250</lpage><pub-id pub-id-type="pmid">18923116</pub-id></mixed-citation></ref><ref id="B97"><mixed-citation publication-type="journal"><name><surname>Sabia</surname><given-names>S</given-names></name><name><surname>Marmot</surname><given-names>M</given-names></name><name><surname>Dufouil</surname><given-names>C</given-names></name><name><surname>Singh-Manoux</surname><given-names>A</given-names></name><article-title>Smoking history and cognitive function in middle age from the Whitehall II study</article-title><source>Arch Intern Med</source><year>2008</year><volume>168</volume><fpage>1165</fpage><lpage>1173</lpage><pub-id pub-id-type="pmid">18541824</pub-id></mixed-citation></ref><ref id="B98"><mixed-citation publication-type="journal"><name><surname>Alonso</surname><given-names>A</given-names></name><name><surname>Mosley</surname><given-names>TH</given-names><suffix>Jr</suffix></name><name><surname>Gottesman</surname><given-names>RF</given-names></name><name><surname>Catellier</surname><given-names>D</given-names></name><name><surname>Sharrett</surname><given-names>AR</given-names></name><name><surname>Coresh</surname><given-names>J</given-names></name><article-title>Risk of dementia hospitalisation associated with cardiovascular risk factors in midlife and older age: the Atherosclerosis risk in communities (ARIC) study</article-title><source>J Neurol Neurosurg Psychiatry</source><year>2009</year><volume>80</volume><fpage>1194</fpage><lpage>1201</lpage><pub-id pub-id-type="pmid">19692426</pub-id></mixed-citation></ref><ref id="B99"><mixed-citation publication-type="journal"><name><surname>Collins</surname><given-names>N</given-names></name><name><surname>Sachs-Ericsson</surname><given-names>N</given-names></name><name><surname>Preacher</surname><given-names>KJ</given-names></name><name><surname>Sheffield</surname><given-names>KM</given-names></name><name><surname>Markides</surname><given-names>K</given-names></name><article-title>Smoking increases risk for cognitive decline among community-dwelling older Mexican Americans</article-title><source>Am J Geriatr Psychiatry</source><year>2009</year><volume>17</volume><fpage>934</fpage><lpage>942</lpage><pub-id pub-id-type="pmid">20104052</pub-id></mixed-citation></ref><ref id="B100"><mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>CQ</given-names></name><name><surname>Dong</surname><given-names>BR</given-names></name><name><surname>Zhang</surname><given-names>YL</given-names></name><name><surname>Wu</surname><given-names>HM</given-names></name><name><surname>Liu</surname><given-names>QX</given-names></name><article-title>Association of cognitive impairment with smoking, alcohol consumption, tea consumption, and exercise among Chinese nonagenarians/centenarians</article-title><source>Cogn Behav Neurol</source><year>2009</year><volume>22</volume><fpage>190</fpage><lpage>196</lpage><pub-id pub-id-type="pmid">19741330</pub-id></mixed-citation></ref><ref id="B101"><mixed-citation publication-type="journal"><name><surname>Rusanen</surname><given-names>M</given-names></name><name><surname>Rovio</surname><given-names>S</given-names></name><name><surname>Ngandu</surname><given-names>T</given-names></name><name><surname>Nissinen</surname><given-names>A</given-names></name><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Soininen</surname><given-names>H</given-names></name><name><surname>Kivipelto</surname><given-names>M</given-names></name><article-title>Midlife smoking, apolipoprotein E and risk of dementia and Alzheimer's disease: a population-based cardiovascular risk factors, aging and dementia study</article-title><source>Dement Geriatr Cogn Disord</source><year>2010</year><volume>30</volume><fpage>277</fpage><lpage>284</lpage><pub-id pub-id-type="pmid">20847559</pub-id></mixed-citation></ref><ref id="B102"><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>CC</given-names></name><name><surname>Lu</surname><given-names>TH</given-names></name><name><surname>Liao</surname><given-names>WC</given-names></name><name><surname>Yuan</surname><given-names>SC</given-names></name><name><surname>Kuo</surname><given-names>PC</given-names></name><name><surname>Chuang</surname><given-names>HL</given-names></name><name><surname>Lee</surname><given-names>MC</given-names></name><name><surname>Yen</surname><given-names>CH</given-names></name><article-title>Cigarette smoking and cognitive impairment: a 10-year cohort study in Taiwan</article-title><source>Arch Gerontol Geriatr</source><year>2010</year><volume>51</volume><fpage>143</fpage><lpage>148</lpage><pub-id pub-id-type="pmid">19833398</pub-id></mixed-citation></ref><ref id="B103"><mixed-citation publication-type="journal"><name><surname>Ronnemaa</surname><given-names>E</given-names></name><name><surname>Zethelius</surname><given-names>B</given-names></name><name><surname>Lannfelt</surname><given-names>L</given-names></name><name><surname>Kilander</surname><given-names>L</given-names></name><article-title>Vascular risk factors and dementia: 40-year follow-up of a population-based cohort</article-title><source>Dement Geriatr Cogn Disord</source><year>2011</year><volume>31</volume><fpage>460</fpage><lpage>466</lpage><pub-id pub-id-type="pmid">21791923</pub-id></mixed-citation></ref><ref id="B104"><mixed-citation publication-type="journal"><name><surname>Rusanen</surname><given-names>M</given-names></name><name><surname>Kivipelto</surname><given-names>M</given-names></name><name><surname>Quesenberry</surname><given-names>CP</given-names><suffix>Jr</suffix></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Whitmer</surname><given-names>RA</given-names></name><article-title>Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia</article-title><source>Arch Intern Med</source><year>2011</year><volume>171</volume><fpage>333</fpage><lpage>339</lpage><pub-id pub-id-type="pmid">20975015</pub-id></mixed-citation></ref><ref id="B105"><mixed-citation publication-type="journal"><name><surname>Sabia</surname><given-names>S</given-names></name><name><surname>Elbaz</surname><given-names>A</given-names></name><name><surname>Dugravot</surname><given-names>A</given-names></name><name><surname>Head</surname><given-names>J</given-names></name><name><surname>Shipley</surname><given-names>M</given-names></name><name><surname>Hagger-Johnson</surname><given-names>G</given-names></name><name><surname>Kivimaki</surname><given-names>M</given-names></name><name><surname>Singh-Manoux</surname><given-names>A</given-names></name><article-title>Impact of smoking on cognitive decline in early old age: the Whitehall II cohort study</article-title><source>Arch Gen Psychiatry</source><year>2012</year><volume>69</volume><fpage>627</fpage><lpage>635</lpage><pub-id pub-id-type="pmid">22309970</pub-id></mixed-citation></ref><ref id="B106"><mixed-citation publication-type="journal"><name><surname>Hendrie</surname><given-names>HC</given-names></name><name><surname>Gao</surname><given-names>S</given-names></name><name><surname>Hall</surname><given-names>KS</given-names></name><name><surname>Hui</surname><given-names>SL</given-names></name><name><surname>Unverzagt</surname><given-names>FW</given-names></name><article-title>The relationship between alcohol consumption, cognitive performance, and daily functioning in an urban sample of older black Americans</article-title><source>J Am Geriatr Soc</source><year>1996</year><volume>44</volume><fpage>1158</fpage><lpage>1165</lpage><pub-id pub-id-type="pmid">8855993</pub-id></mixed-citation></ref><ref id="B107"><mixed-citation publication-type="journal"><name><surname>Dufouil</surname><given-names>C</given-names></name><name><surname>Ducimetiere</surname><given-names>P</given-names></name><name><surname>Alperovitch</surname><given-names>A</given-names></name><article-title>Sex differences in the association between alcohol consumption and cognitive performance. EVA study group. Epidemiology of vascular aging</article-title><source>Am J Epidemiol</source><year>1997</year><volume>146</volume><fpage>405</fpage><lpage>412</lpage><pub-id pub-id-type="pmid">9290500</pub-id></mixed-citation></ref><ref id="B108"><mixed-citation publication-type="journal"><name><surname>Elias</surname><given-names>PK</given-names></name><name><surname>Elias</surname><given-names>MF</given-names></name><name><surname>D'Agostino</surname><given-names>RB</given-names></name><name><surname>Silbershatz</surname><given-names>H</given-names></name><name><surname>Wolf</surname><given-names>PA</given-names></name><article-title>Alcohol consumption and cognitive performance in the Framingham heart study</article-title><source>Am J Epidemiol</source><year>1999</year><volume>150</volume><fpage>580</fpage><lpage>589</lpage><pub-id pub-id-type="pmid">10489997</pub-id></mixed-citation></ref><ref id="B109"><mixed-citation publication-type="journal"><name><surname>Bond</surname><given-names>GE</given-names></name><name><surname>Burr</surname><given-names>R</given-names></name><name><surname>McCurry</surname><given-names>SM</given-names></name><name><surname>Graves</surname><given-names>AB</given-names></name><name><surname>Larson</surname><given-names>EB</given-names></name><article-title>Alcohol, aging, and cognitive performance in a cohort of Japanese Americans aged 65 and older: the Kame project</article-title><source>Int Psychogeriatr</source><year>2001</year><volume>13</volume><fpage>207</fpage><lpage>223</lpage><pub-id pub-id-type="pmid">11495395</pub-id></mixed-citation></ref><ref id="B110"><mixed-citation publication-type="journal"><name><surname>Zuccala</surname><given-names>G</given-names></name><name><surname>Onder</surname><given-names>G</given-names></name><name><surname>Pedone</surname><given-names>C</given-names></name><name><surname>Cesari</surname><given-names>M</given-names></name><name><surname>Landi</surname><given-names>F</given-names></name><name><surname>Bernabei</surname><given-names>R</given-names></name><name><surname>Cocchi</surname><given-names>A</given-names></name><article-title>Dose-related impact of alcohol consumption on cognitive function in advanced age: results of a multicenter survey</article-title><source>Alcohol Clin Exp Res</source><year>2001</year><volume>25</volume><fpage>1743</fpage><lpage>1748</lpage><pub-id pub-id-type="pmid">11781507</pub-id></mixed-citation></ref><ref id="B111"><mixed-citation publication-type="journal"><name><surname>Leroi</surname><given-names>I</given-names></name><name><surname>Sheppard</surname><given-names>JM</given-names></name><name><surname>Lyketsos</surname><given-names>CG</given-names></name><article-title>Cognitive function after 11.5&#x000a0;years of alcohol use: relation to alcohol use</article-title><source>Am J Epidemiol</source><year>2002</year><volume>156</volume><fpage>747</fpage><lpage>752</lpage><pub-id pub-id-type="pmid">12370163</pub-id></mixed-citation></ref><ref id="B112"><mixed-citation publication-type="journal"><name><surname>Krahn</surname><given-names>D</given-names></name><name><surname>Freese</surname><given-names>J</given-names></name><name><surname>Hauser</surname><given-names>R</given-names></name><name><surname>Barry</surname><given-names>K</given-names></name><name><surname>Goodman</surname><given-names>B</given-names></name><article-title>Alcohol use and cognition at mid-life: the importance of adjusting for baseline cognitive ability and educational attainment</article-title><source>Alcohol Clin Exp Res</source><year>2003</year><volume>27</volume><fpage>1162</fpage><lpage>1166</lpage><pub-id pub-id-type="pmid">12878923</pub-id></mixed-citation></ref><ref id="B113"><mixed-citation publication-type="journal"><name><surname>Anttila</surname><given-names>T</given-names></name><name><surname>Helkala</surname><given-names>EL</given-names></name><name><surname>Viitanen</surname><given-names>M</given-names></name><name><surname>Kareholt</surname><given-names>I</given-names></name><name><surname>Fratiglioni</surname><given-names>L</given-names></name><name><surname>Winblad</surname><given-names>B</given-names></name><name><surname>Soininen</surname><given-names>H</given-names></name><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Nissinen</surname><given-names>A</given-names></name><name><surname>Kivipelto</surname><given-names>M</given-names></name><article-title>Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study</article-title><source>BMJ</source><year>2004</year><volume>329</volume><fpage>539</fpage><pub-id pub-id-type="pmid">15304383</pub-id></mixed-citation></ref><ref id="B114"><mixed-citation publication-type="journal"><name><surname>Bond</surname><given-names>GE</given-names></name><name><surname>Burr</surname><given-names>R</given-names></name><name><surname>McCurry</surname><given-names>SM</given-names></name><name><surname>Rice</surname><given-names>MM</given-names></name><name><surname>Borenstein</surname><given-names>AR</given-names></name><name><surname>Kukull</surname><given-names>WA</given-names></name><name><surname>Teri</surname><given-names>L</given-names></name><name><surname>Bowen</surname><given-names>JD</given-names></name><name><surname>McCormick</surname><given-names>WC</given-names></name><name><surname>Larson</surname><given-names>EB</given-names></name><article-title>Alcohol, gender, and cognitive performance: a longitudinal study comparing older Japanese and non-Hispanic white Americans</article-title><source>J Aging Health</source><year>2004</year><volume>16</volume><fpage>615</fpage><lpage>640</lpage><pub-id pub-id-type="pmid">15448275</pub-id></mixed-citation></ref><ref id="B115"><mixed-citation publication-type="journal"><name><surname>Britton</surname><given-names>A</given-names></name><name><surname>Singh-Manoux</surname><given-names>A</given-names></name><name><surname>Marmot</surname><given-names>M</given-names></name><article-title>Alcohol consumption and cognitive function in the Whitehall II study</article-title><source>Am J Epidemiol</source><year>2004</year><volume>160</volume><fpage>240</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">15257997</pub-id></mixed-citation></ref><ref id="B116"><mixed-citation publication-type="journal"><name><surname>Bond</surname><given-names>GE</given-names></name><name><surname>Burr</surname><given-names>RL</given-names></name><name><surname>McCurry</surname><given-names>SM</given-names></name><name><surname>Rice</surname><given-names>MM</given-names></name><name><surname>Borenstein</surname><given-names>AR</given-names></name><name><surname>Larson</surname><given-names>EB</given-names></name><article-title>Alcohol and cognitive performance: a longitudinal study of older Japanese Americans. The Kame project</article-title><source>Int Psychogeriatr</source><year>2005</year><volume>17</volume><fpage>653</fpage><lpage>668</lpage><pub-id pub-id-type="pmid">16185373</pub-id></mixed-citation></ref><ref id="B117"><mixed-citation publication-type="journal"><name><surname>Ganguli</surname><given-names>M</given-names></name><name><surname>Vander Bilt</surname><given-names>J</given-names></name><name><surname>Saxton</surname><given-names>JA</given-names></name><name><surname>Shen</surname><given-names>C</given-names></name><name><surname>Dodge</surname><given-names>HH</given-names></name><article-title>Alcohol consumption and cognitive function in late life: a longitudinal community study</article-title><source>Neurology</source><year>2005</year><volume>65</volume><fpage>1210</fpage><lpage>1217</lpage><pub-id pub-id-type="pmid">16247047</pub-id></mixed-citation></ref><ref id="B118"><mixed-citation publication-type="journal"><name><surname>Richards</surname><given-names>M</given-names></name><name><surname>Hardy</surname><given-names>R</given-names></name><name><surname>Wadsworth</surname><given-names>ME</given-names></name><article-title>Alcohol consumption and midlife cognitive change in the British 1946 birth cohort study</article-title><source>Alcohol Alcohol</source><year>2005</year><volume>40</volume><fpage>112</fpage><lpage>117</lpage><pub-id pub-id-type="pmid">15582985</pub-id></mixed-citation></ref><ref id="B119"><mixed-citation publication-type="journal"><name><surname>Rodgers</surname><given-names>B</given-names></name><name><surname>Windsor</surname><given-names>TD</given-names></name><name><surname>Anstey</surname><given-names>KJ</given-names></name><name><surname>Dear</surname><given-names>KB</given-names></name><name><surname>FJ</surname><given-names>A</given-names></name><name><surname>Christensen</surname><given-names>H</given-names></name><article-title>Non-linear relationships between cognitive function and alcohol consumption in young, middle-aged and older adults: the PATH through life project</article-title><source>Addiction</source><year>2005</year><volume>100</volume><fpage>1280</fpage><lpage>1290</lpage><pub-id pub-id-type="pmid">16128717</pub-id></mixed-citation></ref><ref id="B120"><mixed-citation publication-type="journal"><name><surname>Stampfer</surname><given-names>MJ</given-names></name><name><surname>Kang</surname><given-names>JH</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Cherry</surname><given-names>R</given-names></name><name><surname>Grodstein</surname><given-names>F</given-names></name><article-title>Effects of moderate alcohol consumption on cognitive function in women</article-title><source>N Engl J Med</source><year>2005</year><volume>352</volume><fpage>245</fpage><lpage>253</lpage><pub-id pub-id-type="pmid">15659724</pub-id></mixed-citation></ref><ref id="B121"><mixed-citation publication-type="journal"><name><surname>Reid</surname><given-names>MC</given-names></name><name><surname>Van Ness</surname><given-names>PH</given-names></name><name><surname>Hawkins</surname><given-names>KA</given-names></name><name><surname>Towle</surname><given-names>V</given-names></name><name><surname>Concato</surname><given-names>J</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><article-title>Light to moderate alcohol consumption is associated with better cognitive function among older male veterans receiving primary care</article-title><source>J Geriatr Psychiatry Neurol</source><year>2006</year><volume>19</volume><fpage>98</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">16690995</pub-id></mixed-citation></ref><ref id="B122"><mixed-citation publication-type="journal"><name><surname>Wright</surname><given-names>CB</given-names></name><name><surname>Elkind</surname><given-names>MS</given-names></name><name><surname>Luo</surname><given-names>X</given-names></name><name><surname>Paik</surname><given-names>MC</given-names></name><name><surname>Sacco</surname><given-names>RL</given-names></name><article-title>Reported alcohol consumption and cognitive decline: the northern Manhattan study</article-title><source>Neuroepidemiology</source><year>2006</year><volume>27</volume><fpage>201</fpage><lpage>207</lpage><pub-id pub-id-type="pmid">17047373</pub-id></mixed-citation></ref><ref id="B123"><mixed-citation publication-type="journal"><name><surname>Ngandu</surname><given-names>T</given-names></name><name><surname>Helkala</surname><given-names>EL</given-names></name><name><surname>Soininen</surname><given-names>H</given-names></name><name><surname>Winblad</surname><given-names>B</given-names></name><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Nissinen</surname><given-names>A</given-names></name><name><surname>Kivipelto</surname><given-names>M</given-names></name><article-title>Alcohol drinking and cognitive functions: findings from the cardiovascular risk factors aging and dementia (CAIDE) study</article-title><source>Dement Geriatr Cogn Disord</source><year>2007</year><volume>23</volume><fpage>140</fpage><lpage>149</lpage><pub-id pub-id-type="pmid">17170526</pub-id></mixed-citation></ref><ref id="B124"><mixed-citation publication-type="journal"><name><surname>Solfrizzi</surname><given-names>V</given-names></name><name><surname>D'Introno</surname><given-names>A</given-names></name><name><surname>Colacicco</surname><given-names>AM</given-names></name><name><surname>Capurso</surname><given-names>C</given-names></name><name><surname>Del Parigi</surname><given-names>A</given-names></name><name><surname>Baldassarre</surname><given-names>G</given-names></name><name><surname>Scapicchio</surname><given-names>P</given-names></name><name><surname>Scafato</surname><given-names>E</given-names></name><name><surname>Amodio</surname><given-names>M</given-names></name><name><surname>Capurso</surname><given-names>A</given-names></name><name><surname>Panza</surname><given-names>F</given-names></name><article-title>Alcohol consumption, mild cognitive impairment, and progression to dementia</article-title><source>Neurology</source><year>2007</year><volume>68</volume><fpage>1790</fpage><lpage>1799</lpage><pub-id pub-id-type="pmid">17515541</pub-id></mixed-citation></ref><ref id="B125"><mixed-citation publication-type="journal"><name><surname>Xu</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Yin</surname><given-names>Q</given-names></name><name><surname>Zhu</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Fan</surname><given-names>X</given-names></name><article-title>Alcohol consumption and transition of mild cognitive impairment to dementia</article-title><source>Psychiatry Clin Neurosci</source><year>2009</year><volume>63</volume><fpage>43</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">19154211</pub-id></mixed-citation></ref><ref id="B126"><mixed-citation publication-type="journal"><name><surname>Au Yeung</surname><given-names>SL</given-names></name><name><surname>Jiang</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Lam</surname><given-names>TH</given-names></name><name><surname>Cheng</surname><given-names>KK</given-names></name><name><surname>Leung</surname><given-names>GM</given-names></name><name><surname>Schooling</surname><given-names>CM</given-names></name><article-title>Moderate alcohol use and cognitive function in the Guangzhou Biobank cohort study</article-title><source>Ann Epidemiol</source><year>2010</year><volume>20</volume><fpage>873</fpage><lpage>882</lpage><pub-id pub-id-type="pmid">20705480</pub-id></mixed-citation></ref><ref id="B127"><mixed-citation publication-type="journal"><name><surname>Chan</surname><given-names>KK</given-names></name><name><surname>Chiu</surname><given-names>KC</given-names></name><name><surname>Chu</surname><given-names>LW</given-names></name><article-title>Association between alcohol consumption and cognitive impairment in Southern Chinese older adults</article-title><source>Int J Geriatr Psychiatry</source><year>2010</year><volume>25</volume><fpage>1272</fpage><lpage>1279</lpage><pub-id pub-id-type="pmid">21086537</pub-id></mixed-citation></ref><ref id="B128"><mixed-citation publication-type="journal"><name><surname>Corley</surname><given-names>J</given-names></name><name><surname>Jia</surname><given-names>X</given-names></name><name><surname>Brett</surname><given-names>CE</given-names></name><name><surname>Gow</surname><given-names>AJ</given-names></name><name><surname>Starr</surname><given-names>JM</given-names></name><name><surname>Kyle</surname><given-names>JA</given-names></name><name><surname>McNeill</surname><given-names>G</given-names></name><name><surname>Deary</surname><given-names>IJ</given-names></name><article-title>Alcohol intake and cognitive abilities in old age: the Lothian birth cohort 1936 study</article-title><source>Neuropsychology</source><year>2011</year><volume>25</volume><fpage>166</fpage><lpage>175</lpage><pub-id pub-id-type="pmid">21381824</pub-id></mixed-citation></ref><ref id="B129"><mixed-citation publication-type="journal"><name><surname>Gross</surname><given-names>AL</given-names></name><name><surname>Rebok</surname><given-names>GW</given-names></name><name><surname>Ford</surname><given-names>DE</given-names></name><name><surname>Chu</surname><given-names>AY</given-names></name><name><surname>Gallo</surname><given-names>JJ</given-names></name><name><surname>Liang</surname><given-names>KY</given-names></name><name><surname>Meoni</surname><given-names>LA</given-names></name><name><surname>Shihab</surname><given-names>HM</given-names></name><name><surname>Wang</surname><given-names>NY</given-names></name><name><surname>Klag</surname><given-names>MJ</given-names></name><article-title>Alcohol consumption and domain-specific cognitive function in older adults: longitudinal data from the Johns Hopkins precursors study</article-title><source>J Gerontol B Psychol Sci Soc Sci</source><year>2011</year><volume>66</volume><fpage>39</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">20937708</pub-id></mixed-citation></ref><ref id="B130"><mixed-citation publication-type="journal"><name><surname>Sabia</surname><given-names>S</given-names></name><name><surname>Gueguen</surname><given-names>A</given-names></name><name><surname>Berr</surname><given-names>C</given-names></name><name><surname>Berkman</surname><given-names>L</given-names></name><name><surname>Ankri</surname><given-names>J</given-names></name><name><surname>Goldberg</surname><given-names>M</given-names></name><name><surname>Zins</surname><given-names>M</given-names></name><name><surname>Singh-Manoux</surname><given-names>A</given-names></name><article-title>High alcohol consumption in middle-aged adults is associated with poorer cognitive performance only in the low socio-economic group. Results from the GAZEL cohort study</article-title><source>Addiction</source><year>2011</year><volume>106</volume><fpage>93</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">20840170</pub-id></mixed-citation></ref><ref id="B131"><mixed-citation publication-type="journal"><name><surname>Zanjani</surname><given-names>F</given-names></name><name><surname>Downer</surname><given-names>BG</given-names></name><name><surname>Kruger</surname><given-names>TM</given-names></name><name><surname>Willis</surname><given-names>SL</given-names></name><name><surname>Schaie</surname><given-names>KW</given-names></name><article-title>Alcohol effects on cognitive change in middle-aged and older adults</article-title><source>Aging Ment Health</source><year>2013</year><volume>17</volume><issue>1</issue><fpage>12</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">22934837</pub-id></mixed-citation></ref><ref id="B132"><mixed-citation publication-type="journal"><name><surname>Ho</surname><given-names>SC</given-names></name><name><surname>Woo</surname><given-names>J</given-names></name><name><surname>Sham</surname><given-names>A</given-names></name><name><surname>Chan</surname><given-names>SG</given-names></name><name><surname>Yu</surname><given-names>AL</given-names></name><article-title>A 3-year follow-up study of social, lifestyle and health predictors of cognitive impairment in a Chinese older cohort</article-title><source>Int J Epidemiol</source><year>2001</year><volume>30</volume><fpage>1389</fpage><lpage>1396</lpage><pub-id pub-id-type="pmid">11821352</pub-id></mixed-citation></ref><ref id="B133"><mixed-citation publication-type="journal"><name><surname>Laurin</surname><given-names>D</given-names></name><name><surname>Verreault</surname><given-names>R</given-names></name><name><surname>Lindsay</surname><given-names>J</given-names></name><name><surname>MacPherson</surname><given-names>K</given-names></name><name><surname>Rockwood</surname><given-names>K</given-names></name><article-title>Physical activity and risk of cognitive impairment and dementia in elderly persons</article-title><source>Arch Neurol</source><year>2001</year><volume>58</volume><fpage>498</fpage><lpage>504</lpage><pub-id pub-id-type="pmid">11255456</pub-id></mixed-citation></ref><ref id="B134"><mixed-citation publication-type="journal"><name><surname>Schuit</surname><given-names>AJ</given-names></name><name><surname>Feskens</surname><given-names>EJ</given-names></name><name><surname>Launer</surname><given-names>LJ</given-names></name><name><surname>Kromhout</surname><given-names>D</given-names></name><article-title>Physical activity and cognitive decline, the role of the apolipoprotein e4 allele</article-title><source>Med Sci Sports Exerc</source><year>2001</year><volume>33</volume><fpage>772</fpage><lpage>777</lpage><pub-id pub-id-type="pmid">11323547</pub-id></mixed-citation></ref><ref id="B135"><mixed-citation publication-type="journal"><name><surname>Yaffe</surname><given-names>K</given-names></name><name><surname>Barnes</surname><given-names>D</given-names></name><name><surname>Nevitt</surname><given-names>M</given-names></name><name><surname>Lui</surname><given-names>LY</given-names></name><name><surname>Covinsky</surname><given-names>K</given-names></name><article-title>A prospective study of physical activity and cognitive decline in elderly women: women who walk</article-title><source>Arch Intern Med</source><year>2001</year><volume>161</volume><fpage>1703</fpage><lpage>1708</lpage><pub-id pub-id-type="pmid">11485502</pub-id></mixed-citation></ref><ref id="B136"><mixed-citation publication-type="journal"><name><surname>Verghese</surname><given-names>J</given-names></name><name><surname>Lipton</surname><given-names>RB</given-names></name><name><surname>Katz</surname><given-names>MJ</given-names></name><name><surname>Hall</surname><given-names>CB</given-names></name><name><surname>Derby</surname><given-names>CA</given-names></name><name><surname>Kuslansky</surname><given-names>G</given-names></name><name><surname>Ambrose</surname><given-names>AF</given-names></name><name><surname>Sliwinski</surname><given-names>M</given-names></name><name><surname>Buschke</surname><given-names>H</given-names></name><article-title>Leisure activities and the risk of dementia in the elderly</article-title><source>N Engl J Med</source><year>2003</year><volume>348</volume><fpage>2508</fpage><lpage>2516</lpage><pub-id pub-id-type="pmid">12815136</pub-id></mixed-citation></ref><ref id="B137"><mixed-citation publication-type="journal"><name><surname>Abbott</surname><given-names>RD</given-names></name><name><surname>White</surname><given-names>LR</given-names></name><name><surname>Ross</surname><given-names>GW</given-names></name><name><surname>Masaki</surname><given-names>KH</given-names></name><name><surname>Curb</surname><given-names>JD</given-names></name><name><surname>Petrovitch</surname><given-names>H</given-names></name><article-title>Walking and dementia in physically capable elderly men</article-title><source>JAMA</source><year>2004</year><volume>292</volume><fpage>1447</fpage><lpage>1453</lpage><pub-id pub-id-type="pmid">15383515</pub-id></mixed-citation></ref><ref id="B138"><mixed-citation publication-type="journal"><name><surname>Lytle</surname><given-names>ME</given-names></name><name><surname>Vander Bilt</surname><given-names>J</given-names></name><name><surname>Pandav</surname><given-names>RS</given-names></name><name><surname>Dodge</surname><given-names>HH</given-names></name><name><surname>Ganguli</surname><given-names>M</given-names></name><article-title>Exercise level and cognitive decline: the MoVIES project</article-title><source>Alzheimer Dis Assoc Disord</source><year>2004</year><volume>18</volume><fpage>57</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">15249848</pub-id></mixed-citation></ref><ref id="B139"><mixed-citation publication-type="journal"><name><surname>van Gelder</surname><given-names>BM</given-names></name><name><surname>Tijhuis</surname><given-names>MA</given-names></name><name><surname>Kalmijn</surname><given-names>S</given-names></name><name><surname>Giampaoli</surname><given-names>S</given-names></name><name><surname>Nissinen</surname><given-names>A</given-names></name><name><surname>Kromhout</surname><given-names>D</given-names></name><article-title>Physical activity in relation to cognitive decline in elderly men: the FINE Study</article-title><source>Neurology</source><year>2004</year><volume>63</volume><fpage>2316</fpage><lpage>2321</lpage><pub-id pub-id-type="pmid">15623693</pub-id></mixed-citation></ref><ref id="B140"><mixed-citation publication-type="journal"><name><surname>Weuve</surname><given-names>J</given-names></name><name><surname>Kang</surname><given-names>JH</given-names></name><name><surname>Manson</surname><given-names>JE</given-names></name><name><surname>Breteler</surname><given-names>MM</given-names></name><name><surname>Ware</surname><given-names>JH</given-names></name><name><surname>Grodstein</surname><given-names>F</given-names></name><article-title>Physical activity, including walking, and cognitive function in older women</article-title><source>JAMA</source><year>2004</year><volume>292</volume><fpage>1454</fpage><lpage>1461</lpage><pub-id pub-id-type="pmid">15383516</pub-id></mixed-citation></ref><ref id="B141"><mixed-citation publication-type="journal"><name><surname>Podewils</surname><given-names>LJ</given-names></name><name><surname>Guallar</surname><given-names>E</given-names></name><name><surname>Kuller</surname><given-names>LH</given-names></name><name><surname>Fried</surname><given-names>LP</given-names></name><name><surname>Lopez</surname><given-names>OL</given-names></name><name><surname>Carlson</surname><given-names>M</given-names></name><name><surname>Lyketsos</surname><given-names>CG</given-names></name><article-title>Physical activity, APOE genotype, and dementia risk: findings from the cardiovascular health cognition study</article-title><source>Am J Epidemiol</source><year>2005</year><volume>161</volume><fpage>639</fpage><lpage>651</lpage><pub-id pub-id-type="pmid">15781953</pub-id></mixed-citation></ref><ref id="B142"><mixed-citation publication-type="journal"><name><surname>Rovio</surname><given-names>S</given-names></name><name><surname>Kareholt</surname><given-names>I</given-names></name><name><surname>Helkala</surname><given-names>EL</given-names></name><name><surname>Viitanen</surname><given-names>M</given-names></name><name><surname>Winblad</surname><given-names>B</given-names></name><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Soininen</surname><given-names>H</given-names></name><name><surname>Nissinen</surname><given-names>A</given-names></name><name><surname>Kivipelto</surname><given-names>M</given-names></name><article-title>Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease</article-title><source>Lancet Neurol</source><year>2005</year><volume>4</volume><fpage>705</fpage><lpage>711</lpage><pub-id pub-id-type="pmid">16239176</pub-id></mixed-citation></ref><ref id="B143"><mixed-citation publication-type="journal"><name><surname>Sturman</surname><given-names>MT</given-names></name><name><surname>Morris</surname><given-names>MC</given-names></name><name><surname>de Leon CF</surname><given-names>M</given-names></name><name><surname>Bienias</surname><given-names>JL</given-names></name><name><surname>Wilson</surname><given-names>RS</given-names></name><name><surname>Evans</surname><given-names>DA</given-names></name><article-title>Physical activity, cognitive activity, and cognitive decline in a biracial community population</article-title><source>Arch Neurol</source><year>2005</year><volume>62</volume><fpage>1750</fpage><lpage>1754</lpage><pub-id pub-id-type="pmid">16286550</pub-id></mixed-citation></ref><ref id="B144"><mixed-citation publication-type="journal"><name><surname>Karp</surname><given-names>A</given-names></name><name><surname>Paillard-Borg</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>HX</given-names></name><name><surname>Silverstein</surname><given-names>M</given-names></name><name><surname>Winblad</surname><given-names>B</given-names></name><name><surname>Fratiglioni</surname><given-names>L</given-names></name><article-title>Mental, physical and social components in leisure activities equally contribute to decrease dementia risk</article-title><source>Dement Geriatr Cogn Disord</source><year>2006</year><volume>21</volume><fpage>65</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">16319455</pub-id></mixed-citation></ref><ref id="B145"><mixed-citation publication-type="journal"><name><surname>Larson</surname><given-names>EB</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Bowen</surname><given-names>JD</given-names></name><name><surname>McCormick</surname><given-names>WC</given-names></name><name><surname>Teri</surname><given-names>L</given-names></name><name><surname>Crane</surname><given-names>P</given-names></name><name><surname>Kukull</surname><given-names>W</given-names></name><article-title>Exercise is associated with reduced risk for incident dementia among persons 65&#x000a0;years of age and older</article-title><source>Ann Intern Med</source><year>2006</year><volume>144</volume><fpage>73</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">16418406</pub-id></mixed-citation></ref><ref id="B146"><mixed-citation publication-type="journal"><name><surname>Landi</surname><given-names>F</given-names></name><name><surname>Russo</surname><given-names>A</given-names></name><name><surname>Barillaro</surname><given-names>C</given-names></name><name><surname>Cesari</surname><given-names>M</given-names></name><name><surname>Pahor</surname><given-names>M</given-names></name><name><surname>Danese</surname><given-names>P</given-names></name><name><surname>Bernabei</surname><given-names>R</given-names></name><name><surname>Onder</surname><given-names>G</given-names></name><article-title>Physical activity and risk of cognitive impairment among older persons living in the community</article-title><source>Aging Clin Exp Res</source><year>2007</year><volume>19</volume><fpage>410</fpage><lpage>416</lpage><pub-id pub-id-type="pmid">18007121</pub-id></mixed-citation></ref><ref id="B147"><mixed-citation publication-type="journal"><name><surname>Psaltopoulou</surname><given-names>T</given-names></name><name><surname>Kyrozis</surname><given-names>A</given-names></name><name><surname>Stathopoulos</surname><given-names>P</given-names></name><name><surname>Trichopoulos</surname><given-names>D</given-names></name><name><surname>Vassilopoulos</surname><given-names>D</given-names></name><name><surname>Trichopoulou</surname><given-names>A</given-names></name><article-title>Diet, physical activity and cognitive impairment among elders: the EPIC-Greece cohort (European Prospective Investigation into Cancer and Nutrition)</article-title><source>Public Health Nutr</source><year>2008</year><volume>11</volume><fpage>1054</fpage><lpage>1062</lpage><pub-id pub-id-type="pmid">18205988</pub-id></mixed-citation></ref><ref id="B148"><mixed-citation publication-type="journal"><name><surname>Taaffe</surname><given-names>DR</given-names></name><name><surname>Irie</surname><given-names>F</given-names></name><name><surname>Masaki</surname><given-names>KH</given-names></name><name><surname>Abbott</surname><given-names>RD</given-names></name><name><surname>Petrovitch</surname><given-names>H</given-names></name><name><surname>Ross</surname><given-names>GW</given-names></name><name><surname>White</surname><given-names>LR</given-names></name><article-title>Physical activity, physical function, and incident dementia in elderly men: the Honolulu-Asia aging study</article-title><source>J Gerontol A Biol Sci Med Sci</source><year>2008</year><volume>63</volume><fpage>529</fpage><lpage>535</lpage><pub-id pub-id-type="pmid">18511759</pub-id></mixed-citation></ref><ref id="B149"><mixed-citation publication-type="journal"><name><surname>Gallucci</surname><given-names>M</given-names></name><name><surname>Antuono</surname><given-names>P</given-names></name><name><surname>Ongaro</surname><given-names>F</given-names></name><name><surname>Forloni</surname><given-names>PL</given-names></name><name><surname>Albani</surname><given-names>D</given-names></name><name><surname>Amici</surname><given-names>GP</given-names></name><name><surname>Regini</surname><given-names>C</given-names></name><article-title>Physical activity, socialization and reading in the elderly over the age of seventy: what is the relation with cognitive decline? Evidence from "The Treviso Longeva (TRELONG) study"</article-title><source>Arch Gerontol Geriatr</source><year>2009</year><volume>48</volume><fpage>284</fpage><lpage>286</lpage><pub-id pub-id-type="pmid">18374429</pub-id></mixed-citation></ref><ref id="B150"><mixed-citation publication-type="journal"><name><surname>Scarmeas</surname><given-names>N</given-names></name><name><surname>Luchsinger</surname><given-names>JA</given-names></name><name><surname>Schupf</surname><given-names>N</given-names></name><name><surname>Brickman</surname><given-names>AM</given-names></name><name><surname>Cosentino</surname><given-names>S</given-names></name><name><surname>Tang</surname><given-names>MX</given-names></name><name><surname>Stern</surname><given-names>Y</given-names></name><article-title>Physical activity, diet, and risk of Alzheimer disease</article-title><source>JAMA</source><year>2009</year><volume>302</volume><fpage>627</fpage><lpage>637</lpage><pub-id pub-id-type="pmid">19671904</pub-id></mixed-citation></ref><ref id="B151"><mixed-citation publication-type="journal"><name><surname>Yaffe</surname><given-names>K</given-names></name><name><surname>Fiocco</surname><given-names>AJ</given-names></name><name><surname>Lindquist</surname><given-names>K</given-names></name><name><surname>Vittinghoff</surname><given-names>E</given-names></name><name><surname>Simonsick</surname><given-names>EM</given-names></name><name><surname>Newman</surname><given-names>AB</given-names></name><name><surname>Satterfield</surname><given-names>S</given-names></name><name><surname>Rosano</surname><given-names>C</given-names></name><name><surname>Rubin</surname><given-names>SM</given-names></name><name><surname>Ayonayon</surname><given-names>HN</given-names></name><name><surname>Harris</surname><given-names>TB</given-names></name><article-title>Predictors of maintaining cognitive function in older adults: the Health ABC study</article-title><source>Neurology</source><year>2009</year><volume>72</volume><fpage>2029</fpage><lpage>2035</lpage><pub-id pub-id-type="pmid">19506226</pub-id></mixed-citation></ref><ref id="B152"><mixed-citation publication-type="journal"><name><surname>Chang</surname><given-names>M</given-names></name><name><surname>Jonsson</surname><given-names>PV</given-names></name><name><surname>Snaedal</surname><given-names>J</given-names></name><name><surname>Bjornsson</surname><given-names>S</given-names></name><name><surname>Saczynski</surname><given-names>JS</given-names></name><name><surname>Aspelund</surname><given-names>T</given-names></name><name><surname>Eiriksdottir</surname><given-names>G</given-names></name><name><surname>Jonsdottir</surname><given-names>MK</given-names></name><name><surname>Lopez</surname><given-names>OL</given-names></name><name><surname>Harris</surname><given-names>TB</given-names></name><name><surname>Gudnason</surname><given-names>V</given-names></name><name><surname>Launer</surname><given-names>LJ</given-names></name><article-title>The effect of midlife physical activity on cognitive function among older adults: AGES&#x02013;Reykjavik study</article-title><source>J Gerontol A Biol Sci Med Sci</source><year>2010</year><volume>65</volume><fpage>1369</fpage><lpage>1374</lpage><pub-id pub-id-type="pmid">20805238</pub-id></mixed-citation></ref><ref id="B153"><mixed-citation publication-type="journal"><name><surname>Etgen</surname><given-names>T</given-names></name><name><surname>Sander</surname><given-names>D</given-names></name><name><surname>Huntgeburth</surname><given-names>U</given-names></name><name><surname>Poppert</surname><given-names>H</given-names></name><name><surname>Forstl</surname><given-names>H</given-names></name><name><surname>Bickel</surname><given-names>H</given-names></name><article-title>Physical activity and incident cognitive impairment in elderly persons: the INVADE study</article-title><source>Arch Intern Med</source><year>2010</year><volume>170</volume><fpage>186</fpage><lpage>193</lpage><pub-id pub-id-type="pmid">20101014</pub-id></mixed-citation></ref><ref id="B154"><mixed-citation publication-type="journal"><name><surname>Gillum</surname><given-names>RF</given-names></name><name><surname>Obisesan</surname><given-names>TO</given-names></name><article-title>Physical activity, cognitive function, and mortality in a US national cohort</article-title><source>Ann Epidemiol</source><year>2010</year><volume>20</volume><fpage>251</fpage><lpage>257</lpage><pub-id pub-id-type="pmid">20171901</pub-id></mixed-citation></ref><ref id="B155"><mixed-citation publication-type="journal"><name><surname>Middleton</surname><given-names>LE</given-names></name><name><surname>Barnes</surname><given-names>DE</given-names></name><name><surname>Lui</surname><given-names>LY</given-names></name><name><surname>Yaffe</surname><given-names>K</given-names></name><article-title>Physical activity over the life course and its association with cognitive performance and impairment in old age</article-title><source>J Am Geriatr Soc</source><year>2010</year><volume>58</volume><fpage>1322</fpage><lpage>1326</lpage><pub-id pub-id-type="pmid">20609030</pub-id></mixed-citation></ref><ref id="B156"><mixed-citation publication-type="journal"><name><surname>Buchman</surname><given-names>AS</given-names></name><name><surname>Boyle</surname><given-names>PA</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Shah</surname><given-names>RC</given-names></name><name><surname>Wilson</surname><given-names>RS</given-names></name><name><surname>Bennett</surname><given-names>DA</given-names></name><article-title>Total daily physical activity and the risk of AD and cognitive decline in older adults</article-title><source>Neurology</source><year>2012</year><volume>78</volume><fpage>1323</fpage><lpage>1329</lpage><pub-id pub-id-type="pmid">22517108</pub-id></mixed-citation></ref><ref id="B157"><mixed-citation publication-type="journal"><name><surname>Lin</surname><given-names>F</given-names></name><name><surname>Friedman</surname><given-names>E</given-names></name><name><surname>Quinn</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>DG</given-names></name><name><surname>Mapstone</surname><given-names>M</given-names></name><article-title>Effect of leisure activities on inflammation and cognitive function in an aging sample</article-title><source>Arch Gerontol Geriatr</source><year>2012</year><volume>54</volume><fpage>e398</fpage><lpage>404</lpage><pub-id pub-id-type="pmid">22377120</pub-id></mixed-citation></ref><ref id="B158"><mixed-citation publication-type="journal"><name><surname>Norton</surname><given-names>MC</given-names></name><name><surname>Dew</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>H</given-names></name><name><surname>Fauth</surname><given-names>E</given-names></name><name><surname>Piercy</surname><given-names>KW</given-names></name><name><surname>Breitner</surname><given-names>JC</given-names></name><name><surname>Tschanz</surname><given-names>J</given-names></name><name><surname>Wengreen</surname><given-names>H</given-names></name><name><surname>Welsh-Bohmer</surname><given-names>K</given-names></name><article-title>Lifestyle behavior pattern is associated with different levels of risk for incident dementia and Alzheimer's disease: the Cache county study</article-title><source>J Am Geriatr Soc</source><year>2012</year><volume>60</volume><fpage>405</fpage><lpage>412</lpage><pub-id pub-id-type="pmid">22316091</pub-id></mixed-citation></ref><ref id="B159"><mixed-citation publication-type="journal"><name><surname>Jarvis</surname><given-names>MJ</given-names></name><article-title>Does caffeine intake enhance absolute levels of cognitive performance?</article-title><source>Psychopharmacology (Berl)</source><year>1993</year><volume>110</volume><fpage>45</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">7870897</pub-id></mixed-citation></ref><ref id="B160"><mixed-citation publication-type="journal"><name><surname>Johnson-Kozlow</surname><given-names>M</given-names></name><name><surname>Kritz-Silverstein</surname><given-names>D</given-names></name><name><surname>Barrett-Connor</surname><given-names>E</given-names></name><name><surname>Morton</surname><given-names>D</given-names></name><article-title>Coffee consumption and cognitive function among older adults</article-title><source>Am J Epidemiol</source><year>2002</year><volume>156</volume><fpage>842</fpage><lpage>850</lpage><pub-id pub-id-type="pmid">12397002</pub-id></mixed-citation></ref><ref id="B161"><mixed-citation publication-type="journal"><name><surname>van Boxtel</surname><given-names>MP</given-names></name><name><surname>Schmitt</surname><given-names>JA</given-names></name><name><surname>Bosma</surname><given-names>H</given-names></name><name><surname>Jolles</surname><given-names>J</given-names></name><article-title>The effects of habitual caffeine use on cognitive change: a longitudinal perspective</article-title><source>Pharmacol Biochem Behav</source><year>2003</year><volume>75</volume><fpage>921</fpage><lpage>927</lpage><pub-id pub-id-type="pmid">12957237</pub-id></mixed-citation></ref><ref id="B162"><mixed-citation publication-type="journal"><name><surname>Kuriyama</surname><given-names>S</given-names></name><name><surname>Hozawa</surname><given-names>A</given-names></name><name><surname>Ohmori</surname><given-names>K</given-names></name><name><surname>Shimazu</surname><given-names>T</given-names></name><name><surname>Matsui</surname><given-names>T</given-names></name><name><surname>Ebihara</surname><given-names>S</given-names></name><name><surname>Awata</surname><given-names>S</given-names></name><name><surname>Nagatomi</surname><given-names>R</given-names></name><name><surname>Arai</surname><given-names>H</given-names></name><name><surname>Tsuji</surname><given-names>I</given-names></name><article-title>Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project 1</article-title><source>Am J Clin Nutr</source><year>2006</year><volume>83</volume><fpage>355</fpage><lpage>361</lpage><pub-id pub-id-type="pmid">16469995</pub-id></mixed-citation></ref><ref id="B163"><mixed-citation publication-type="journal"><name><surname>van Gelder</surname><given-names>BM</given-names></name><name><surname>Buijsse</surname><given-names>B</given-names></name><name><surname>Tijhuis</surname><given-names>M</given-names></name><name><surname>Kalmijn</surname><given-names>S</given-names></name><name><surname>Giampaoli</surname><given-names>S</given-names></name><name><surname>Nissinen</surname><given-names>A</given-names></name><name><surname>Kromhout</surname><given-names>D</given-names></name><article-title>Coffee consumption is inversely associated with cognitive decline in elderly European men: the FINE Study</article-title><source>Eur J Clin Nutr</source><year>2007</year><volume>61</volume><fpage>226</fpage><lpage>232</lpage><pub-id pub-id-type="pmid">16929246</pub-id></mixed-citation></ref><ref id="B164"><mixed-citation publication-type="journal"><name><surname>Ng</surname><given-names>TP</given-names></name><name><surname>Feng</surname><given-names>L</given-names></name><name><surname>Niti</surname><given-names>M</given-names></name><name><surname>Kua</surname><given-names>EH</given-names></name><name><surname>Yap</surname><given-names>KB</given-names></name><article-title>Tea consumption and cognitive impairment and decline in older Chinese adults</article-title><source>Am J Clin Nutr</source><year>2008</year><volume>88</volume><fpage>224</fpage><lpage>231</lpage><pub-id pub-id-type="pmid">18614745</pub-id></mixed-citation></ref><ref id="B165"><mixed-citation publication-type="journal"><name><surname>Eskelinen</surname><given-names>MH</given-names></name><name><surname>Ngandu</surname><given-names>T</given-names></name><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Soininen</surname><given-names>H</given-names></name><name><surname>Kivipelto</surname><given-names>M</given-names></name><article-title>Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study</article-title><source>J Alzheimers Dis</source><year>2009</year><volume>16</volume><fpage>85</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">19158424</pub-id></mixed-citation></ref><ref id="B166"><mixed-citation publication-type="journal"><name><surname>Laitala</surname><given-names>VS</given-names></name><name><surname>Kaprio</surname><given-names>J</given-names></name><name><surname>Koskenvuo</surname><given-names>M</given-names></name><name><surname>Raiha</surname><given-names>I</given-names></name><name><surname>Rinne</surname><given-names>JO</given-names></name><name><surname>Silventoinen</surname><given-names>K</given-names></name><article-title>Coffee drinking in middle age is not associated with cognitive performance in old age</article-title><source>Am J Clin Nutr</source><year>2009</year><volume>90</volume><fpage>640</fpage><lpage>646</lpage><pub-id pub-id-type="pmid">19587088</pub-id></mixed-citation></ref><ref id="B167"><mixed-citation publication-type="journal"><name><surname>Nurk</surname><given-names>E</given-names></name><name><surname>Refsum</surname><given-names>H</given-names></name><name><surname>Drevon</surname><given-names>CA</given-names></name><name><surname>Tell</surname><given-names>GS</given-names></name><name><surname>Nygaard</surname><given-names>HA</given-names></name><name><surname>Engedal</surname><given-names>K</given-names></name><name><surname>Smith</surname><given-names>AD</given-names></name><article-title>Intake of flavonoid-rich wine, tea, and chocolate by elderly men and women is associated with better cognitive test performance</article-title><source>J Nutr</source><year>2009</year><volume>139</volume><fpage>120</fpage><lpage>127</lpage><pub-id pub-id-type="pmid">19056649</pub-id></mixed-citation></ref><ref id="B168"><mixed-citation publication-type="journal"><name><surname>Smith</surname><given-names>AP</given-names></name><article-title>Caffeine, cognitive failures and health in a non-working community sample</article-title><source>Hum Psychopharmacol</source><year>2009</year><volume>24</volume><fpage>29</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">19016251</pub-id></mixed-citation></ref><ref id="B169"><mixed-citation publication-type="journal"><name><surname>Corley</surname><given-names>J</given-names></name><name><surname>Jia</surname><given-names>X</given-names></name><name><surname>Kyle</surname><given-names>JA</given-names></name><name><surname>Gow</surname><given-names>AJ</given-names></name><name><surname>Brett</surname><given-names>CE</given-names></name><name><surname>Starr</surname><given-names>JM</given-names></name><name><surname>McNeill</surname><given-names>G</given-names></name><name><surname>Deary</surname><given-names>IJ</given-names></name><article-title>Caffeine consumption and cognitive function at age 70: the Lothian birth cohort 1936 study</article-title><source>Psychosom Med</source><year>2010</year><volume>72</volume><fpage>206</fpage><lpage>214</lpage><pub-id pub-id-type="pmid">19995882</pub-id></mixed-citation></ref><ref id="B170"><mixed-citation publication-type="journal"><name><surname>Feng</surname><given-names>L</given-names></name><name><surname>Gwee</surname><given-names>X</given-names></name><name><surname>Kua</surname><given-names>EH</given-names></name><name><surname>Ng</surname><given-names>TP</given-names></name><article-title>Cognitive function and tea consumption in community dwelling older Chinese in Singapore</article-title><source>J Nutr Health Aging</source><year>2010</year><volume>14</volume><fpage>433</fpage><lpage>438</lpage><pub-id pub-id-type="pmid">20617284</pub-id></mixed-citation></ref><ref id="B171"><mixed-citation publication-type="journal"><name><surname>Ritchie</surname><given-names>K</given-names></name><name><surname>Artero</surname><given-names>S</given-names></name><name><surname>Portet</surname><given-names>F</given-names></name><name><surname>Brickman</surname><given-names>A</given-names></name><name><surname>Muraskin</surname><given-names>J</given-names></name><name><surname>Beanino</surname><given-names>E</given-names></name><name><surname>Ancelin</surname><given-names>ML</given-names></name><name><surname>Carriere</surname><given-names>I</given-names></name><article-title>Caffeine, cognitive functioning, and white matter lesions in the elderly: establishing causality from epidemiological evidence</article-title><source>J Alzheimers Dis</source><year>2010</year><volume>20</volume><issue>Suppl 1</issue><fpage>S161</fpage><lpage>166</lpage><pub-id pub-id-type="pmid">20164564</pub-id></mixed-citation></ref><ref id="B172"><mixed-citation publication-type="journal"><name><surname>Santos</surname><given-names>C</given-names></name><name><surname>Lunet</surname><given-names>N</given-names></name><name><surname>Azevedo</surname><given-names>A</given-names></name><name><surname>de Mendonca</surname><given-names>A</given-names></name><name><surname>Ritchie</surname><given-names>K</given-names></name><name><surname>Barros</surname><given-names>H</given-names></name><article-title>Caffeine intake is associated with a lower risk of cognitive decline: a cohort study from Portugal</article-title><source>J Alzheimers Dis</source><year>2010</year><volume>20</volume><issue>Suppl 1</issue><fpage>S175</fpage><lpage>185</lpage><pub-id pub-id-type="pmid">20182036</pub-id></mixed-citation></ref><ref id="B173"><mixed-citation publication-type="journal"><name><surname>Arab</surname><given-names>L</given-names></name><name><surname>Biggs</surname><given-names>ML</given-names></name><name><surname>O'Meara</surname><given-names>ES</given-names></name><name><surname>Longstreth</surname><given-names>WT</given-names></name><name><surname>Crane</surname><given-names>PK</given-names></name><name><surname>Fitzpatrick</surname><given-names>AL</given-names></name><article-title>Gender differences in tea, coffee, and cognitive decline in the elderly: the cardiovascular health study</article-title><source>J Alzheimers Dis</source><year>2011</year><volume>27</volume><fpage>553</fpage><lpage>566</lpage><pub-id pub-id-type="pmid">21841254</pub-id></mixed-citation></ref><ref id="B174"><mixed-citation publication-type="journal"><name><surname>Gelber</surname><given-names>RP</given-names></name><name><surname>Petrovitch</surname><given-names>H</given-names></name><name><surname>Masaki</surname><given-names>KH</given-names></name><name><surname>Ross</surname><given-names>GW</given-names></name><name><surname>White</surname><given-names>LR</given-names></name><article-title>Coffee intake in midlife and risk of dementia and its neuropathologic correlates</article-title><source>J Alzheimers Dis</source><year>2011</year><volume>23</volume><fpage>607</fpage><lpage>615</lpage><pub-id pub-id-type="pmid">21157028</pub-id></mixed-citation></ref><ref id="B175"><mixed-citation publication-type="journal"><name><surname>Feng</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Ng</surname><given-names>TP</given-names></name><name><surname>Lee</surname><given-names>TS</given-names></name><name><surname>Kua</surname><given-names>EH</given-names></name><name><surname>Zeng</surname><given-names>Y</given-names></name><article-title>Tea drinking and cognitive function in oldest-old chinese</article-title><source>J Nutr Health Aging</source><year>2012</year><volume>16</volume><fpage>754</fpage><lpage>758</lpage><pub-id pub-id-type="pmid">23131816</pub-id></mixed-citation></ref><ref id="B176"><mixed-citation publication-type="journal"><name><surname>Jama</surname><given-names>JW</given-names></name><name><surname>Launer</surname><given-names>LJ</given-names></name><name><surname>Witteman</surname><given-names>JC</given-names></name><name><surname>den Breeijen</surname><given-names>JH</given-names></name><name><surname>Breteler</surname><given-names>MM</given-names></name><name><surname>Grobbee</surname><given-names>DE</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><article-title>Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam Study</article-title><source>Am J Epidemiol</source><year>1996</year><volume>144</volume><fpage>275</fpage><lpage>280</lpage><pub-id pub-id-type="pmid">8686696</pub-id></mixed-citation></ref><ref id="B177"><mixed-citation publication-type="journal"><name><surname>Mendelsohn</surname><given-names>AB</given-names></name><name><surname>Belle</surname><given-names>SH</given-names></name><name><surname>Stoehr</surname><given-names>GP</given-names></name><name><surname>Ganguli</surname><given-names>M</given-names></name><article-title>
Use of antioxidant supplements and its association with cognitive function in a rural elderly cohort: the MoVIES project. Monongahela Valley independent elders survey</article-title><source>Am J Epidemiol</source><year>1998</year><volume>148</volume><fpage>38</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">9663402</pub-id></mixed-citation></ref><ref id="B178"><mixed-citation publication-type="journal"><name><surname>Morris</surname><given-names>MC</given-names></name><name><surname>Beckett</surname><given-names>LA</given-names></name><name><surname>Scherr</surname><given-names>PA</given-names></name><name><surname>Hebert</surname><given-names>LE</given-names></name><name><surname>Bennett</surname><given-names>DA</given-names></name><name><surname>Field</surname><given-names>TS</given-names></name><name><surname>Evans</surname><given-names>DA</given-names></name><article-title>Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease</article-title><source>Alzheimer Dis Assoc Disord</source><year>1998</year><volume>12</volume><fpage>121</fpage><lpage>126</lpage><pub-id pub-id-type="pmid">9772012</pub-id></mixed-citation></ref><ref id="B179"><mixed-citation publication-type="journal"><name><surname>Schmidt</surname><given-names>R</given-names></name><name><surname>Hayn</surname><given-names>M</given-names></name><name><surname>Reinhart</surname><given-names>B</given-names></name><name><surname>Roob</surname><given-names>G</given-names></name><name><surname>Schmidt</surname><given-names>H</given-names></name><name><surname>Schumacher</surname><given-names>M</given-names></name><name><surname>Watzinger</surname><given-names>N</given-names></name><name><surname>Launer</surname><given-names>LJ</given-names></name><article-title>Plasma antioxidants and cognitive performance in middle-aged and older adults: results of the Austrian stroke prevention study</article-title><source>J Am Geriatr Soc</source><year>1998</year><volume>46</volume><fpage>1407</fpage><lpage>1410</lpage><pub-id pub-id-type="pmid">9809763</pub-id></mixed-citation></ref><ref id="B180"><mixed-citation publication-type="journal"><name><surname>Masaki</surname><given-names>KH</given-names></name><name><surname>Losonczy</surname><given-names>KG</given-names></name><name><surname>Izmirlian</surname><given-names>G</given-names></name><name><surname>Foley</surname><given-names>DJ</given-names></name><name><surname>Ross</surname><given-names>GW</given-names></name><name><surname>Petrovitch</surname><given-names>H</given-names></name><name><surname>Havlik</surname><given-names>R</given-names></name><name><surname>White</surname><given-names>LR</given-names></name><article-title>Association of vitamin E and C supplement use with cognitive function and dementia in elderly men</article-title><source>Neurology</source><year>2000</year><volume>54</volume><fpage>1265</fpage><lpage>1272</lpage><pub-id pub-id-type="pmid">10746596</pub-id></mixed-citation></ref><ref id="B181"><mixed-citation publication-type="journal"><name><surname>Peacock</surname><given-names>JM</given-names></name><name><surname>Folsom</surname><given-names>AR</given-names></name><name><surname>Knopman</surname><given-names>DS</given-names></name><name><surname>Mosley</surname><given-names>TH</given-names></name><name><surname>Goff</surname><given-names>DC</given-names><suffix>Jr</suffix></name><name><surname>Szklo</surname><given-names>M</given-names></name><article-title>Dietary antioxidant intake and cognitive performance in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study investigators</article-title><source>Public Health Nutr</source><year>2000</year><volume>3</volume><fpage>337</fpage><lpage>343</lpage><pub-id pub-id-type="pmid">10980106</pub-id></mixed-citation></ref><ref id="B182"><mixed-citation publication-type="journal"><name><surname>Engelhart</surname><given-names>MJ</given-names></name><name><surname>Geerlings</surname><given-names>MI</given-names></name><name><surname>Ruitenberg</surname><given-names>A</given-names></name><name><surname>van Swieten</surname><given-names>JC</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Witteman</surname><given-names>JC</given-names></name><name><surname>Breteler</surname><given-names>MM</given-names></name><article-title>Dietary intake of antioxidants and risk of Alzheimer disease</article-title><source>JAMA</source><year>2002</year><volume>287</volume><fpage>3223</fpage><lpage>3229</lpage><pub-id pub-id-type="pmid">12076218</pub-id></mixed-citation></ref><ref id="B183"><mixed-citation publication-type="journal"><name><surname>Morris</surname><given-names>MC</given-names></name><name><surname>Evans</surname><given-names>DA</given-names></name><name><surname>Bienias</surname><given-names>JL</given-names></name><name><surname>Tangney</surname><given-names>CC</given-names></name><name><surname>Bennett</surname><given-names>DA</given-names></name><name><surname>Aggarwal</surname><given-names>N</given-names></name><name><surname>Wilson</surname><given-names>RS</given-names></name><name><surname>Scherr</surname><given-names>PA</given-names></name><article-title>Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study</article-title><source>JAMA</source><year>2002</year><volume>287</volume><fpage>3230</fpage><lpage>3237</lpage><pub-id pub-id-type="pmid">12076219</pub-id></mixed-citation></ref><ref id="B184"><mixed-citation publication-type="journal"><name><surname>Morris</surname><given-names>MC</given-names></name><name><surname>Evans</surname><given-names>DA</given-names></name><name><surname>Bienias</surname><given-names>JL</given-names></name><name><surname>Tangney</surname><given-names>CC</given-names></name><name><surname>Wilson</surname><given-names>RS</given-names></name><article-title>Vitamin E and cognitive decline in older persons</article-title><source>Arch Neurol</source><year>2002</year><volume>59</volume><fpage>1125</fpage><lpage>1132</lpage><pub-id pub-id-type="pmid">12117360</pub-id></mixed-citation></ref><ref id="B185"><mixed-citation publication-type="journal"><name><surname>Gray</surname><given-names>SL</given-names></name><name><surname>Hanlon</surname><given-names>JT</given-names></name><name><surname>Landerman</surname><given-names>LR</given-names></name><name><surname>Artz</surname><given-names>M</given-names></name><name><surname>Schmader</surname><given-names>KE</given-names></name><name><surname>Fillenbaum</surname><given-names>GG</given-names></name><article-title>Is antioxidant use protective of cognitive function in the community-dwelling elderly?</article-title><source>Am J Geriatr Pharmacother</source><year>2003</year><volume>1</volume><fpage>3</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">15555461</pub-id></mixed-citation></ref><ref id="B186"><mixed-citation publication-type="journal"><name><surname>Grodstein</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Willett</surname><given-names>WC</given-names></name><article-title>High-dose antioxidant supplements and cognitive function in community-dwelling elderly women</article-title><source>Am J Clin Nutr</source><year>2003</year><volume>77</volume><fpage>975</fpage><lpage>984</lpage><pub-id pub-id-type="pmid">12663300</pub-id></mixed-citation></ref><ref id="B187"><mixed-citation publication-type="journal"><name><surname>Luchsinger</surname><given-names>JA</given-names></name><name><surname>Tang</surname><given-names>MX</given-names></name><name><surname>Shea</surname><given-names>S</given-names></name><name><surname>Mayeux</surname><given-names>R</given-names></name><article-title>Antioxidant vitamin intake and risk of Alzheimer disease</article-title><source>Arch Neurol</source><year>2003</year><volume>60</volume><fpage>203</fpage><lpage>208</lpage><pub-id pub-id-type="pmid">12580704</pub-id></mixed-citation></ref><ref id="B188"><mixed-citation publication-type="journal"><name><surname>Laurin</surname><given-names>D</given-names></name><name><surname>Masaki</surname><given-names>KH</given-names></name><name><surname>Foley</surname><given-names>DJ</given-names></name><name><surname>White</surname><given-names>LR</given-names></name><name><surname>Launer</surname><given-names>LJ</given-names></name><article-title>Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia aging study</article-title><source>Am J Epidemiol</source><year>2004</year><volume>159</volume><fpage>959</fpage><lpage>967</lpage><pub-id pub-id-type="pmid">15128608</pub-id></mixed-citation></ref><ref id="B189"><mixed-citation publication-type="journal"><name><surname>Zandi</surname><given-names>PP</given-names></name><name><surname>Anthony</surname><given-names>JC</given-names></name><name><surname>Khachaturian</surname><given-names>AS</given-names></name><name><surname>Stone</surname><given-names>SV</given-names></name><name><surname>Gustafson</surname><given-names>D</given-names></name><name><surname>Tschanz</surname><given-names>JT</given-names></name><name><surname>Norton</surname><given-names>MC</given-names></name><name><surname>Welsh-Bohmer</surname><given-names>KA</given-names></name><name><surname>Breitner</surname><given-names>JC</given-names></name><article-title>Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache county study</article-title><source>Arch Neurol</source><year>2004</year><volume>61</volume><fpage>82</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">14732624</pub-id></mixed-citation></ref><ref id="B190"><mixed-citation publication-type="journal"><name><surname>Cherubini</surname><given-names>A</given-names></name><name><surname>Martin</surname><given-names>A</given-names></name><name><surname>Andres-Lacueva</surname><given-names>C</given-names></name><name><surname>Di Iorio</surname><given-names>A</given-names></name><name><surname>Lamponi</surname><given-names>M</given-names></name><name><surname>Mecocci</surname><given-names>P</given-names></name><name><surname>Bartali</surname><given-names>B</given-names></name><name><surname>Corsi</surname><given-names>A</given-names></name><name><surname>Senin</surname><given-names>U</given-names></name><name><surname>Ferrucci</surname><given-names>L</given-names></name><article-title>Vitamin E levels, cognitive impairment and dementia in older persons: the InCHIANTI study</article-title><source>Neurobiol Aging</source><year>2005</year><volume>26</volume><fpage>987</fpage><lpage>994</lpage><pub-id pub-id-type="pmid">15748776</pub-id></mixed-citation></ref><ref id="B191"><mixed-citation publication-type="journal"><name><surname>Engelhart</surname><given-names>MJ</given-names></name><name><surname>Ruitenberg</surname><given-names>A</given-names></name><name><surname>Meijer</surname><given-names>J</given-names></name><name><surname>Kiliaan</surname><given-names>A</given-names></name><name><surname>van Swieten</surname><given-names>JC</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Witteman</surname><given-names>JC</given-names></name><name><surname>Breteler</surname><given-names>MM</given-names></name><article-title>Plasma levels of antioxidants are not associated with Alzheimer's disease or cognitive decline</article-title><source>Dement Geriatr Cogn Disord</source><year>2005</year><volume>19</volume><fpage>134</fpage><lpage>139</lpage><pub-id pub-id-type="pmid">15627760</pub-id></mixed-citation></ref><ref id="B192"><mixed-citation publication-type="journal"><name><surname>Fillenbaum</surname><given-names>GG</given-names></name><name><surname>Kuchibhatla</surname><given-names>MN</given-names></name><name><surname>Hanlon</surname><given-names>JT</given-names></name><name><surname>Artz</surname><given-names>MB</given-names></name><name><surname>Pieper</surname><given-names>CF</given-names></name><name><surname>Schmader</surname><given-names>KE</given-names></name><name><surname>Dysken</surname><given-names>MW</given-names></name><name><surname>Gray</surname><given-names>SL</given-names></name><article-title>Dementia and Alzheimer's disease in community-dwelling elders taking vitamin C and/or vitamin E</article-title><source>Ann Pharmacother</source><year>2005</year><volume>39</volume><fpage>2009</fpage><lpage>2014</lpage><pub-id pub-id-type="pmid">16227448</pub-id></mixed-citation></ref><ref id="B193"><mixed-citation publication-type="journal"><name><surname>Maxwell</surname><given-names>CJ</given-names></name><name><surname>Hicks</surname><given-names>MS</given-names></name><name><surname>Hogan</surname><given-names>DB</given-names></name><name><surname>Basran</surname><given-names>J</given-names></name><name><surname>Ebly</surname><given-names>EM</given-names></name><article-title>Supplemental use of antioxidant vitamins and subsequent risk of cognitive decline and dementia</article-title><source>Dement Geriatr Cogn Disord</source><year>2005</year><volume>20</volume><fpage>45</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">15832036</pub-id></mixed-citation></ref><ref id="B194"><mixed-citation publication-type="journal"><name><surname>Morris</surname><given-names>MC</given-names></name><name><surname>Evans</surname><given-names>DA</given-names></name><name><surname>Tangney</surname><given-names>CC</given-names></name><name><surname>Bienias</surname><given-names>JL</given-names></name><name><surname>Wilson</surname><given-names>RS</given-names></name><name><surname>Aggarwal</surname><given-names>NT</given-names></name><name><surname>Scherr</surname><given-names>PA</given-names></name><article-title>Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change</article-title><source>Am J Clin Nutr</source><year>2005</year><volume>81</volume><fpage>508</fpage><lpage>514</lpage><pub-id pub-id-type="pmid">15699242</pub-id></mixed-citation></ref><ref id="B195"><mixed-citation publication-type="journal"><name><surname>Akbaraly</surname><given-names>NT</given-names></name><name><surname>Faure</surname><given-names>H</given-names></name><name><surname>Gourlet</surname><given-names>V</given-names></name><name><surname>Favier</surname><given-names>A</given-names></name><name><surname>Berr</surname><given-names>C</given-names></name><article-title>Plasma carotenoid levels and cognitive performance in an elderly population: results of the EVA study</article-title><source>J Gerontol A Biol Sci Med Sci</source><year>2007</year><volume>62</volume><fpage>308</fpage><lpage>316</lpage><pub-id pub-id-type="pmid">17389729</pub-id></mixed-citation></ref><ref id="B196"><mixed-citation publication-type="journal"><name><surname>Dunn</surname><given-names>JE</given-names></name><name><surname>Weintraub</surname><given-names>S</given-names></name><name><surname>Stoddard</surname><given-names>AM</given-names></name><name><surname>Banks</surname><given-names>S</given-names></name><article-title>Serum alpha-tocopherol, concurrent and past vitamin E intake, and mild cognitive impairment</article-title><source>Neurology</source><year>2007</year><volume>68</volume><fpage>670</fpage><lpage>676</lpage><pub-id pub-id-type="pmid">17325274</pub-id></mixed-citation></ref><ref id="B197"><mixed-citation publication-type="journal"><name><surname>Wengreen</surname><given-names>HJ</given-names></name><name><surname>Munger</surname><given-names>RG</given-names></name><name><surname>Corcoran</surname><given-names>CD</given-names></name><name><surname>Zandi</surname><given-names>P</given-names></name><name><surname>Hayden</surname><given-names>KM</given-names></name><name><surname>Fotuhi</surname><given-names>M</given-names></name><name><surname>Skoog</surname><given-names>I</given-names></name><name><surname>Norton</surname><given-names>MC</given-names></name><name><surname>Tschanz</surname><given-names>J</given-names></name><name><surname>Breitner</surname><given-names>JC</given-names></name><name><surname>Welsh-Bohmer</surname><given-names>KA</given-names></name><article-title>Antioxidant intake and cognitive function of elderly men and women: the Cache county study</article-title><source>J Nutr Health Aging</source><year>2007</year><volume>11</volume><fpage>230</fpage><lpage>237</lpage><pub-id pub-id-type="pmid">17508099</pub-id></mixed-citation></ref><ref id="B198"><mixed-citation publication-type="journal"><name><surname>Fotuhi</surname><given-names>M</given-names></name><name><surname>Zandi</surname><given-names>PP</given-names></name><name><surname>Hayden</surname><given-names>KM</given-names></name><name><surname>Khachaturian</surname><given-names>AS</given-names></name><name><surname>Szekely</surname><given-names>CA</given-names></name><name><surname>Wengreen</surname><given-names>H</given-names></name><name><surname>Munger</surname><given-names>RG</given-names></name><name><surname>Norton</surname><given-names>MC</given-names></name><name><surname>Tschanz</surname><given-names>JT</given-names></name><name><surname>Lyketsos</surname><given-names>CG</given-names></name><name><surname>Breitner</surname><given-names>JC</given-names></name><name><surname>Welsh-Bohmer</surname><given-names>K</given-names></name><article-title>Better cognitive performance in elderly taking antioxidant vitamins E and C supplements in combination with nonsteroidal anti-inflammatory drugs: the Cache county study</article-title><source>Alzheimers Dement</source><year>2008</year><volume>4</volume><fpage>223</fpage><lpage>227</lpage><pub-id pub-id-type="pmid">18631971</pub-id></mixed-citation></ref><ref id="B199"><mixed-citation publication-type="journal"><name><surname>Gray</surname><given-names>SL</given-names></name><name><surname>Anderson</surname><given-names>ML</given-names></name><name><surname>Crane</surname><given-names>PK</given-names></name><name><surname>Breitner</surname><given-names>JC</given-names></name><name><surname>McCormick</surname><given-names>W</given-names></name><name><surname>Bowen</surname><given-names>JD</given-names></name><name><surname>Teri</surname><given-names>L</given-names></name><name><surname>Larson</surname><given-names>E</given-names></name><article-title>Antioxidant vitamin supplement use and risk of dementia or Alzheimer's disease in older adults</article-title><source>J Am Geriatr Soc</source><year>2008</year><volume>56</volume><fpage>291</fpage><lpage>295</lpage><pub-id pub-id-type="pmid">18047492</pub-id></mixed-citation></ref><ref id="B200"><mixed-citation publication-type="journal"><name><surname>Ravaglia</surname><given-names>G</given-names></name><name><surname>Forti</surname><given-names>P</given-names></name><name><surname>Lucicesare</surname><given-names>A</given-names></name><name><surname>Pisacane</surname><given-names>N</given-names></name><name><surname>Rietti</surname><given-names>E</given-names></name><name><surname>Mangialasche</surname><given-names>F</given-names></name><name><surname>Cecchetti</surname><given-names>R</given-names></name><name><surname>Patterson</surname><given-names>C</given-names></name><name><surname>Mecocci</surname><given-names>P</given-names></name><article-title>Plasma tocopherols and risk of cognitive impairment in an elderly Italian cohort</article-title><source>Am J Clin Nutr</source><year>2008</year><volume>87</volume><fpage>1306</fpage><lpage>1313</lpage><pub-id pub-id-type="pmid">18469254</pub-id></mixed-citation></ref><ref id="B201"><mixed-citation publication-type="journal"><name><surname>Devore</surname><given-names>EE</given-names></name><name><surname>Kang</surname><given-names>JH</given-names></name><name><surname>Stampfer</surname><given-names>MJ</given-names></name><name><surname>Grodstein</surname><given-names>F</given-names></name><article-title>Total antioxidant capacity of diet in relation to cognitive function and decline</article-title><source>Am J Clin Nutr</source><year>2010</year><volume>92</volume><fpage>1157</fpage><lpage>1164</lpage><pub-id pub-id-type="pmid">20826624</pub-id></mixed-citation></ref><ref id="B202"><mixed-citation publication-type="journal"><name><surname>McNeill</surname><given-names>G</given-names></name><name><surname>Jia</surname><given-names>X</given-names></name><name><surname>Whalley</surname><given-names>LJ</given-names></name><name><surname>Fox</surname><given-names>HC</given-names></name><name><surname>Corley</surname><given-names>J</given-names></name><name><surname>Gow</surname><given-names>AJ</given-names></name><name><surname>Brett</surname><given-names>CE</given-names></name><name><surname>Starr</surname><given-names>JM</given-names></name><name><surname>Deary</surname><given-names>IJ</given-names></name><article-title>Antioxidant and B vitamin intake in relation to cognitive function in later life in the Lothian birth cohort 1936</article-title><source>Eur J Clin Nutr</source><year>2011</year><volume>65</volume><fpage>619</fpage><lpage>626</lpage><pub-id pub-id-type="pmid">21346712</pub-id></mixed-citation></ref><ref id="B203"><mixed-citation publication-type="journal"><name><surname>Kalmijn</surname><given-names>S</given-names></name><name><surname>Launer</surname><given-names>LJ</given-names></name><name><surname>Lindemans</surname><given-names>J</given-names></name><name><surname>Bots</surname><given-names>ML</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Breteler</surname><given-names>MM</given-names></name><article-title>Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam study</article-title><source>Am J Epidemiol</source><year>1999</year><volume>150</volume><fpage>283</fpage><lpage>289</lpage><pub-id pub-id-type="pmid">10430233</pub-id></mixed-citation></ref><ref id="B204"><mixed-citation publication-type="journal"><name><surname>Duthie</surname><given-names>SJ</given-names></name><name><surname>Whalley</surname><given-names>LJ</given-names></name><name><surname>Collins</surname><given-names>AR</given-names></name><name><surname>Leaper</surname><given-names>S</given-names></name><name><surname>Berger</surname><given-names>K</given-names></name><name><surname>Deary</surname><given-names>IJ</given-names></name><article-title>Homocysteine, B vitamin status, and cognitive function in the elderly</article-title><source>Am J Clin Nutr</source><year>2002</year><volume>75</volume><fpage>908</fpage><lpage>913</lpage><pub-id pub-id-type="pmid">11976166</pub-id></mixed-citation></ref><ref id="B205"><mixed-citation publication-type="journal"><name><surname>Prins</surname><given-names>ND</given-names></name><name><surname>Den Heijer</surname><given-names>T</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Koudstaal</surname><given-names>PJ</given-names></name><name><surname>Jolles</surname><given-names>J</given-names></name><name><surname>Clarke</surname><given-names>R</given-names></name><name><surname>Breteler</surname><given-names>MM</given-names></name><article-title>Homocysteine and cognitive function in the elderly: the Rotterdam scan study</article-title><source>Neurology</source><year>2002</year><volume>59</volume><fpage>1375</fpage><lpage>1380</lpage><pub-id pub-id-type="pmid">12427887</pub-id></mixed-citation></ref><ref id="B206"><mixed-citation publication-type="journal"><name><surname>Seshadri</surname><given-names>S</given-names></name><name><surname>Beiser</surname><given-names>A</given-names></name><name><surname>Selhub</surname><given-names>J</given-names></name><name><surname>Jacques</surname><given-names>PF</given-names></name><name><surname>Rosenberg</surname><given-names>IH</given-names></name><name><surname>D'Agostino</surname><given-names>RB</given-names></name><name><surname>Wilson</surname><given-names>PW</given-names></name><name><surname>Wolf</surname><given-names>PA</given-names></name><article-title>Plasma homocysteine as a risk factor for dementia and Alzheimer's disease</article-title><source>N Engl J Med</source><year>2002</year><volume>346</volume><fpage>476</fpage><lpage>483</lpage><pub-id pub-id-type="pmid">11844848</pub-id></mixed-citation></ref><ref id="B207"><mixed-citation publication-type="journal"><name><surname>Miller</surname><given-names>JW</given-names></name><name><surname>Green</surname><given-names>R</given-names></name><name><surname>Ramos</surname><given-names>MI</given-names></name><name><surname>Allen</surname><given-names>LH</given-names></name><name><surname>Mungas</surname><given-names>DM</given-names></name><name><surname>Jagust</surname><given-names>WJ</given-names></name><name><surname>Haan</surname><given-names>MN</given-names></name><article-title>Homocysteine and cognitive function in the Sacramento area Latino study on aging</article-title><source>Am J Clin Nutr</source><year>2003</year><volume>78</volume><fpage>441</fpage><lpage>447</lpage><pub-id pub-id-type="pmid">12936927</pub-id></mixed-citation></ref><ref id="B208"><mixed-citation publication-type="journal"><name><surname>Ravaglia</surname><given-names>G</given-names></name><name><surname>Forti</surname><given-names>P</given-names></name><name><surname>Maioli</surname><given-names>F</given-names></name><name><surname>Muscari</surname><given-names>A</given-names></name><name><surname>Sacchetti</surname><given-names>L</given-names></name><name><surname>Arnone</surname><given-names>G</given-names></name><name><surname>Nativio</surname><given-names>V</given-names></name><name><surname>Talerico</surname><given-names>T</given-names></name><name><surname>Mariani</surname><given-names>E</given-names></name><article-title>Homocysteine and cognitive function in healthy elderly community dwellers in Italy</article-title><source>Am J Clin Nutr</source><year>2003</year><volume>77</volume><fpage>668</fpage><lpage>673</lpage><pub-id pub-id-type="pmid">12600859</pub-id></mixed-citation></ref><ref id="B209"><mixed-citation publication-type="journal"><name><surname>Luchsinger</surname><given-names>JA</given-names></name><name><surname>Tang</surname><given-names>MX</given-names></name><name><surname>Shea</surname><given-names>S</given-names></name><name><surname>Miller</surname><given-names>J</given-names></name><name><surname>Green</surname><given-names>R</given-names></name><name><surname>Mayeux</surname><given-names>R</given-names></name><article-title>Plasma homocysteine levels and risk of Alzheimer disease</article-title><source>Neurology</source><year>2004</year><volume>62</volume><fpage>1972</fpage><lpage>1976</lpage><pub-id pub-id-type="pmid">15184599</pub-id></mixed-citation></ref><ref id="B210"><mixed-citation publication-type="journal"><name><surname>Ariogul</surname><given-names>S</given-names></name><name><surname>Cankurtaran</surname><given-names>M</given-names></name><name><surname>Dagli</surname><given-names>N</given-names></name><name><surname>Khalil</surname><given-names>M</given-names></name><name><surname>Yavuz</surname><given-names>B</given-names></name><article-title>Vitamin B12, folate, homocysteine and dementia: are they really related?</article-title><source>Arch Gerontol Geriatr</source><year>2005</year><volume>40</volume><fpage>139</fpage><lpage>146</lpage><pub-id pub-id-type="pmid">15680498</pub-id></mixed-citation></ref><ref id="B211"><mixed-citation publication-type="journal"><name><surname>Campbell</surname><given-names>AK</given-names></name><name><surname>Jagust</surname><given-names>WJ</given-names></name><name><surname>Mungas</surname><given-names>DM</given-names></name><name><surname>Miller</surname><given-names>JW</given-names></name><name><surname>Green</surname><given-names>R</given-names></name><name><surname>Haan</surname><given-names>MN</given-names></name><name><surname>Allen</surname><given-names>LH</given-names></name><article-title>Low erythrocyte folate, but not plasma vitamin B-12 or homocysteine, is associated with dementia in elderly Latinos</article-title><source>J Nutr Health Aging</source><year>2005</year><volume>9</volume><fpage>39</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">15750664</pub-id></mixed-citation></ref><ref id="B212"><mixed-citation publication-type="journal"><name><surname>Elias</surname><given-names>MF</given-names></name><name><surname>Sullivan</surname><given-names>LM</given-names></name><name><surname>D'Agostino</surname><given-names>RB</given-names></name><name><surname>Elias</surname><given-names>PK</given-names></name><name><surname>Jacques</surname><given-names>PF</given-names></name><name><surname>Selhub</surname><given-names>J</given-names></name><name><surname>Seshadri</surname><given-names>S</given-names></name><name><surname>Au</surname><given-names>R</given-names></name><name><surname>Beiser</surname><given-names>A</given-names></name><name><surname>Wolf</surname><given-names>PA</given-names></name><article-title>Homocysteine and cognitive performance in the Framingham offspring study: age is important</article-title><source>Am J Epidemiol</source><year>2005</year><volume>162</volume><fpage>644</fpage><lpage>653</lpage><pub-id pub-id-type="pmid">16107567</pub-id></mixed-citation></ref><ref id="B213"><mixed-citation publication-type="journal"><name><surname>Kado</surname><given-names>DM</given-names></name><name><surname>Karlamangla</surname><given-names>AS</given-names></name><name><surname>Huang</surname><given-names>MH</given-names></name><name><surname>Troen</surname><given-names>A</given-names></name><name><surname>Rowe</surname><given-names>JW</given-names></name><name><surname>Selhub</surname><given-names>J</given-names></name><name><surname>Seeman</surname><given-names>TE</given-names></name><article-title>Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur studies of successful aging</article-title><source>Am J Med</source><year>2005</year><volume>118</volume><fpage>161</fpage><lpage>167</lpage><pub-id pub-id-type="pmid">15694902</pub-id></mixed-citation></ref><ref id="B214"><mixed-citation publication-type="journal"><name><surname>Mooijaart</surname><given-names>SP</given-names></name><name><surname>Gussekloo</surname><given-names>J</given-names></name><name><surname>Frolich</surname><given-names>M</given-names></name><name><surname>Jolles</surname><given-names>J</given-names></name><name><surname>Stott</surname><given-names>DJ</given-names></name><name><surname>Westendorp</surname><given-names>RG</given-names></name><name><surname>de Craen</surname><given-names>AJ</given-names></name><article-title>Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus study</article-title><source>Am J Clin Nutr</source><year>2005</year><volume>82</volume><fpage>866</fpage><lpage>871</lpage><pub-id pub-id-type="pmid">16210718</pub-id></mixed-citation></ref><ref id="B215"><mixed-citation publication-type="journal"><name><surname>Quadri</surname><given-names>P</given-names></name><name><surname>Fragiacomo</surname><given-names>C</given-names></name><name><surname>Pezzati</surname><given-names>R</given-names></name><name><surname>Zanda</surname><given-names>E</given-names></name><name><surname>Tettamanti</surname><given-names>M</given-names></name><name><surname>Lucca</surname><given-names>U</given-names></name><article-title>Homocysteine and B vitamins in mild cognitive impairment and dementia</article-title><source>Clin Chem Lab Med</source><year>2005</year><volume>43</volume><fpage>1096</fpage><lpage>1100</lpage><pub-id pub-id-type="pmid">16197304</pub-id></mixed-citation></ref><ref id="B216"><mixed-citation publication-type="journal"><name><surname>Ramos</surname><given-names>MI</given-names></name><name><surname>Allen</surname><given-names>LH</given-names></name><name><surname>Mungas</surname><given-names>DM</given-names></name><name><surname>Jagust</surname><given-names>WJ</given-names></name><name><surname>Haan</surname><given-names>MN</given-names></name><name><surname>Green</surname><given-names>R</given-names></name><name><surname>Miller</surname><given-names>JW</given-names></name><article-title>Low folate status is associated with impaired cognitive function and dementia in the Sacramento area Latino study on aging</article-title><source>Am J Clin Nutr</source><year>2005</year><volume>82</volume><fpage>1346</fpage><lpage>1352</lpage><pub-id pub-id-type="pmid">16332669</pub-id></mixed-citation></ref><ref id="B217"><mixed-citation publication-type="journal"><name><surname>Ravaglia</surname><given-names>G</given-names></name><name><surname>Forti</surname><given-names>P</given-names></name><name><surname>Maioli</surname><given-names>F</given-names></name><name><surname>Martelli</surname><given-names>M</given-names></name><name><surname>Servadei</surname><given-names>L</given-names></name><name><surname>Brunetti</surname><given-names>N</given-names></name><name><surname>Porcellini</surname><given-names>E</given-names></name><name><surname>Licastro</surname><given-names>F</given-names></name><article-title>Homocysteine and folate as risk factors for dementia and Alzheimer disease</article-title><source>Am J Clin Nutr</source><year>2005</year><volume>82</volume><fpage>636</fpage><lpage>643</lpage><pub-id pub-id-type="pmid">16155278</pub-id></mixed-citation></ref><ref id="B218"><mixed-citation publication-type="journal"><name><surname>Schafer</surname><given-names>JH</given-names></name><name><surname>Glass</surname><given-names>TA</given-names></name><name><surname>Bolla</surname><given-names>KI</given-names></name><name><surname>Mintz</surname><given-names>M</given-names></name><name><surname>Jedlicka</surname><given-names>AE</given-names></name><name><surname>Schwartz</surname><given-names>BS</given-names></name><article-title>Homocysteine and cognitive function in a population-based study of older adults</article-title><source>J Am Geriatr Soc</source><year>2005</year><volume>53</volume><fpage>381</fpage><lpage>388</lpage><pub-id pub-id-type="pmid">15743278</pub-id></mixed-citation></ref><ref id="B219"><mixed-citation publication-type="journal"><name><surname>Tucker</surname><given-names>KL</given-names></name><name><surname>Qiao</surname><given-names>N</given-names></name><name><surname>Scott</surname><given-names>T</given-names></name><name><surname>Rosenberg</surname><given-names>I</given-names></name><name><surname>Spiro</surname><given-names>A</given-names><suffix>3rd</suffix></name><article-title>High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans affairs normative aging study</article-title><source>Am J Clin Nutr</source><year>2005</year><volume>82</volume><fpage>627</fpage><lpage>635</lpage><pub-id pub-id-type="pmid">16155277</pub-id></mixed-citation></ref><ref id="B220"><mixed-citation publication-type="journal"><name><surname>Elias</surname><given-names>MF</given-names></name><name><surname>Robbins</surname><given-names>MA</given-names></name><name><surname>Budge</surname><given-names>MM</given-names></name><name><surname>Elias</surname><given-names>PK</given-names></name><name><surname>Brennan</surname><given-names>SL</given-names></name><name><surname>Johnston</surname><given-names>C</given-names></name><name><surname>Nagy</surname><given-names>Z</given-names></name><name><surname>Bates</surname><given-names>CJ</given-names></name><article-title>Homocysteine, folate, and vitamins B6 and B12 blood levels in relation to cognitive performance: the Maine-Syracuse study</article-title><source>Psychosom Med</source><year>2006</year><volume>68</volume><fpage>547</fpage><lpage>554</lpage><pub-id pub-id-type="pmid">16868263</pub-id></mixed-citation></ref><ref id="B221"><mixed-citation publication-type="journal"><name><surname>Feng</surname><given-names>L</given-names></name><name><surname>Ng</surname><given-names>TP</given-names></name><name><surname>Chuah</surname><given-names>L</given-names></name><name><surname>Niti</surname><given-names>M</given-names></name><name><surname>Kua</surname><given-names>EH</given-names></name><article-title>Homocysteine, folate, and vitamin B-12 and cognitive performance in older Chinese adults: findings from the Singapore longitudinal ageing study</article-title><source>Am J Clin Nutr</source><year>2006</year><volume>84</volume><fpage>1506</fpage><lpage>1512</lpage><pub-id pub-id-type="pmid">17158436</pub-id></mixed-citation></ref><ref id="B222"><mixed-citation publication-type="journal"><name><surname>van Raamt</surname><given-names>AF</given-names></name><name><surname>Kalmijn</surname><given-names>S</given-names></name><name><surname>Mali</surname><given-names>WP</given-names></name><name><surname>van Zandvoort</surname><given-names>MJ</given-names></name><name><surname>van der Graaf</surname><given-names>Y</given-names></name><article-title>Homocysteine level and cognitive function in patients with arterial disease: the second manifestations of ARTerial disease study</article-title><source>J Am Geriatr Soc</source><year>2006</year><volume>54</volume><fpage>575</fpage><lpage>579</lpage><pub-id pub-id-type="pmid">16686865</pub-id></mixed-citation></ref><ref id="B223"><mixed-citation publication-type="journal"><name><surname>Clarke</surname><given-names>R</given-names></name><name><surname>Birks</surname><given-names>J</given-names></name><name><surname>Nexo</surname><given-names>E</given-names></name><name><surname>Ueland</surname><given-names>PM</given-names></name><name><surname>Schneede</surname><given-names>J</given-names></name><name><surname>Scott</surname><given-names>J</given-names></name><name><surname>Molloy</surname><given-names>A</given-names></name><name><surname>Evans</surname><given-names>JG</given-names></name><article-title>Low vitamin B-12 status and risk of cognitive decline in older adults</article-title><source>Am J Clin Nutr</source><year>2007</year><volume>86</volume><fpage>1384</fpage><lpage>1391</lpage><pub-id pub-id-type="pmid">17991650</pub-id></mixed-citation></ref><ref id="B224"><mixed-citation publication-type="journal"><name><surname>Haan</surname><given-names>MN</given-names></name><name><surname>Miller</surname><given-names>JW</given-names></name><name><surname>Aiello</surname><given-names>AE</given-names></name><name><surname>Whitmer</surname><given-names>RA</given-names></name><name><surname>Jagust</surname><given-names>WJ</given-names></name><name><surname>Mungas</surname><given-names>DM</given-names></name><name><surname>Allen</surname><given-names>LH</given-names></name><name><surname>Green</surname><given-names>R</given-names></name><article-title>Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento area Latino study on aging</article-title><source>Am J Clin Nutr</source><year>2007</year><volume>85</volume><fpage>511</fpage><lpage>517</lpage><pub-id pub-id-type="pmid">17284751</pub-id></mixed-citation></ref><ref id="B225"><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>MH</given-names></name><name><surname>Kim</surname><given-names>E</given-names></name><name><surname>Han</surname><given-names>C</given-names></name><name><surname>Jo</surname><given-names>SA</given-names></name><name><surname>Jo</surname><given-names>I</given-names></name><article-title>Plasma homocysteine is associated with the risk of mild cognitive impairment in an elderly Korean population</article-title><source>J Nutr</source><year>2007</year><volume>137</volume><fpage>2093</fpage><lpage>2097</lpage><pub-id pub-id-type="pmid">17709448</pub-id></mixed-citation></ref><ref id="B226"><mixed-citation publication-type="journal"><name><surname>Elias</surname><given-names>MF</given-names></name><name><surname>Robbins</surname><given-names>MA</given-names></name><name><surname>Budge</surname><given-names>MM</given-names></name><name><surname>Elias</surname><given-names>PK</given-names></name><name><surname>Dore</surname><given-names>GA</given-names></name><name><surname>Brennan</surname><given-names>SL</given-names></name><name><surname>Johnston</surname><given-names>C</given-names></name><name><surname>Nagy</surname><given-names>Z</given-names></name><article-title>Homocysteine and cognitive performance: modification by the ApoE genotype</article-title><source>Neurosci Lett</source><year>2008</year><volume>430</volume><fpage>64</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">18023533</pub-id></mixed-citation></ref><ref id="B227"><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>JM</given-names></name><name><surname>Kim</surname><given-names>SW</given-names></name><name><surname>Shin</surname><given-names>IS</given-names></name><name><surname>Yang</surname><given-names>SJ</given-names></name><name><surname>Park</surname><given-names>WY</given-names></name><name><surname>Kim</surname><given-names>SJ</given-names></name><name><surname>Shin</surname><given-names>HY</given-names></name><name><surname>Yoon</surname><given-names>JS</given-names></name><article-title>Folate, vitamin b(12), and homocysteine as risk factors for cognitive decline in the elderly</article-title><source>Psychiatry Investig</source><year>2008</year><volume>5</volume><fpage>36</fpage><lpage>40</lpage></mixed-citation></ref><ref id="B228"><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>JM</given-names></name><name><surname>Stewart</surname><given-names>R</given-names></name><name><surname>Kim</surname><given-names>SW</given-names></name><name><surname>Shin</surname><given-names>IS</given-names></name><name><surname>Yang</surname><given-names>SJ</given-names></name><name><surname>Shin</surname><given-names>HY</given-names></name><name><surname>Yoon</surname><given-names>JS</given-names></name><article-title>Changes in folate, vitamin B12 and homocysteine associated with incident dementia</article-title><source>J Neurol Neurosurg Psychiatry</source><year>2008</year><volume>79</volume><fpage>864</fpage><lpage>868</lpage><pub-id pub-id-type="pmid">18252751</pub-id></mixed-citation></ref><ref id="B229"><mixed-citation publication-type="journal"><name><surname>Reitz</surname><given-names>C</given-names></name><name><surname>Tang</surname><given-names>MX</given-names></name><name><surname>Miller</surname><given-names>J</given-names></name><name><surname>Green</surname><given-names>R</given-names></name><name><surname>Luchsinger</surname><given-names>JA</given-names></name><article-title>Plasma homocysteine and risk of mild cognitive impairment</article-title><source>Dement Geriatr Cogn Disord</source><year>2009</year><volume>27</volume><fpage>11</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">19088473</pub-id></mixed-citation></ref><ref id="B230"><mixed-citation publication-type="journal"><name><surname>Redeen</surname><given-names>S</given-names></name><name><surname>Ryberg</surname><given-names>A</given-names></name><name><surname>Petersson</surname><given-names>F</given-names></name><name><surname>Eriksson</surname><given-names>O</given-names></name><name><surname>Nagga</surname><given-names>K</given-names></name><name><surname>Borch</surname><given-names>K</given-names></name><article-title>Homocysteine levels in chronic gastritis and other conditions: relations to incident cardiovascular disease and dementia</article-title><source>Dig Dis Sci</source><year>2010</year><volume>55</volume><fpage>351</fpage><lpage>358</lpage><pub-id pub-id-type="pmid">19267198</pub-id></mixed-citation></ref><ref id="B231"><mixed-citation publication-type="journal"><name><surname>van den Kommer</surname><given-names>TN</given-names></name><name><surname>Dik</surname><given-names>MG</given-names></name><name><surname>Comijs</surname><given-names>HC</given-names></name><name><surname>Jonker</surname><given-names>C</given-names></name><name><surname>Deeg</surname><given-names>DJ</given-names></name><article-title>Homocysteine and inflammation: predictors of cognitive decline in older persons?</article-title><source>Neurobiol Aging</source><year>2010</year><volume>31</volume><fpage>1700</fpage><lpage>1709</lpage><pub-id pub-id-type="pmid">19004529</pub-id></mixed-citation></ref><ref id="B232"><mixed-citation publication-type="journal"><name><surname>Perneczky</surname><given-names>R</given-names></name><name><surname>Alexopoulos</surname><given-names>P</given-names></name><name><surname>Kurz</surname><given-names>A</given-names></name><name><surname>Bickel</surname><given-names>H</given-names></name><article-title>Cognitive reserve, homocysteine, and cognition in the Bavarian school sisters study</article-title><source>J Am Geriatr Soc</source><year>2011</year><volume>59</volume><fpage>1754</fpage><lpage>1756</lpage><pub-id pub-id-type="pmid">22136539</pub-id></mixed-citation></ref><ref id="B233"><mixed-citation publication-type="journal"><name><surname>Zylberstein</surname><given-names>DE</given-names></name><name><surname>Lissner</surname><given-names>L</given-names></name><name><surname>Bjorkelund</surname><given-names>C</given-names></name><name><surname>Mehlig</surname><given-names>K</given-names></name><name><surname>Thelle</surname><given-names>DS</given-names></name><name><surname>Gustafson</surname><given-names>D</given-names></name><name><surname>Ostling</surname><given-names>S</given-names></name><name><surname>Waern</surname><given-names>M</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Skoog</surname><given-names>I</given-names></name><article-title>Midlife homocysteine and late-life dementia in women. A prospective population study</article-title><source>Neurobiol Aging</source><year>2011</year><volume>32</volume><fpage>380</fpage><lpage>386</lpage><pub-id pub-id-type="pmid">19342123</pub-id></mixed-citation></ref><ref id="B234"><mixed-citation publication-type="journal"><name><surname>Ford</surname><given-names>AH</given-names></name><name><surname>Flicker</surname><given-names>L</given-names></name><name><surname>Alfonso</surname><given-names>H</given-names></name><name><surname>Hankey</surname><given-names>GJ</given-names></name><name><surname>Norman</surname><given-names>PE</given-names></name><name><surname>van Bockxmeer</surname><given-names>FM</given-names></name><name><surname>Almeida</surname><given-names>OP</given-names></name><article-title>Plasma homocysteine and MTHFRC677T polymorphism as risk factors for incident dementia</article-title><source>J Neurol Neurosurg Psychiatry</source><year>2012</year><volume>83</volume><fpage>70</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">21746742</pub-id></mixed-citation></ref><ref id="B235"><mixed-citation publication-type="journal"><name><surname>Ford</surname><given-names>AH</given-names></name><name><surname>Flicker</surname><given-names>L</given-names></name><name><surname>Hankey</surname><given-names>GJ</given-names></name><name><surname>Norman</surname><given-names>P</given-names></name><name><surname>van Bockxmeer</surname><given-names>FM</given-names></name><name><surname>Almeida</surname><given-names>OP</given-names></name><article-title>Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism and cognitive impairment: the health in men study</article-title><source>Mol Psychiatry</source><year>2012</year><volume>17</volume><fpage>559</fpage><lpage>566</lpage><pub-id pub-id-type="pmid">21358708</pub-id></mixed-citation></ref><ref id="B236"><mixed-citation publication-type="journal"><name><surname>Kalmijn</surname><given-names>S</given-names></name><name><surname>Feskens</surname><given-names>EJ</given-names></name><name><surname>Launer</surname><given-names>LJ</given-names></name><name><surname>Kromhout</surname><given-names>D</given-names></name><article-title>Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men</article-title><source>Am J Epidemiol</source><year>1997</year><volume>145</volume><fpage>33</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">8982020</pub-id></mixed-citation></ref><ref id="B237"><mixed-citation publication-type="journal"><name><surname>Kalmijn</surname><given-names>S</given-names></name><name><surname>Launer</surname><given-names>LJ</given-names></name><name><surname>Ott</surname><given-names>A</given-names></name><name><surname>Witteman</surname><given-names>JC</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Breteler</surname><given-names>MM</given-names></name><article-title>Dietary fat intake and the risk of incident dementia in the Rotterdam study</article-title><source>Ann Neurol</source><year>1997</year><volume>42</volume><fpage>776</fpage><lpage>782</lpage><pub-id pub-id-type="pmid">9392577</pub-id></mixed-citation></ref><ref id="B238"><mixed-citation publication-type="journal"><name><surname>Engelhart</surname><given-names>MJ</given-names></name><name><surname>Geerlings</surname><given-names>MI</given-names></name><name><surname>Ruitenberg</surname><given-names>A</given-names></name><name><surname>Van Swieten</surname><given-names>JC</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Witteman</surname><given-names>JC</given-names></name><name><surname>Breteler</surname><given-names>MM</given-names></name><article-title>Diet and risk of dementia: does fat matter?: the Rotterdam study</article-title><source>Neurology</source><year>2002</year><volume>59</volume><fpage>1915</fpage><lpage>1921</lpage><pub-id pub-id-type="pmid">12499483</pub-id></mixed-citation></ref><ref id="B239"><mixed-citation publication-type="journal"><name><surname>Morris</surname><given-names>MC</given-names></name><name><surname>Evans</surname><given-names>DA</given-names></name><name><surname>Bienias</surname><given-names>JL</given-names></name><name><surname>Tangney</surname><given-names>CC</given-names></name><name><surname>Bennett</surname><given-names>DA</given-names></name><name><surname>Wilson</surname><given-names>RS</given-names></name><name><surname>Aggarwal</surname><given-names>N</given-names></name><name><surname>Schneider</surname><given-names>J</given-names></name><article-title>Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease</article-title><source>Arch Neurol</source><year>2003</year><volume>60</volume><fpage>940</fpage><lpage>946</lpage><pub-id pub-id-type="pmid">12873849</pub-id></mixed-citation></ref><ref id="B240"><mixed-citation publication-type="journal"><name><surname>Kalmijn</surname><given-names>S</given-names></name><name><surname>van Boxtel</surname><given-names>MP</given-names></name><name><surname>Ocke</surname><given-names>M</given-names></name><name><surname>Verschuren</surname><given-names>WM</given-names></name><name><surname>Kromhout</surname><given-names>D</given-names></name><name><surname>Launer</surname><given-names>LJ</given-names></name><article-title>Dietary intake of fatty acids and fish in relation to cognitive performance at middle age</article-title><source>Neurology</source><year>2004</year><volume>62</volume><fpage>275</fpage><lpage>280</lpage><pub-id pub-id-type="pmid">14745067</pub-id></mixed-citation></ref><ref id="B241"><mixed-citation publication-type="journal"><name><surname>Morris</surname><given-names>MC</given-names></name><name><surname>Evans</surname><given-names>DA</given-names></name><name><surname>Tangney</surname><given-names>CC</given-names></name><name><surname>Bienias</surname><given-names>JL</given-names></name><name><surname>Wilson</surname><given-names>RS</given-names></name><article-title>Fish consumption and cognitive decline with age in a large community study</article-title><source>Arch Neurol</source><year>2005</year><volume>62</volume><issue>12</issue><fpage>1849</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">16216930</pub-id></mixed-citation></ref><ref id="B242"><mixed-citation publication-type="journal"><name><surname>Barberger-Gateau</surname><given-names>P</given-names></name><name><surname>Raffaitin</surname><given-names>C</given-names></name><name><surname>Letenneur</surname><given-names>L</given-names></name><name><surname>Berr</surname><given-names>C</given-names></name><name><surname>Tzourio</surname><given-names>C</given-names></name><name><surname>Dartigues</surname><given-names>JF</given-names></name><name><surname>Alperovitch</surname><given-names>A</given-names></name><article-title>Dietary patterns and risk of dementia: the Three-City cohort study</article-title><source>Neurology</source><year>2007</year><volume>69</volume><fpage>1921</fpage><lpage>1930</lpage><pub-id pub-id-type="pmid">17998483</pub-id></mixed-citation></ref><ref id="B243"><mixed-citation publication-type="journal"><name><surname>Beydoun</surname><given-names>MA</given-names></name><name><surname>Kaufman</surname><given-names>JS</given-names></name><name><surname>Satia</surname><given-names>JA</given-names></name><name><surname>Rosamond</surname><given-names>W</given-names></name><name><surname>Folsom</surname><given-names>AR</given-names></name><article-title>Plasma n-3 fatty acids and risk of cognitive decline among older adults: the atherosclerosis risk in communities (ARIC) study</article-title><source>Am J Clin Nutr</source><year>2007</year><volume>84</volume><issue>4</issue><fpage>1103</fpage><lpage>11</lpage><comment>In press</comment><pub-id pub-id-type="pmid">17413112</pub-id></mixed-citation></ref><ref id="B244"><mixed-citation publication-type="journal"><name><surname>Cherubini</surname><given-names>A</given-names></name><name><surname>Andres-Lacueva</surname><given-names>C</given-names></name><name><surname>Martin</surname><given-names>A</given-names></name><name><surname>Lauretani</surname><given-names>F</given-names></name><name><surname>Iorio</surname><given-names>AD</given-names></name><name><surname>Bartali</surname><given-names>B</given-names></name><name><surname>Corsi</surname><given-names>A</given-names></name><name><surname>Bandinelli</surname><given-names>S</given-names></name><name><surname>Mattson</surname><given-names>MP</given-names></name><name><surname>Ferrucci</surname><given-names>L</given-names></name><article-title>Low plasma N-3 fatty acids and dementia in older persons: the InCHIANTI study</article-title><source>J Gerontol A Biol Sci Med Sci</source><year>2007</year><volume>62</volume><fpage>1120</fpage><lpage>1126</lpage><pub-id pub-id-type="pmid">17921425</pub-id></mixed-citation></ref><ref id="B245"><mixed-citation publication-type="journal"><name><surname>Dullemeijer</surname><given-names>C</given-names></name><name><surname>Durga</surname><given-names>J</given-names></name><name><surname>Brouwer</surname><given-names>IA</given-names></name><name><surname>van de Rest</surname><given-names>O</given-names></name><name><surname>Kok</surname><given-names>FJ</given-names></name><name><surname>Brummer</surname><given-names>RJ</given-names></name><name><surname>van Boxtel</surname><given-names>MP</given-names></name><name><surname>Verhoef</surname><given-names>P</given-names></name><article-title>n 3 fatty acid proportions in plasma and cognitive performance in older adults</article-title><source>Am J Clin Nutr</source><year>2007</year><volume>86</volume><fpage>1479</fpage><lpage>1485</lpage><pub-id pub-id-type="pmid">17991662</pub-id></mixed-citation></ref><ref id="B246"><mixed-citation publication-type="journal"><name><surname>Beydoun</surname><given-names>MA</given-names></name><name><surname>Kaufman</surname><given-names>JS</given-names></name><name><surname>Sloane</surname><given-names>PD</given-names></name><name><surname>Heiss</surname><given-names>G</given-names></name><name><surname>Ibrahim</surname><given-names>J</given-names></name><article-title>n-3 Fatty acids, hypertension and risk of cognitive decline among older adults in the atherosclerosis risk in communities (ARIC) study</article-title><source>Public Health Nutr</source><year>2008</year><volume>11</volume><fpage>17</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">17625029</pub-id></mixed-citation></ref><ref id="B247"><mixed-citation publication-type="journal"><name><surname>Eskelinen</surname><given-names>MH</given-names></name><name><surname>Ngandu</surname><given-names>T</given-names></name><name><surname>Helkala</surname><given-names>EL</given-names></name><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Nissinen</surname><given-names>A</given-names></name><name><surname>Soininen</surname><given-names>H</given-names></name><name><surname>Kivipelto</surname><given-names>M</given-names></name><article-title>Fat intake at midlife and cognitive impairment later in life: a population-based CAIDE study</article-title><source>Int J Geriatr Psychiatry</source><year>2008</year><volume>23</volume><fpage>741</fpage><lpage>747</lpage><pub-id pub-id-type="pmid">18188871</pub-id></mixed-citation></ref><ref id="B248"><mixed-citation publication-type="journal"><name><surname>Samieri</surname><given-names>C</given-names></name><name><surname>Feart</surname><given-names>C</given-names></name><name><surname>Letenneur</surname><given-names>L</given-names></name><name><surname>Dartigues</surname><given-names>JF</given-names></name><name><surname>Peres</surname><given-names>K</given-names></name><name><surname>Auriacombe</surname><given-names>S</given-names></name><name><surname>Peuchant</surname><given-names>E</given-names></name><name><surname>Delcourt</surname><given-names>C</given-names></name><name><surname>Barberger-Gateau</surname><given-names>P</given-names></name><article-title>Low plasma eicosapentaenoic acid and depressive symptomatology are independent predictors of dementia risk</article-title><source>Am J Clin Nutr</source><year>2008</year><volume>88</volume><fpage>714</fpage><lpage>721</lpage><pub-id pub-id-type="pmid">18779288</pub-id></mixed-citation></ref><ref id="B249"><mixed-citation publication-type="journal"><name><surname>Albanese</surname><given-names>E</given-names></name><name><surname>Dangour</surname><given-names>AD</given-names></name><name><surname>Uauy</surname><given-names>R</given-names></name><name><surname>Acosta</surname><given-names>D</given-names></name><name><surname>Guerra</surname><given-names>M</given-names></name><name><surname>Guerra</surname><given-names>SS</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Jacob</surname><given-names>KS</given-names></name><name><surname>de Rodriguez</surname><given-names>JL</given-names></name><name><surname>Noriega</surname><given-names>LH</given-names></name><name><surname>Salas</surname><given-names>A</given-names></name><name><surname>Sosa</surname><given-names>AL</given-names></name><name><surname>Sousa</surname><given-names>RM</given-names></name><name><surname>Williams</surname><given-names>J</given-names></name><name><surname>Ferri</surname><given-names>CP</given-names></name><name><surname>Prince</surname><given-names>MJ</given-names></name><article-title>Dietary fish and meat intake and dementia in Latin America, China, and India: a 10/66 dementia research group population-based study</article-title><source>Am J Clin Nutr</source><year>2009</year><volume>90</volume><fpage>392</fpage><lpage>400</lpage><pub-id pub-id-type="pmid">19553298</pub-id></mixed-citation></ref><ref id="B250"><mixed-citation publication-type="journal"><name><surname>Devore</surname><given-names>EE</given-names></name><name><surname>Grodstein</surname><given-names>F</given-names></name><name><surname>van Rooij</surname><given-names>FJ</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Rosner</surname><given-names>B</given-names></name><name><surname>Stampfer</surname><given-names>MJ</given-names></name><name><surname>Witteman</surname><given-names>JC</given-names></name><name><surname>Breteler</surname><given-names>MM</given-names></name><article-title>Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk</article-title><source>Am J Clin Nutr</source><year>2009</year><volume>90</volume><fpage>170</fpage><lpage>176</lpage><pub-id pub-id-type="pmid">19474131</pub-id></mixed-citation></ref><ref id="B251"><mixed-citation publication-type="journal"><name><surname>Kroger</surname><given-names>E</given-names></name><name><surname>Verreault</surname><given-names>R</given-names></name><name><surname>Carmichael</surname><given-names>PH</given-names></name><name><surname>Lindsay</surname><given-names>J</given-names></name><name><surname>Julien</surname><given-names>P</given-names></name><name><surname>Dewailly</surname><given-names>E</given-names></name><name><surname>Ayotte</surname><given-names>P</given-names></name><name><surname>Laurin</surname><given-names>D</given-names></name><article-title>Omega-3 fatty acids and risk of dementia: the Canadian study of health and aging</article-title><source>Am J Clin Nutr</source><year>2009</year><volume>90</volume><fpage>184</fpage><lpage>192</lpage><pub-id pub-id-type="pmid">19474137</pub-id></mixed-citation></ref><ref id="B252"><mixed-citation publication-type="journal"><name><surname>van de Rest</surname><given-names>O</given-names></name><name><surname>Spiro</surname><given-names>A</given-names><suffix>3rd</suffix></name><name><surname>Krall-Kaye</surname><given-names>E</given-names></name><name><surname>Geleijnse</surname><given-names>JM</given-names></name><name><surname>de Groot</surname><given-names>LC</given-names></name><name><surname>Tucker</surname><given-names>KL</given-names></name><article-title>Intakes of (n-3) fatty acids and fatty fish are not associated with cognitive performance and 6-year cognitive change in men participating in the Veterans affairs normative aging study</article-title><source>J Nutr</source><year>2009</year><volume>139</volume><fpage>2329</fpage><lpage>2336</lpage><pub-id pub-id-type="pmid">19828689</pub-id></mixed-citation></ref><ref id="B253"><mixed-citation publication-type="journal"><name><surname>Vercambre</surname><given-names>MN</given-names></name><name><surname>Boutron-Ruault</surname><given-names>MC</given-names></name><name><surname>Ritchie</surname><given-names>K</given-names></name><name><surname>Clavel-Chapelon</surname><given-names>F</given-names></name><name><surname>Berr</surname><given-names>C</given-names></name><article-title>Long-term association of food and nutrient intakes with cognitive and functional decline: a 13-year follow-up study of elderly French women</article-title><source>Br J Nutr</source><year>2009</year><volume>102</volume><fpage>419</fpage><lpage>427</lpage><pub-id pub-id-type="pmid">19203415</pub-id></mixed-citation></ref><ref id="B254"><mixed-citation publication-type="journal"><name><surname>Gonzalez</surname><given-names>S</given-names></name><name><surname>Huerta</surname><given-names>JM</given-names></name><name><surname>Fernandez</surname><given-names>S</given-names></name><name><surname>Patterson</surname><given-names>AM</given-names></name><name><surname>Lasheras</surname><given-names>C</given-names></name><article-title>The relationship between dietary lipids and cognitive performance in an elderly population</article-title><source>Int J Food Sci Nutr</source><year>2010</year><volume>61</volume><fpage>217</fpage><lpage>225</lpage><pub-id pub-id-type="pmid">20001761</pub-id></mixed-citation></ref><ref id="B255"><mixed-citation publication-type="journal"><name><surname>Muldoon</surname><given-names>MF</given-names></name><name><surname>Ryan</surname><given-names>CM</given-names></name><name><surname>Sheu</surname><given-names>L</given-names></name><name><surname>Yao</surname><given-names>JK</given-names></name><name><surname>Conklin</surname><given-names>SM</given-names></name><name><surname>Manuck</surname><given-names>SB</given-names></name><article-title>Serum phospholipid docosahexaenonic acid is associated with cognitive functioning during middle adulthood</article-title><source>J Nutr</source><year>2010</year><volume>140</volume><fpage>848</fpage><lpage>853</lpage><pub-id pub-id-type="pmid">20181791</pub-id></mixed-citation></ref><ref id="B256"><mixed-citation publication-type="journal"><name><surname>Gao</surname><given-names>Q</given-names></name><name><surname>Niti</surname><given-names>M</given-names></name><name><surname>Feng</surname><given-names>L</given-names></name><name><surname>Yap</surname><given-names>KB</given-names></name><name><surname>Ng</surname><given-names>TP</given-names></name><article-title>Omega-3 polyunsaturated fatty acid supplements and cognitive decline: Singapore longitudinal aging studies</article-title><source>J Nutr Health Aging</source><year>2011</year><volume>15</volume><fpage>32</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">21267519</pub-id></mixed-citation></ref><ref id="B257"><mixed-citation publication-type="journal"><name><surname>Kesse-Guyot</surname><given-names>E</given-names></name><name><surname>Peneau</surname><given-names>S</given-names></name><name><surname>Ferry</surname><given-names>M</given-names></name><name><surname>Jeandel</surname><given-names>C</given-names></name><name><surname>Hercberg</surname><given-names>S</given-names></name><name><surname>Galan</surname><given-names>P</given-names></name><article-title>Thirteen-year prospective study between fish consumption, long-chain n-3 fatty acids intakes and cognitive function</article-title><source>J Nutr Health Aging</source><year>2011</year><volume>15</volume><fpage>115</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">21365164</pub-id></mixed-citation></ref><ref id="B258"><mixed-citation publication-type="journal"><name><surname>Samieri</surname><given-names>C</given-names></name><name><surname>Feart</surname><given-names>C</given-names></name><name><surname>Proust-Lima</surname><given-names>C</given-names></name><name><surname>Peuchant</surname><given-names>E</given-names></name><name><surname>Dartigues</surname><given-names>JF</given-names></name><name><surname>Amieva</surname><given-names>H</given-names></name><name><surname>Barberger-Gateau</surname><given-names>P</given-names></name><article-title>omega-3 fatty acids and cognitive decline: modulation by ApoEepsilon4 allele and depression</article-title><source>Neurobiol Aging</source><year>2011</year><volume>32</volume><fpage>2317</fpage><comment>e2313-2322</comment><pub-id pub-id-type="pmid">20570406</pub-id></mixed-citation></ref><ref id="B259"><mixed-citation publication-type="book"><name><surname>Thomson</surname><given-names>TM</given-names></name><source>Endnote X3</source><year>2010</year><publisher-name>Philadelphia, PA: Thomson Reuters</publisher-name></mixed-citation></ref><ref id="B260"><mixed-citation publication-type="book"><name><surname>Petitti</surname><given-names>DB</given-names></name><person-group person-group-type="editor">Petitti DB</person-group><article-title>Statistical methods in meat-analysis</article-title><source>Meta-analysis. Decision Analysis, and cost-effectiveness analysis</source><year>2000</year><edition>2000</edition><publisher-name>New York, NY: Oxford University Press</publisher-name></mixed-citation></ref><ref id="B261"><mixed-citation publication-type="journal"><name><surname>Hildebrandt</surname><given-names>M</given-names></name><name><surname>Bender</surname><given-names>R</given-names></name><name><surname>Gehrmann</surname><given-names>U</given-names></name><name><surname>Blettner</surname><given-names>M</given-names></name><article-title>Calculating confidence intervals for impact numbers</article-title><source>BMC Med Res Methodol</source><year>2006</year><volume>6</volume><fpage>32</fpage><pub-id pub-id-type="pmid">16836748</pub-id></mixed-citation></ref><ref id="B262"><mixed-citation publication-type="book"><name><surname>Egger</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>GD</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name><source>Systematic Reviews in heatlh care: Meta-analysis in context</source><year>2001</year><edition>2</edition><publisher-name>London. UK: the BMJ Publishing Group</publisher-name></mixed-citation></ref><ref id="B263"><mixed-citation publication-type="journal"><name><surname>Egger</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>GD</given-names></name><name><surname>Schneider</surname><given-names>M</given-names></name><name><surname>Minder</surname><given-names>C</given-names></name><article-title>Bias in meta-analysis detected by a simple, graphical test</article-title><source>BMJ</source><year>1997</year><volume>315</volume><fpage>629</fpage><lpage>634</lpage><pub-id pub-id-type="pmid">9310563</pub-id></mixed-citation></ref><ref id="B264"><mixed-citation publication-type="journal"><name><surname>Begg</surname><given-names>CB</given-names></name><name><surname>Mazumdar</surname><given-names>M</given-names></name><article-title>Operating characteristics of a rank correlation test for publication bias</article-title><source>Biometrics</source><year>1994</year><volume>50</volume><fpage>1088</fpage><lpage>1101</lpage><pub-id pub-id-type="pmid">7786990</pub-id></mixed-citation></ref><ref id="B265"><mixed-citation publication-type="journal"><name><surname>Egger</surname><given-names>M</given-names></name><name><surname>Davey Smith</surname><given-names>G</given-names></name><name><surname>Schneider</surname><given-names>M</given-names></name><name><surname>Minder</surname><given-names>C</given-names></name><name><surname>Davey Smith</surname><given-names>G</given-names></name><name><surname>Schneider</surname><given-names>M</given-names></name><name><surname>Minder</surname><given-names>C</given-names></name><article-title>Bias in meta-analysis detected by a simple, graphical test</article-title><source>BMJ</source><year>1997</year><volume>315</volume><fpage>629</fpage><lpage>634</lpage><pub-id pub-id-type="pmid">9310563</pub-id></mixed-citation></ref><ref id="B266"><mixed-citation publication-type="book"><collab>STATA</collab><person-group person-group-type="editor">Editor ed</person-group><article-title>Statistics/Data Analysis: Release 11.0</article-title><source>Book Statistics/Data Analysis: Release 11.0</source><year>2009</year><publisher-name>City: Stata Corporation</publisher-name></mixed-citation></ref><ref id="B267"><mixed-citation publication-type="journal"><name><surname>Albert</surname><given-names>MS</given-names></name><article-title>How does education affect cognitive function?</article-title><source>Ann Epidemiol</source><year>1995</year><volume>5</volume><fpage>76</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">7728289</pub-id></mixed-citation></ref><ref id="B268"><mixed-citation publication-type="journal"><name><surname>Wilson</surname><given-names>RS</given-names></name><name><surname>Bennett</surname><given-names>DA</given-names></name><name><surname>Beckett</surname><given-names>LA</given-names></name><name><surname>Morris</surname><given-names>MC</given-names></name><name><surname>Gilley</surname><given-names>DW</given-names></name><name><surname>Bienias</surname><given-names>JL</given-names></name><name><surname>Scherr</surname><given-names>PA</given-names></name><name><surname>Evans</surname><given-names>DA</given-names></name><article-title>Cognitive activity in older persons from a geographically defined population</article-title><source>J Gerontol B Psychol Sci Soc Sci</source><year>1999</year><volume>54</volume><fpage>P155</fpage><lpage>160</lpage><pub-id pub-id-type="pmid">10363036</pub-id></mixed-citation></ref><ref id="B269"><mixed-citation publication-type="journal"><name><surname>Gorelick</surname><given-names>PB</given-names></name><name><surname>Sacco</surname><given-names>RL</given-names></name><name><surname>Smith</surname><given-names>DB</given-names></name><name><surname>Alberts</surname><given-names>M</given-names></name><name><surname>Mustone-Alexander</surname><given-names>L</given-names></name><name><surname>Rader</surname><given-names>D</given-names></name><name><surname>Ross</surname><given-names>JL</given-names></name><name><surname>Raps</surname><given-names>E</given-names></name><name><surname>Ozer</surname><given-names>MN</given-names></name><name><surname>Brass</surname><given-names>LM</given-names></name><name><surname>Malone</surname><given-names>ME</given-names></name><name><surname>Goldberg</surname><given-names>S</given-names></name><name><surname>Booss</surname><given-names>J</given-names></name><name><surname>Hanley</surname><given-names>DF</given-names></name><name><surname>Toole</surname><given-names>JF</given-names></name><name><surname>Greengold</surname><given-names>NL</given-names></name><name><surname>Rhew</surname><given-names>DC</given-names></name><article-title>Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association</article-title><source>JAMA</source><year>1999</year><volume>281</volume><fpage>1112</fpage><lpage>1120</lpage><pub-id pub-id-type="pmid">10188663</pub-id></mixed-citation></ref><ref id="B270"><mixed-citation publication-type="journal"><name><surname>Markesbery</surname><given-names>WR</given-names></name><name><surname>Carney</surname><given-names>JM</given-names></name><article-title>Oxidative alterations in Alzheimer's disease</article-title><source>Brain Pathol</source><year>1999</year><volume>9</volume><fpage>133</fpage><lpage>146</lpage><pub-id pub-id-type="pmid">9989456</pub-id></mixed-citation></ref><ref id="B271"><mixed-citation publication-type="book"><person-group person-group-type="editor">Kellar KJ, Wonnacott S</person-group><source>Nicotinic cholinergic receptors in Alzheimer's disease, in nicotine psychopharmacology: molecular, cellular, and behavioral aspects</source><year>1990</year><publisher-name>Oxford: Oxford University Press</publisher-name></mixed-citation></ref><ref id="B272"><mixed-citation publication-type="journal"><name><surname>Nordberg</surname><given-names>A</given-names></name><article-title>Biological markers and the cholinergic hypothesis in Alzheimer's disease</article-title><source>Acta Neurol Scand Suppl</source><year>1992</year><volume>139</volume><fpage>54</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">1414270</pub-id></mixed-citation></ref><ref id="B273"><mixed-citation publication-type="journal"><name><surname>Letenneur</surname><given-names>L</given-names></name><name><surname>Larrieu</surname><given-names>S</given-names></name><name><surname>Barberger-Gateau</surname><given-names>P</given-names></name><article-title>Alcohol and tobacco consumption as risk factors of dementia: a review of epidemiological studies</article-title><source>Biomed Pharmacother</source><year>2004</year><volume>58</volume><fpage>95</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">14992790</pub-id></mixed-citation></ref><ref id="B274"><mixed-citation publication-type="journal"><name><surname>Rogers</surname><given-names>RL</given-names></name><name><surname>Meyer</surname><given-names>JS</given-names></name><name><surname>Mortel</surname><given-names>KF</given-names></name><article-title>After reaching retirement age physical activity sustains cerebral perfusion and cognition</article-title><source>J Am Geriatr Soc</source><year>1990</year><volume>38</volume><fpage>123</fpage><lpage>128</lpage><pub-id pub-id-type="pmid">2299115</pub-id></mixed-citation></ref><ref id="B275"><mixed-citation publication-type="journal"><name><surname>Dustman</surname><given-names>RE</given-names></name><name><surname>Ruhling</surname><given-names>RO</given-names></name><name><surname>Russell</surname><given-names>EM</given-names></name><name><surname>Shearer</surname><given-names>DE</given-names></name><name><surname>Bonekat</surname><given-names>HW</given-names></name><name><surname>Shigeoka</surname><given-names>JW</given-names></name><name><surname>Wood</surname><given-names>JS</given-names></name><name><surname>Bradford</surname><given-names>DC</given-names></name><article-title>Aerobic exercise training and improved neuropsychological function of older individuals</article-title><source>Neurobiol Aging</source><year>1984</year><volume>5</volume><fpage>35</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">6738784</pub-id></mixed-citation></ref><ref id="B276"><mixed-citation publication-type="journal"><name><surname>Spirduso</surname><given-names>WW</given-names></name><article-title>Physical fitness, aging, and psychomotor speed: a review</article-title><source>J Gerontol</source><year>1980</year><volume>35</volume><fpage>850</fpage><lpage>865</lpage><pub-id pub-id-type="pmid">7002994</pub-id></mixed-citation></ref><ref id="B277"><mixed-citation publication-type="journal"><name><surname>Gomez-Pinilla</surname><given-names>F</given-names></name><name><surname>Dao</surname><given-names>L</given-names></name><name><surname>So</surname><given-names>V</given-names></name><article-title>Physical exercise induces FGF-2 and its mRNA in the hippocampus</article-title><source>Brain Res</source><year>1997</year><volume>764</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">9295187</pub-id></mixed-citation></ref><ref id="B278"><mixed-citation publication-type="journal"><name><surname>Cotman</surname><given-names>CW</given-names></name><name><surname>Engesser-Cesar</surname><given-names>C</given-names></name><article-title>Exercise enhances and protects brain function</article-title><source>Exerc Sport Sci Rev</source><year>2002</year><volume>30</volume><fpage>75</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">11991541</pub-id></mixed-citation></ref><ref id="B279"><mixed-citation publication-type="journal"><name><surname>Pignatti</surname><given-names>F</given-names></name><name><surname>Rozzini</surname><given-names>R</given-names></name><name><surname>Trabucchi</surname><given-names>M</given-names></name><article-title>Physical activity and cognitive decline in elderly persons</article-title><source>Arch Intern Med</source><year>2002</year><volume>162</volume><fpage>361</fpage><lpage>362</lpage><pub-id pub-id-type="pmid">11822936</pub-id></mixed-citation></ref><ref id="B280"><mixed-citation publication-type="book"><name><surname>James</surname><given-names>JE</given-names></name><source>Caffeine &#x00026; health</source><year>1991</year><publisher-name>London, England: Academic</publisher-name></mixed-citation></ref><ref id="B281"><mixed-citation publication-type="journal"><name><surname>Battig</surname><given-names>K</given-names></name><name><surname>Buzzi</surname><given-names>R</given-names></name><article-title>Effect of coffee on the speed of subject-paced information processing</article-title><source>Neuropsychobiology</source><year>1986</year><volume>16</volume><fpage>126</fpage><lpage>130</lpage><pub-id pub-id-type="pmid">3587571</pub-id></mixed-citation></ref><ref id="B282"><mixed-citation publication-type="journal"><name><surname>Riedel</surname><given-names>W</given-names></name><name><surname>Hogervorst</surname><given-names>E</given-names></name><name><surname>Leboux</surname><given-names>R</given-names></name><name><surname>Verhey</surname><given-names>F</given-names></name><name><surname>van Praag</surname><given-names>H</given-names></name><name><surname>Jolles</surname><given-names>J</given-names></name><article-title>Caffeine attenuates scopolamine-induced memory impairment in humans</article-title><source>Psychopharmacology (Berl)</source><year>1995</year><volume>122</volume><fpage>158</fpage><lpage>168</lpage><pub-id pub-id-type="pmid">8848531</pub-id></mixed-citation></ref><ref id="B283"><mixed-citation publication-type="journal"><name><surname>Behl</surname><given-names>C</given-names></name><article-title>Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease</article-title><source>Cell Tissue Res</source><year>1997</year><volume>290</volume><fpage>471</fpage><lpage>480</lpage><pub-id pub-id-type="pmid">9369525</pub-id></mixed-citation></ref><ref id="B284"><mixed-citation publication-type="journal"><name><surname>Christen</surname><given-names>Y</given-names></name><article-title>Oxidative stress and Alzheimer disease</article-title><source>Am J Clin Nutr</source><year>2000</year><volume>71</volume><fpage>621S</fpage><lpage>629S</lpage><pub-id pub-id-type="pmid">10681270</pub-id></mixed-citation></ref><ref id="B285"><mixed-citation publication-type="journal"><name><surname>Grundman</surname><given-names>M</given-names></name><article-title>Vitamin E and Alzheimer disease: the basis for additional clinical trials</article-title><source>Am J Clin Nutr</source><year>2000</year><volume>71</volume><fpage>630S</fpage><lpage>636S</lpage><pub-id pub-id-type="pmid">10681271</pub-id></mixed-citation></ref><ref id="B286"><mixed-citation publication-type="journal"><name><surname>Refsum</surname><given-names>H</given-names></name><name><surname>Ueland</surname><given-names>PM</given-names></name><name><surname>Nygard</surname><given-names>O</given-names></name><name><surname>Vollset</surname><given-names>SE</given-names></name><article-title>Homocysteine and cardiovascular disease</article-title><source>Annu Rev Med</source><year>1998</year><volume>49</volume><fpage>31</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">9509248</pub-id></mixed-citation></ref><ref id="B287"><mixed-citation publication-type="journal"><name><surname>Garcia</surname><given-names>A</given-names></name><name><surname>Haron</surname><given-names>Y</given-names></name><name><surname>Pulman</surname><given-names>K</given-names></name><name><surname>Hua</surname><given-names>L</given-names></name><name><surname>Freedman</surname><given-names>M</given-names></name><article-title>Increases in homocysteine are related to worsening of stroop scores in healthy elderly persons: a prospective follow-up study</article-title><source>J Gerontol A Biol Sci Med Sci</source><year>2004</year><volume>59</volume><fpage>1323</fpage><lpage>1327</lpage><pub-id pub-id-type="pmid">15699533</pub-id></mixed-citation></ref><ref id="B288"><mixed-citation publication-type="journal"><name><surname>Teunissen</surname><given-names>CE</given-names></name><name><surname>Blom</surname><given-names>AH</given-names></name><name><surname>Van Boxtel</surname><given-names>MP</given-names></name><name><surname>Bosma</surname><given-names>H</given-names></name><name><surname>de Bruijn</surname><given-names>C</given-names></name><name><surname>Jolles</surname><given-names>J</given-names></name><name><surname>Wauters</surname><given-names>BA</given-names></name><name><surname>Steinbusch</surname><given-names>HW</given-names></name><name><surname>de Vente</surname><given-names>J</given-names></name><article-title>Homocysteine: a marker for cognitive performance? A longitudinal follow-up study</article-title><source>J Nutr Health Aging</source><year>2003</year><volume>7</volume><fpage>153</fpage><lpage>159</lpage><pub-id pub-id-type="pmid">12766792</pub-id></mixed-citation></ref><ref id="B289"><mixed-citation publication-type="journal"><name><surname>Scott</surname><given-names>TM</given-names></name><name><surname>Tucker</surname><given-names>KL</given-names></name><name><surname>Bhadelia</surname><given-names>A</given-names></name><name><surname>Benjamin</surname><given-names>B</given-names></name><name><surname>Patz</surname><given-names>S</given-names></name><name><surname>Bhadelia</surname><given-names>R</given-names></name><name><surname>Liebson</surname><given-names>E</given-names></name><name><surname>Price</surname><given-names>LL</given-names></name><name><surname>Griffith</surname><given-names>J</given-names></name><name><surname>Rosenberg</surname><given-names>I</given-names></name><name><surname>Folstein</surname><given-names>MF</given-names></name><article-title>Homocysteine and B vitamins relate to brain volume and white-matter changes in geriatric patients with psychiatric disorders</article-title><source>Am J Geriatr Psychiatry</source><year>2004</year><volume>12</volume><fpage>631</fpage><lpage>638</lpage><pub-id pub-id-type="pmid">15545331</pub-id></mixed-citation></ref><ref id="B290"><mixed-citation publication-type="journal"><name><surname>Dufouil</surname><given-names>C</given-names></name><name><surname>Alperovitch</surname><given-names>A</given-names></name><name><surname>Ducros</surname><given-names>V</given-names></name><name><surname>Tzourio</surname><given-names>C</given-names></name><article-title>Homocysteine, white matter hyperintensities, and cognition in healthy elderly people</article-title><source>Ann Neurol</source><year>2003</year><volume>53</volume><fpage>214</fpage><lpage>221</lpage><pub-id pub-id-type="pmid">12557288</pub-id></mixed-citation></ref><ref id="B291"><mixed-citation publication-type="journal"><name><surname>Sachdev</surname><given-names>PS</given-names></name><name><surname>Valenzuela</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>XL</given-names></name><name><surname>Looi</surname><given-names>JC</given-names></name><name><surname>Brodaty</surname><given-names>H</given-names></name><article-title>Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals</article-title><source>Neurology</source><year>2002</year><volume>58</volume><fpage>1539</fpage><lpage>1541</lpage><pub-id pub-id-type="pmid">12034795</pub-id></mixed-citation></ref><ref id="B292"><mixed-citation publication-type="journal"><name><surname>Bleich</surname><given-names>S</given-names></name><name><surname>Kornhuber</surname><given-names>J</given-names></name><article-title>Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals</article-title><source>Neurology</source><year>2003</year><volume>60</volume><fpage>1220</fpage><comment>author reply 1220</comment><pub-id pub-id-type="pmid">12682348</pub-id></mixed-citation></ref><ref id="B293"><mixed-citation publication-type="journal"><name><surname>den Heijer</surname><given-names>T</given-names></name><name><surname>Vermeer</surname><given-names>SE</given-names></name><name><surname>Clarke</surname><given-names>R</given-names></name><name><surname>Oudkerk</surname><given-names>M</given-names></name><name><surname>Koudstaal</surname><given-names>PJ</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Breteler</surname><given-names>MM</given-names></name><article-title>Homocysteine and brain atrophy on MRI of non-demented elderly</article-title><source>Brain</source><year>2003</year><volume>126</volume><fpage>170</fpage><lpage>175</lpage><pub-id pub-id-type="pmid">12477704</pub-id></mixed-citation></ref><ref id="B294"><mixed-citation publication-type="journal"><name><surname>Bottiglieri</surname><given-names>T</given-names></name><article-title>Homocysteine and folate metabolism in depression</article-title><source>Prog Neuropsychopharmacol Biol Psychiatry</source><year>2005</year><volume>29</volume><fpage>1103</fpage><lpage>1112</lpage><pub-id pub-id-type="pmid">16109454</pub-id></mixed-citation></ref><ref id="B295"><mixed-citation publication-type="journal"><name><surname>Selhub</surname><given-names>J</given-names></name><name><surname>Jacques</surname><given-names>PF</given-names></name><name><surname>Wilson</surname><given-names>PW</given-names></name><name><surname>Rush</surname><given-names>D</given-names></name><name><surname>Rosenberg</surname><given-names>IH</given-names></name><article-title>Vitamin status and intake as primary determinants of homocysteinemia in an elderly population</article-title><source>JAMA</source><year>1993</year><volume>270</volume><fpage>2693</fpage><lpage>2698</lpage><pub-id pub-id-type="pmid">8133587</pub-id></mixed-citation></ref><ref id="B296"><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Cao</surname><given-names>D</given-names></name><name><surname>Desmond</surname><given-names>R</given-names></name><name><surname>Rahman</surname><given-names>A</given-names></name><name><surname>Lah</surname><given-names>JJ</given-names></name><name><surname>Levey</surname><given-names>AI</given-names></name><name><surname>Zamrini</surname><given-names>E</given-names></name><article-title>Cognitive performance and plasma levels of homocysteine, vitamin B12, folate and lipids in patients with Alzheimer disease</article-title><source>Dement Geriatr Cogn Disord</source><year>2008</year><volume>26</volume><fpage>384</fpage><lpage>390</lpage><pub-id pub-id-type="pmid">18931498</pub-id></mixed-citation></ref><ref id="B297"><mixed-citation publication-type="journal"><name><surname>Vidal</surname><given-names>JS</given-names></name><name><surname>Dufouil</surname><given-names>C</given-names></name><name><surname>Ducros</surname><given-names>V</given-names></name><name><surname>Tzourio</surname><given-names>C</given-names></name><article-title>Homocysteine, folate and cognition in a large community-based sample of elderly people&#x02013;the 3C Dijon Study</article-title><source>Neuroepidemiology</source><year>2008</year><volume>30</volume><fpage>207</fpage><lpage>214</lpage><pub-id pub-id-type="pmid">18424901</pub-id></mixed-citation></ref><ref id="B298"><mixed-citation publication-type="journal"><name><surname>Kruman</surname><given-names>II</given-names></name><name><surname>Culmsee</surname><given-names>C</given-names></name><name><surname>Chan</surname><given-names>SL</given-names></name><name><surname>Kruman</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Penix</surname><given-names>L</given-names></name><name><surname>Mattson</surname><given-names>MP</given-names></name><article-title>Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity</article-title><source>J Neurosci</source><year>2000</year><volume>20</volume><fpage>6920</fpage><lpage>6926</lpage><pub-id pub-id-type="pmid">10995836</pub-id></mixed-citation></ref><ref id="B299"><mixed-citation publication-type="journal"><name><surname>Parsons</surname><given-names>RB</given-names></name><name><surname>Waring</surname><given-names>RH</given-names></name><name><surname>Ramsden</surname><given-names>DB</given-names></name><name><surname>Williams</surname><given-names>AC</given-names></name><article-title>In vitro effect of the cysteine metabolites homocysteic acid, homocysteine and cysteic acid upon human neuronal cell lines</article-title><source>Neurotoxicology</source><year>1998</year><volume>19</volume><fpage>599</fpage><lpage>603</lpage><pub-id pub-id-type="pmid">9745917</pub-id></mixed-citation></ref><ref id="B300"><mixed-citation publication-type="journal"><name><surname>Arab</surname><given-names>L</given-names></name><article-title>Biomarkers of fat and fatty acid intake</article-title><source>J Nutr</source><year>2003</year><volume>133</volume><issue>Suppl 3</issue><fpage>925S</fpage><lpage>932S</lpage><pub-id pub-id-type="pmid">12612178</pub-id></mixed-citation></ref><ref id="B301"><mixed-citation publication-type="journal"><name><surname>Andreassi</surname><given-names>M</given-names></name><name><surname>Forleo</surname><given-names>P</given-names></name><name><surname>Di Lorio</surname><given-names>A</given-names></name><name><surname>Masci</surname><given-names>S</given-names></name><name><surname>Abate</surname><given-names>G</given-names></name><name><surname>Amerio</surname><given-names>P</given-names></name><article-title>Efficacy of gamma-linolenic acid in the treatment of patients with atopic dermatitis</article-title><source>J Int Med Res</source><year>1997</year><volume>25</volume><fpage>266</fpage><lpage>274</lpage><pub-id pub-id-type="pmid">9364289</pub-id></mixed-citation></ref><ref id="B302"><mixed-citation publication-type="journal"><name><surname>Cerolini</surname><given-names>S</given-names></name><name><surname>Kelso</surname><given-names>KA</given-names></name><name><surname>Noble</surname><given-names>RC</given-names></name><name><surname>Speake</surname><given-names>BK</given-names></name><name><surname>Pizzi</surname><given-names>F</given-names></name><name><surname>Cavalchini</surname><given-names>LG</given-names></name><article-title>Relationship between spermatozoan lipid composition and fertility during aging of chickens</article-title><source>Biol Reprod</source><year>1997</year><volume>57</volume><fpage>976</fpage><lpage>980</lpage><pub-id pub-id-type="pmid">9369160</pub-id></mixed-citation></ref><ref id="B303"><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>L</given-names></name><article-title>The effects of essential fatty acids preparation in the treatment of intrauterine growth retardation</article-title><source>Am J Perinatol</source><year>1997</year><volume>14</volume><fpage>535</fpage><lpage>537</lpage><pub-id pub-id-type="pmid">9394162</pub-id></mixed-citation></ref><ref id="B304"><mixed-citation publication-type="journal"><name><surname>Bjerve</surname><given-names>KS</given-names></name><article-title>Omega 3 fatty acid deficiency in man: implications for the requirement of alpha-linolenic acid and long-chain omega 3 fatty acids</article-title><source>World Rev Nutr Diet</source><year>1991</year><volume>66</volume><fpage>133</fpage><lpage>142</lpage><pub-id pub-id-type="pmid">1675825</pub-id></mixed-citation></ref><ref id="B305"><mixed-citation publication-type="journal"><name><surname>Wainwright</surname><given-names>PE</given-names></name><article-title>Dietary essential fatty acids and brain function: a developmental perspective on mechanisms</article-title><source>Proc Nutr Soc</source><year>2002</year><volume>61</volume><fpage>61</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">12002796</pub-id></mixed-citation></ref><ref id="B306"><mixed-citation publication-type="journal"><name><surname>Haag</surname><given-names>M</given-names></name><article-title>Essential fatty acids and the brain</article-title><source>Can J Psychiatry</source><year>2003</year><volume>48</volume><fpage>195</fpage><lpage>203</lpage><pub-id pub-id-type="pmid">12728744</pub-id></mixed-citation></ref><ref id="B307"><mixed-citation publication-type="journal"><name><surname>de Wilde</surname><given-names>MC</given-names></name><name><surname>Hogyes</surname><given-names>E</given-names></name><name><surname>Kiliaan</surname><given-names>AJ</given-names></name><name><surname>Farkas</surname><given-names>T</given-names></name><name><surname>Luiten</surname><given-names>PG</given-names></name><name><surname>Farkas</surname><given-names>E</given-names></name><article-title>Dietary fatty acids alter blood pressure, behavior and brain membrane composition of hypertensive rats</article-title><source>Brain Res</source><year>2003</year><volume>988</volume><fpage>9</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">14519522</pub-id></mixed-citation></ref></ref-list></back></article>